You are on page 1of 91

List of European Pharmacopoeia Reference Standards Effective from 2017/2/5

Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
New Y0001916 Teriparatide 1 1 mg 1 see leaflet 2829 Yes -20C 5C 79
Y0001561 Abacavir sulfate 1 20 mg 1 2589 Yes +5C 3C 79
Y0001552 Abacavir for peak identification 1 10 mg 1 2589 Yes +5C 3C 79
Y0001551 Abacavir for system suitability 1 10 mg 1 2589 Yes +5C 3C 79
Y0000055 Acamprosate calcium - reference spectrum 1 n/a 1 1585 79
Y0000116 Acamprosate impurity A 2 110 mg 1 3-aminopropane-1-sulfonic acid (homotaurine) ; Batch 1 is valid until 31 1585 Yes +5C 3C 79
January 2017
Y0000500 Acarbose 3 100 mg 1 See leaflet 2089 Yes +5C 3C 79
Y0000354 Acarbose for identification 1 10 mg 1 2089 Yes +5C 3C 79
New Y0000427 Acarbose for peak identification 4 20 mg 1 Batch 3 is valid until 31 May 2017 2089 Yes +5C 3C 79
A0040000 Acebutolol hydrochloride 1 50 mg 1 0871 Yes +5C 3C 79
Y0000359 Acebutolol impurity B 2 10 mg 1 N-[3-acetyl-4-[(2RS)-2-hydroxy-3-[(1-methylethyl)amino] propoxy] 0871 Yes +5C 3C 79
phenyl]acetamide (diacetolol)
Y0000127 Acebutolol impurity C 1 20 mg 1 N-(3-acetyl-4-hydroxyphenyl)butanamide 0871 Yes +5C 3C 79
Y0000128 Acebutolol impurity I 2 0.004 mg 1 N-[3-acetyl-4-[(2RS)-3-(ethylamino)-2-hydroxypropoxy]phenyl]butanamide 0871 Yes +5C 3C 79
Y0000056 Aceclofenac - reference spectrum 1 n/a 1 1281 79
Y0000085 Aceclofenac impurity F 2 15 mg 1 benzyl[[[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]acetate (benzyl 1281 Yes +5C 3C 79
ester of aceclofenac)
Y0000086 Aceclofenac impurity H 1 10 mg 1 [[[[[[[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]acetyl] oxy]acetyl]oxy] 1281 Yes +5C 3C 79
acetic acid (diacetic aceclofenac)
Y0001094 Aceclofenac for peak identification 1 10 mg 1 1281 Yes +5C 3C 79
Y0000810 Acemetacin 1 100 mg 1 1686 Yes +5C 3C 79
Y0000811 Acemetacin impurity A 1 10 mg 1 4-chlorobenzoic acid 1686 Yes +5C 3C 79
Y0000842 Acemetacin impurity mixture 1 0.06 mg 1 1686 Yes +5C 3C 79
A0070000 Acesulfame potassium 2 50 mg 1 1282 Yes +5C 3C 79
A0070020 Acesulfame potassium impurity B 4 15 mg 1 see leaflet; 5-chloro-6-methyl-1,2,3-oxathiazin-4(3)-one 2,2-dioxide 1282 Yes +5C 3C 79
A0100000 Acetazolamide 1 100 mg 1 0454 Yes +5C 3C 79
Y0001084 Acetazolamide for system suitability 2 0.0068 mg 1 0454 Yes +5C 3C 79
Y0000002 Acetylcholine chloride 1 50 mg 1 1485,1971 Yes -20C 5C 79
A0150000 Acetylcysteine 3 50 mg 1 0967 Yes +5C 3C 79
A0152000 Acetylcysteine impurity C 11 10 mg 1 (2R,2'R)-3,3'-disulfanediylbis[2-(acetylamino)propanoic acid] (N,N'-diacetyl- 0967 Yes +5C 3C 79
L-cystine)
; Batch 9 is valid until 31 July 2016
New A0153000 Acetylcysteine impurity D 7 10 mg 1 (2R)-2-(acetylamino)-3-(acetylsulfanyl)propanoic acid (N,S-diacetyl-L- 0967 Yes +5C 3C 79
cysteine)
; Batch 6 is valid until 31 May 2017
Y0000565 -Acetyldigoxin 2 50 mg 1 See leaflet CHO 2168 Yes +5C 3C 79
Y0000642 -Acetyldigoxin for peak identification 1 10 mg 1 2168 Yes +5C 3C 79

Council of Europe, all rights reserved 2017 1 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
A0200000 Acetylsalicylic acid 5 10 mg 1 Batch 4 is valid until 31 December 2016 0309 Yes +5C 3C 79
Y0001460 Acetylsalicylic acid for peak identification 3 10.3 mg 1 Batch 2 is valid until 31 December 2016 0309 Yes +5C 3C 79
Y0001462 Acetylsulfadiazine 1 0.002 mg 1 0294 Yes +5C 3C 79
A0208000 N-Acetyltryptophan 2 125 mg 1 1383 Yes +5C 3C 79
A0202000 N-Acetyltyrosine 1 200 mg 1 1384 Yes +5C 3C 79
Y0000693 Acholeplasma laidlawii BRP 1 1 ml 1 20607 Yes -80C 10C 120
A0220000 Aciclovir 3 75 mg 1 0968 Yes +5C 3C 79
Y0001271 Aciclovir for peak identification 1 4 0.3 mg 1 Batch 3 is valid until 31 July 2016 0968 Yes +5C 3C 79
Y0001269 Aciclovir for peak identification 2 4 0.004 mg 1 Batch 3 is valid until 31 August 2016 0968 Yes +5C 3C 79
Y0001264 Aciclovir for system suitability 1 10 mg 1 0968 Yes +5C 3C 79
A0225000 Acitretin 2 100 mg 1 See leaflet CHO 1385 Yes +5C 3C 79
Y0001463 Actaea racemosa HRS 1 1200 mg 1 2069 Yes +5C 3C 79
Y0001543 Actaea racemosa for assay CRS 1 300 mg 1 See leaflet CHNO; Monoammonium glycyrrhizate 2069 Yes +5C 3C 79
Y0001464 Actaea racemosa dry extract for system suitability HRS 1 1200 mg 1 2069 Yes -20C 5C 79
Y0001121 Adapalene 1 100 mg 1 See leaflet CHO 2445 Yes +5C 3C 79
Y0001120 Adapalene impurity C 3 6 mg 1 1-(2-methoxyphenyl)tricyclo[3.3.1.1]decane 2445 Yes +5C 3C 79
Y0001119 Adapalene for peak identification 2 2.02 mg 1 Batch 1 is valid until 31 March 2016 2445 Yes +5C 3C 79
A0230000 Adenine 2 50 mg 1 0800 Yes +5C 3C 79
A0230200 Adenosine 1 50 mg 1 1486 Yes +5C 3C 79
Y0000110 Adipic acid 1 50 mg 1 1586 Yes +5C 3C 79
Y0000882 Adrenaline 1 5 mg 1 2303 Yes +5C 3C 79
Y0000740 Adrenaline impurity mixture 3 0.005 mg 1 0254,2303 Yes +5C 3C 79
Y0000883 Adrenaline with impurity F 1 10 mg 1 2303 Yes +5C 3C 79
A0300000 Adrenaline tartrate 6 100 mg 1 Batch 5 is valid until 31 October 2016 0254 Yes +5C 3C 79
Y0000707 Adrenaline tartrate with impurity A 1 15 mg 1 0254 Yes +5C 3C 79
Y0001527 Aescin for LC assay HRS 1 150 mg 1 see leaflet CHO 1830,1829 Yes +5C 3C 79
Y0001724 Agnus castus fruit dry extract 1 350 mg 1 see leaflet 2309, 2147 Yes -20C 5C 79
A0325000 Alanine 3 60 mg 1 0752 Yes +5C 3C 79
A0325100 Albendazole 2 50 mg 1 1386 Yes +5C 3C 79
A0325200 Alcuronium chloride 2 50 mg 1 1285 Yes -20C 5C 79
A0325450 Alfacalcidol 9 5 mg 1 See leaflet 1286 Yes -20C 5C 300
Y0001601 Alfacalcidol for system suitability 1 2.5 mg 1 1286 Yes -20C 5C 79
A0325451 Alfacalcidol - reference spectrum 1 n/a 1 1286 79
A1225000 Alfadex 3 150 mg 1 See leaflet [CH0] 1070,1487 Yes +5C 3C 79
A0325500 Alfentanil hydrochloride - reference spectrum 1 n/a 1 1062 79
New Y0001883 Alfuzosin for peak identification 1 10 mg 1 1287 Yes +5C 3C 79

Council of Europe, all rights reserved 2017 2 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0000832 Alfuzosin for system suitability 1 10 mg 1 The reference standard Y0000832 will be deleted from monograph 1287 Yes +5C 3C 79
04/2008:1287 and replaced by the reference standard Y0001883 on
2017/04/01. ; Batch 1 is valid until 31 March 2017
New Y0001906 Alfuzosin for system suitability A 1 10 mg 1 1287 Yes +5C 3C 79
A0325800 Alfuzosin hydrochloride 2 10 mg 1 1287 Yes +5C 3C 79
Y0001583 Alimemazine hemitartrate 1 15 mg 1 2650 Yes +5C 3C 79
Y0001581 Alimemazine for system suitability 1 5 mg 1 2650 Yes +5C 3C 79
A0349000 Allantoin 1 60 mg 1 1288 Yes +5C 3C 79
A0350000 Allopurinol 3 100 mg 1 See leaflet 0576 Yes +5C 3C 79
A0350010 Allopurinol impurity A 2 10 mg 1 5-amino-1H-pyrazole-4-carboxamide 0576 Yes +5C 3C 79
A0350020 Allopurinol impurity B 3 10 mg 1 5-formylamino-1H-pyrazole-4-carboxamide 0576 Yes +5C 3C 79
A0350030 Allopurinol impurity C 3 10 mg 1 5-(4H-1,2,4-triazol-4-yl)-1H-pyrazole-4-carboxamide 0576 Yes +5C 3C 79
A0350040 Allopurinol impurity D 4 15 mg 1 ethyl 5-amino-1H-pyrazole-4-carboxylate 0576 Yes +5C 3C 79
A0350050 Allopurinol impurity E 1 20 mg 1 ethyl 5-(formylamino)-1H-pyrazole-4-carboxylate 0576 Yes +5C 3C 79
A0351000 Allylstrychnine bromide 1 10 mg 1 1285 Yes -20C 5C 79
Y0000235 Almagate 2 50 mg 1 See leaflet ; Batch 1 is valid until 1 March 2016 2010 Yes +5C 3C 79
Y0000255 Almagate - reference spectrum 1 n/a 1 2010 79
A0357000 Alprazolam - * psy 2 100 mg 1 1065 Yes +5C 3C 79
A0360000 Alprenolol hydrochloride 1 100 mg 1 0628,0876 Yes +5C 3C 79
Y0000054 Alprostadil 3 25 mg 1 See leaflet ; Batch 2 is valid until 31 July 2016 1488 Yes -20C 5C 79
Y0000606 Altizide 2 150 mg 1 See leaflet CHClNOS 0370,2185 Yes +5C 3C 79
Y0000843 Altizide impurity B 1 15 mg 1 3-[(2,2-dimethoxyethyl)sulphanyl]prop-1-ene 2185 Yes +5C 3C 79
Y0000687 Alverine citrate 1 5 mg 1 2156 Yes +5C 3C 79
Y0001819 Alverine impurity C 2 40 mg 1 N-ethyl-3-phenylpropan-1-amine ; Batch 1 is valid until 4 February 2017 2156 Yes -20C 5C 79
Y0000607 Alverine impurity D 1 10 mg 1 N-(3-cyclohexylpropyl)-N-ethyl-3-phenylpropan-1-amine 2156 Yes +5C 3C 79
A0363000 Amantadine hydrochloride 1 100 mg 1 0463 Yes +5C 3C 79
A0363700 Ambroxol hydrochloride 3 125 mg 1 1489 Yes +5C 3C 79
A0900000 Amfetamine sulfate - reference spectrum 1 n/a 1 0368 79
A0365000 Amidotrizoic acid dihydrate 1 100 mg 1 0873 Yes +5C 3C 79
Y0001461 Amidotrizoic acid for system suitability 1 0.08 mg 1 0873 Yes +5C 3C 79
A0368000 Amikacin 3 200 mg 1 See leaflet 1289,1290 Yes +5C 3C 79
Y0001467 Amikacin impurity I 1 20 mg 1 (2S)-4-amino-2-hydroxybutanoic acid 1289, 1290 Yes +5C 3C 79
Y0001117 Amikacin for system suitability 3 10 mg 1 Batch 2 is valid until 30 June 2016 1289,1290 Yes +5C 3C 79
A0365900 Amikacin sulfate 3 200 mg 1 The batch 3 is not suitable for use in the assay in monograph 1290:07/2014. 1290 Yes +5C 3C 79
Amikacin CRS A0368000 is also needed. See leaflet.
A0370000 Amiloride hydrochloride 2 100 mg 1 0651 Yes +5C 3C 79
Y0000020 Amiloride impurity A 3 20 mg 1 methyl-3,5-diamino-6-chloropyrazine-2-carboxylate 0651 Yes +5C 3C 79

Council of Europe, all rights reserved 2017 3 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0000173 4-Aminobenzoic acid 2 60 mg 1 1687 Yes +5C 3C 79
A0420000 Aminocaproic acid 1 50 mg 1 0874 Yes +5C 3C 79
A0460000 7-Aminodesacetoxycephalosporanic acid 2 20 mg 1 Cefadroxyl impurity B 0708,0813 Yes +5C 3C 79
A0496000 Aminoglutethimide 1 125 mg 1 1291 Yes +5C 3C 79
A0496005 Aminoglutethimide impurity A 1 20 mg 1 (3)-3-(3-aminophenyl)-3-ethylpiperidine-2,6-dione (3-aminoglutethimide) 1291 Yes +5C 3C 79
A0496020 Aminoglutethimide impurity D 1 10 mg 1 3,3'-[diazenediylbis(4,1-phenylene)]bis(3-ethylpiperidine-2,6-dione) 1291 Yes +5C 3C 79
(azoglutethimide)
A0575000 Amiodarone hydrochloride 3 100 mg 1 0803 Yes +5C 3C 79
Y0000129 Amiodarone impurity D 3 20 mg 1 (2-butylbenzofuran-3-yl)(4-hydroxy-3,5-diiodophenyl)methanone 0803 Yes +5C 3C 79
Y0000130 Amiodarone impurity E 3 20 mg 1 (2-butylbenzofuran-3-yl)(4-hydroxyphenyl)methanone 0803 Yes +5C 3C 79
A0590000 Amisulpride 2 10 mg 1 1490 Yes +5C 3C 79
Y0001534 Amisulpride for system suitability 1 1.0015 mg 1 1490 Yes +5C 3C 79
Y0000563 Amitriptyline hydrochloride 1 10 mg 1 0464 Yes +5C 3C 79
Y0000049 Amlodipine besilate 4 150 mg 1 See leaflet 1491 Yes +5C 3C 79
Y0001068 Amlodipine impurity A 3 15 mg 1 3-ethyl 5-methyl (4RS)-4-(2-chlorophenyl)-2-[[2-(1,3-dioxo-1,3-dihydro-2H- 1491 Yes +5C 3C 79
isoindol-2-yl)ethoxy]methyl]-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
Y0001069 Amlodipine impurity B 3 15 mg 1 3-ethyl 5-methyl (4RS)-4-(2-chlorophenyl)-6-methyl-2-[[2-[[2- 1491 Yes +5C 3C 79
(methylcarbamoyl)benzoyl]amino]ethoxy]methyl]-1,4-dihydropyridine-3,5-
dicarboxylate ; Batch 2 is valid until 31 December 2016
Y0001070 Amlodipine impurity G 3 10 mg 1 dimethyl 4-(2-chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5- 1491 Yes +5C 3C 79
dicarboxylate
Y0001067 Amlodipine for peak identification 3 15 mg 1 Batch 2 is valid until 30 November 2016 1491 Yes +5C 3C 79
Y0000302 Ammonio methacrylate copolymer(type A) - reference 1 n/a 1 2081 79
spectrum
Y0000303 Ammonio methacrylate copolymer(type B) - reference 1 n/a 1 2082 79
spectrum
A0650000 Amobarbital - * psy 1 500 mg 1 0594 Yes +5C 3C 79
A0700000 Amobarbital sodium - * psy 1 500 mg 1 0166 Yes +5C 3C 79
Y0001794 Amorolfine Hydrochloride 1 10 mg 1 2756 Yes +5C 3C 79
Y0001795 Amorolfine for system suitability 1 10 mg 1 2756 Yes +5C 3C 79
A0800000 Amoxicillin trihydrate 5 200 mg 1 See leaflet CHNOS 0167,0168,0 Yes +5C 3C 79
260,
0577,0578,0
813,
1140,1653
New Y0001521 Amoxicillin trihydrate for performance verification 2 5000 mg 1 See leaflet ; Batch 1 is valid until 30 April 2017 20232, Yes +5C 3C 79
20512,
Y0000005 Amphotericin B 5 100 mg 1 See leaflet 20532
1292 Yes -20C 5C 79
Y0001361 Amphotericin B for microbiological assay 1 100 mg 1 See leaflet 20702 Yes -20C 5C 79
Y0001014 Amphotericin B for peak identification 2 10 mg 1 1292 Yes -20C 5C 79
Council of Europe, all rights reserved 2017 4 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
A1000000 Ampicillin (anhydrous) 5 220 mg 1 See leaflet CHNOS 0167,0168,0 Yes +5C 3C 79
578,
1168,1169
A1100000 Ampicillin trihydrate 2 150 mg 1 0168,0260,0 Yes +5C 3C 79
577,
0578,0808,2
211, 2212
Y0001244 Amylmetacresol 1 285 mg 1 See leaflet CHO 2405 Yes +5C 3C 79
Y0001245 Amylmetacresol for peak identification 1 10 mg 1 2405 Yes +5C 3C 79
Y0001522 Anastrozole 1 100 mg 1 See leaflet CHN 2406 Yes +5C 3C 79
Y0001531 Anastrozole impurity E 1 10 mg 1 2,2'-[5-(hydroxymethyl)benzene-1,3-diyl]bis(2-methylpropanenitrile) 2406 Yes +5C 3C 79
Y0001870 Andrographis herb HRS 1 2050 mg 1 2712 Yes +5C 3C 79
Y0001866 Andrographolide 1 15 mg 1 see leaflet CHO 2712 Yes +5C 3C 79
Y0001753 Anemarrhena rhizome for system suitability HRS 1 150 mg 1 2661 Yes +5C 3C 79
Y0001386 Angelica dahurica root HRS 1 160 mg 1 2556 Yes +5C 3C 79
Y0001385 Angelica pubescens root 1 500 mg 1 2557 Yes +5C 3C 79
A1200000 Anhydrotetracycline hydrochloride 5 25 mg 1 See leaflet ; Batch 4 is valid until 28 February 2017 0210,0211,1 Yes +5C 3C 79
654
Y0001466 Anhydrous Docetaxel 1 15 mg 1 2593 Yes +5C 3C 79
A1210000 Antazoline hydrochloride 1 50 mg 1 0972 Yes +5C 3C 79
Y0001777 Apigenin 7-glucoside 1 25 mg 1 see leaflet CHO 0404 Yes +5C 3C 79
Y0001465 Apomorphine hydrochloride hemihydrate 1 15 mg 1 0136 Yes +5C 3C 79
Y0001471 Apomorphine impurity B (morphine sulfate) -* narc 1 40 mg 1 See leaflet; 7,8-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol 0136 Yes +5C 3C 90
(morphine)
Y0001825 Aprepitant 1 150 mg 1 see leaflet CHFNO 2757 Yes +5C 3C 79
Y0001826 Aprepitant for system suitability 1 15 mg 1 2757 Yes +5C 3C 79
Y0001154 Aprotinin for system suitability 1 2.7 mg 1 0580, 0579 Yes +5C 3C 79
A1250000 Aprotinin solution BRP 4 0.5 mL 1 See leaflet ; Batch 3 is valid until 28 February 2016 0579,0580 Yes +5C 3C 79
A1269000 L-Arabinitol 2 10 mg 1 Batch 1 is valid until 31 March 2016 1381 Yes +5C 3C 79
Y0000806 Arbutin 2 110 mg 1 See leaflet CHO ; Batch 1 is valid until 30 September 2016 1054 Yes +5C 3C 79
A1270000 Arginine 4 60 mg 1 See leaflet ; Batch 3 is valid until 30 April 2016 0806, 1654, Yes +5C 3C 79
2114, 2566
Y0000304 Arginine aspartate 1 20 mg 1 2096 Yes +5C 3C 79
A1271000 Arginine hydrochloride 3 60 mg 1 0805,0885 Yes +5C 3C 79
Y0001649 Aripiprazole 2 170 mg 1 See leaflet ; Batch 1 is valid until 31 March 2017 2617 Yes +5C 3C 79
Y0001650 Aripiprazole impurity F 2 15 mg 1 7-[4-[4-(2,3-dichlorophenyl)-1-oxidopiperazin-1-yl]butoxy]-3,4- 2617 Yes +5C 3C 79
dihydroquinolin-2(1H)-one
; Batch 1 is valid until 31 May 2016
Y0001323 Aristolochia 1 140 mg 1 See leaflet 20821 Yes +5C 3C 79
Council of Europe, all rights reserved 2017 5 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0001185 Aristolochic acid I 1 11 mg 1 See leaflet 20821 Yes +5C 3C 79
Y0001175 Aristolochic acid for system suitability 1 1 mg 1 20821 Yes +5C 3C 79
Y0000079 Articaine hydrochloride 3 200 mg 1 1688 Yes +5C 3C 79
Y0000080 Articaine impurity A 3 25 mg 1 methyl 4-methyl-3-[[2-(propylamino)acetyl]amino]thiophene-2-carboxylate 1688 Yes +5C 3C 79
(acetamidoarticaine)
Y0000081 Articaine impurity E 2 10 mg 1 methyl 4-methyl-3-[[(2RS)-2-[(1-methylethyl)amino]propanoyl]amino] 1688 Yes +5C 3C 79
thiophene-2-carboxylate (isopropylarticaine)
Y0001091 Artichoke leaf dry extract HRS 1 60 mg 1 2389 Yes -20C 5C 79
A1300000 Ascorbic acid 4 100 mg 1 Vitamin C 0253,0958,1 Yes +5C 3C 79
791
Y0001024 Ascorbic acid impurity C 3 20 mg 1 see leaflet CHO; L-xylo-hex-2-ulosonic acid (L-sorbosonic acid) 0253,1791 Yes +5C 3C 79
Y0001170 Ascorbic acid impurity D 2 10 mg 1 methyl L-xylo-hex-2-ulosonate (methyl L-sorbosonate) 0253,1791 Yes +5C 3C 79
Y0000800 Ascorbyl palmitate 1 10 mg 1 0807 Yes +5C 3C 79
Y0001206 Asiaticoside 1 40 mg 1 see leaflet CHO 1498 Yes +5C 3C 79
Y0000305 Asparagine monohydrate 2 60 mg 1 Batch 1 is valid until 31 January 2017 2086 Yes +5C 3C 79
A1320000 Aspartame 2 40 mg 1 0973 Yes +5C 3C 79
New A1321000 Aspartame impurity A 5 10 mg 1 2-[(2S,5S)-5-benzyl-3,6-dioxopiperazin-2-yl]acetic acid 0973 Yes +5C 3C 79
; Batch 4 is valid until 30 June 2017
A1330000 Aspartic acid 2 50 mg 1 0750,0797 Yes +5C 3C 79
Y0001171 Astragaloside IV 1 40 mg 1 See leaflet CHO 2435 Yes -20C 5C 79
A1340000 Atenolol 3 100 mg 1 0703 Yes +5C 3C 79
Y0001089 Atenolol for system suitability 2 5 mg 1 Batch 1 is valid until 31 October 2016 0703 Yes +5C 3C 79
Y0001586 Atomoxetine hydrochloride 1 110 mg 1 See leaflet CHClNO 2640 Yes +5C 3C 79
Y0001588 Atomoxetine impurity B 1 10 mg 1 (3S)-N-methyl-3-(2-methylphenoxy)-3-phenylpropan-1- 2640 Yes +5C 3C 79
amine
Y0001589 Atomoxetine impurity D 1 5 mg 1 (3R)-N-methyl-3-(3-methylphenoxy)-3-phenylpropan-1- 2640 Yes +5C 3C 79
amine
Y0001587 Atomoxetine for impurity A identification 1 10 mg 1 N-methyl-3-phenoxy-3-phenylpropan-1-amine 2640 Yes +5C 3C 79
Y0001327 Atorvastatin calcium trihydrate 3 150 mg 1 See leaflet CHCaFNO ; Batch 2 is valid until 31 August 2016 2191 Yes +5C 3C 79
New Y0001328 Atorvastatin impurity A 3 5 mg 1 (3R,5R)-3,5-dihydroxy-7-[5-(1-methylethyl)-2,3-diphenyl-4- 2191 Yes +5C 3C 79
(phenylcarbamoyl)-1H-pyrrol-1-yl]heptanoic acid (desfluoroatorvastatin)
; Batch 2 is valid until 31 July 2017
New Y0001329 Atorvastatin impurity B 4 10 mg 1 (3RS,5SR)-7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4- 2191 Yes +5C 3C 79
(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid
; Batch 2 is valid until 31 October 2016
Batch 3 is valid until 30 June 2017
Y0001330 Atorvastatin impurity C 2 10 mg 1 (3R,5R)-7-[2,3-bis(4-fluorophenyl)-5-(1-methylethyl)-4- 2191 Yes +5C 3C 79
(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid
(fluoroatorvastatin)

Council of Europe, all rights reserved 2017 6 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0001331 Atorvastatin impurity D 4 5 mg 1 3-[(4-fluorophenyl)carbonyl]-2-(2-methylpropanoyl)-N,3-diphenyloxirane-2- 2191 Yes +5C 3C 79
carboxamide ; Batch 2 is valid until 31 October 2016
Batch 3 is valid until 30 April 2017
Y0001332 Atorvastatin impurity E 4 5 mg 1 (3S,5S)-7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4- 2191 Yes +5C 3C 79
(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid (ent-
atorvastatin)
; Batch 2 is valid until 31 August 2016
Batch 3 is valid until 4 May 2017
Y0001572 Atovaquone 1 270 mg 1 See leaflet CHClO 2192 Yes +5C 3C 79
Y0001573 Atovaquone for system suitability 1 10 mg 1 2192 Yes +5C 3C 79
Y0000424 Atracurium besilate 2 120 mg 1 see leaflet CHNOS 1970 Yes +5C 3C 79
Y0000503 Atracurium for impurity F identification 1 5 mg 1 1970 Yes +5C 3C 79
Y0000504 Atracurium for peak identification 1 5 mg 1 1970 Yes +5C 3C 79
Y0000878 Atropine 1 30 mg 1 2056 Yes +5C 3C 79
Y0000816 Atropine impurity B 2 10 mg 1 (1R,3r,5S)-8-azabicyclo[3.2.1]oct-3-yl (2RS)-3-hydroxy-2-phenylpropanoate 0068,2056 Yes +5C 3C 79
(noratropine) ; Batch 1 is valid until 31 December 2016
Y0000845 Atropine for peak identification 2 0.25 mg 1 0068,2056 Yes +5C 3C 79
A1400000 Atropine sulfate 4 20 mg 1 0068 Yes +5C 3C 79
Y0000029 Azaperone 1 50 mg 1 1708 Yes +5C 3C 79
A1500000 Azathioprine 1 100 mg 1 0369 Yes +5C 3C 79
Y0001240 Azathioprine impurity A 1 10 mg 1 1-methyl-4-nitro-1H-imidazol-5-amine 0369 Yes +5C 3C 79
Y0001246 Azathioprine impurity G 2 5 mg 1 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)sulfanyl]-7H-purin-2-amine 0369 Yes +5C 3C 79
(thiamiprine)
Y0000326 Azelastine hydrochloride 1 25 mg 1 1633 Yes +5C 3C 79
Y0000327 Azelastine impurity B 1 5 mg 1 N'-[(4RS)-1-methylhexahydro-1H-azepin-4-yl]benzohydrazide 1633 Yes +5C 3C 79
Y0000328 Azelastine impurity D 1 5 mg 1 4-[(4-chlorophenyl)methyl]phthalazin-1(2H)-one 1633 Yes +5C 3C 79
Y0000329 Azelastine impurity E 1 5 mg 1 (3E)-3-[(4-chlorophenyl)methylidene]-2-benzofuran-1(3H)-one 1633 Yes +5C 3C 79
Y0000306 Azithromycin 4 200 mg 1 See leaflet CHNO 1649 Yes +5C 3C 79
Y0000307 Azithromycin impurity A 2 10 mg 1 6-demethylazithromycin 1649 Yes +5C 3C 79
Y0000637 Azithromycin for peak identification 3 15 mg 1 1649 Yes +5C 3C 79
New Y0000641 Azithromycin for system suitability 9 0.05 mg 1 Batch 7 is valid until 28 February 2016 1649 Yes +5C 3C 79
Batch 8 is valid until 30 June 2017
Y0000285 B19 virus DNA for NAT testing BRP 1 150 mg 5 See leaflet 0557, Yes -20C 5C 242
1527,1646
B0070000 Bacampicillin hydrochloride 3 120 mg 1 See leaflet CHClNOS 0808,0852 Yes +5C 3C 79
Y0001867 Bacitracin for system suitability 1 40 mg 1 0465,0466 Yes -20C 5C 79
B0100000 Bacitracin zinc 3 150 mg 1 See leaflet; The reference standard B0100000 will be deleted from the LC test 0465,0466,2 Yes -20C 5C 79
from monographs 04/2017:0465 and 04/2017:0466 on 2017/04/01 and 0702
replaced by the reference standard Y0001867.
B0200000 Baclofen 2 130 mg 1 Batch 1 is valid until 30 September 2016 0653 Yes +5C 3C 79
Council of Europe, all rights reserved 2017 7 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
B0200050 Baclofen impurity A 4 60 mg 1 (4RS)-4-(4-chlorophenyl)pyrrolidin-2-one 0653 Yes +5C 3C 79
Y0001273 Baicalin 1 10 mg 1 See leaflet CHO 2438 Yes +5C 3C 79
B0250000 Bambuterol hydrochloride 1 100 mg 1 1293 Yes +5C 3C 79
B0300000 Barbital - * psy 1 500 mg 1 0170 Yes +5C 3C 79
Y0001525 Basic butylated methacrylate copolymer 1 20 mg 1 1975 Yes +5C 3C 79
B0305000 Beclometasone dipropionate anhydrous 4 150 mg 1 See leaflet CHClO 0654,1449, Yes +5C 3C 79
1709
Y0000469 Beclometasone dipropionate for peak identification 2 10 mg 1 Batch 1 is valid until 30 November 2016 0654,1709 Yes +5C 3C 79
Y0000352 Beclometasone dipropionate for system suitability 3 15 mg 1 0654,1709 Yes +5C 3C 79
Y0001073 Beclometasone dipropionate impurities F and N 2 0.052 mg 1 0654,1709 Yes +5C 3C 79
Y0000351 Beclometasone dipropionate monohydrate 1 10 mg 1 1709 Yes +5C 3C 79
Y0001607 Belamcanda chinensis rhizome HRS 1 110 mg 1 2561 Yes +5C 3C 79
Y0001025 Benazepril hydrochloride 1 160 mg 1 See leaflet CHClNO 2388 Yes +5C 3C 79
Y0001026 Benazepril impurity A 2 10 mg 1 [(3R)-3-[[(1R)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2-oxo-2,3,4,5- 2388 Yes +5C 3C 79
tetrahydro-1H-1-benzazepin-1-yl]acetic acid
Y0001038 Benazepril for system suitability 2 0.016 mg 1 Batch 1 is valid until 30 April 2017 2388 Yes +5C 3C 79
B0400000 Bendroflumethiazide 1 100 mg 1 0370 Yes +5C 3C 79
Y0000564 Bendroflumethiazide impurity A 1 5 mg 1 4-amino-6-(trifluoromethyl)benzene-1,3-disulfonamide 0370 Yes +5C 3C 79
B0470000 Benperidol 1 100 mg 1 1010,1172,1 Yes +5C 3C 79
254, 1708
B0477000 Benserazide hydrochloride 1 50 mg 1 1173 Yes +5C 3C 79
B0477010 Benserazide impurity A 2 15 mg 1 (2RS)-2-amino-3-hydroxypropanohydrazide ; Batch 1 is valid until 31 May 1173 Yes +5C 3C 79
2016
Y0001071 Benserazide impurity C 1 10 mg 1 (2RS)-2-amino-3-hydroxy-2'-[(1EZ)-(2,3,4-trihydroxybenzylidene)] 1173 Yes +5C 3C 79
propanohydrazide
Y0001079 Benserazide for peak identification 1 10 mg 1 1173 Yes +5C 3C 79
Y0001064 Benzaldehyde 2 150 mg 1 Batch 1 is valid until 30 April 2016 0372,0371,1 Yes +5C 3C 79
740
Y0001060 Benzalkonium chloride for system suitability 4 20 mg 1 0371,0372 Yes +5C 3C 79
B0490000 Benzarone 1 10 mg 1 (2-ethylbenzofuran-3-yl)(4-hydroxyphenyl)methanone 1393 Yes +5C 3C 79
B0500000 Benzathine benzylpenicillin 2 200 mg 1 See leaflet 0373 Yes +5C 3C 79
Y0000775 Benzbromarone 1 10 mg 1 1393 Yes +5C 3C 79
B0550000 Benzethonium chloride 1 100 mg 1 0974 Yes +5C 3C 79
B0600000 Benzocaine 1 50 mg 1 0011,1088 Yes +5C 3C 79
Y0001470 Benzoic acid 1 30 mg 1 0934 Yes +5C 3C 79
Y0000647 Benzophenone 2 40 mg 1 1784 Yes +5C 3C 79
Y0000167 Benzyl alcohol 2 70 mg 1 See leaflet 0256,0371,0 Yes +5C 3C 79
372,1827

Council of Europe, all rights reserved 2017 8 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
B0670000 Benzyl benzoate - reference spectrum 1 n/a 1 0705 79
B0680000 S-Benzylmercaptoacetyltriglycine 1 10 mg 1 1372 Yes +5C 3C 79
New Y0001889 Benzylpenicillin for system suitability 1 10 mg 1 0113,0114 Yes +5C 3C 79
B0700000 Benzylpenicillin potassium 2 100 mg 1 0113,0148,0 Yes +5C 3C 79
149
B0900000 Benzylpenicillin sodium 7 200 mg 1 See leaflet CHNNaOS; The reference standard B0900000 will be deleted 0113,0114,0 Yes +5C 3C 79
from monographs 01/2008:0148 and 01/2008:0149 on 2017/04/01 and 148, 0149
replaced by the reference standard Y0001868. ; Batch 7 is valid until 31
March 2017
Y0001149 Berberine chloride 1 20 mg 1 See leaflet CHClNO 1831,2500, Yes +5C 3C 79
2715
B0950000 Betadex 4 200 mg 1 See leaflet [CHO] 1070,1487,1 Yes +5C 3C 79
804
Y0000391 Betahistine dihydrochloride 2 50 mg 1 1665 Yes +5C 3C 79
B0990000 Betahistine mesilate 2 50 mg 1 1071 Yes +5C 3C 79
B1000000 Betamethasone 5 60 mg 1 0312,0354,0 Yes +5C 3C 79
388, 0811
B1030000 Betamethasone acetate 2 100 mg 1 0548,0975 Yes +5C 3C 79
B1040000 Betamethasone dipropionate 4 200 mg 1 See leaflet CHFO ; Batch 3 is valid until 31 August 2016 0809 Yes +5C 3C 79
Y0001416 Betamethasone dipropionate for peak identification 1 10 mg 1 0809 Yes +5C 3C 79
Y0001418 Betamethasone dipropionate for system suitability 2 10 mg 1 Batch 1 is valid until 30 November 2016 0809 Yes +5C 3C 79
B1045000 Betamethasone sodium phosphate 4 100 mg 1 0549,0810 Yes +5C 3C 79
B1054000 Betamethasone 17-valerate 3 100 mg 1 0322,0811 Yes +5C 3C 79
B1055000 Betamethasone 21-valerate 3 15 mg 1 0811 Yes +5C 3C 79
Y0001027 Betamethasone valerate for system suitability 1 25 mg 1 0811 Yes +5C 3C 79
Y0001065 Betamethasone valerate impurity mixture 2 0.018 mg 1 0811 Yes +5C 3C 79
B1103000 Betaxolol hydrochloride 2 60 mg 1 1072 Yes +5C 3C 79
B1103100 Betaxolol impurity A 3 10 mg 1 (2RS)-1-(4-ethylphenoxy)-3-[(1-methylethyl)amino]propan-2-ol ; Batch 2 is 1072 Yes +5C 3C 79
valid until 28 February 2017
Y0001354 Betaxolol impurity C 1 5 mg 1 (2RS)-2-[[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]methyl]oxirane 1072 Yes -20C 5C 79
Y0001360 Betaxolol for peak identification 1 15 mg 1 1072 Yes +5C 3C 79
B1115000 Bezafibrate 1 100 mg 1 1394 Yes +5C 3C 79
Y0001444 Bicalutamide 1 100 mg 1 See leaflet CHFNOS 2196 Yes +5C 3C 79
Y0001448 Bicalutamide for system suitability 1 15 mg 1 2196 Yes +5C 3C 79
Y0001078 Bicisate labelling kit 1 24 mg 1 2123 Yes +5C 3C 79
B1110000 Bifonazole 2 50 mg 1 1395 Yes +5C 3C 79
Y0001421 Bifonazole for system suitability 1 10 mg 1 1395 Yes +5C 3C 79
Y0001788 Bilberry dry extract HRS 1 250 mg 1 see leaflet 2394,1588,1 Yes -20C 5C 79
602
Council of Europe, all rights reserved 2017 9 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
B1116000 Biotin 2 20 mg 1 Vitamin H 1073 Yes +5C 3C 79
B1120000 Biperiden hydrochloride 1 60 mg 1 1074 Yes +5C 3C 79
B1121000 Biperiden impurity A 2 20 mg 1 (1RS)-1-[(1SR,2SR,4SR)-bicyclo[2.2.1]hept-5-en-2-yl]-1-phenyl- 3- 1074 Yes +5C 3C 79
(piperidin-1-yl)propan-1-ol (endo form)
B1140000 Bisacodyl 3 50 mg 1 0595 Yes +5C 3C 79
Y0000608 Bisacodyl for peak identification 1 10 mg 1 0595 Yes +5C 3C 79
Y0000694 Bisacodyl for system suitability 2 5 mg 1 0595 Yes +5C 3C 79
Y0000812 Bisoprolol fumarate 1 50 mg 1 1710 Yes +5C 3C 79
Y0000877 Bisoprolol for peak identification 3 1.007 mg 1 Bisoprolol for system suitability method A CRS has been renamed as 1710 Yes +5C 3C 79
Bisoprolol for peak identification CRS.
Y0000813 Bisoprolol for system suitability 3 1.003 mg 1 Bisoprolol for system suitability method B CRS has been renamed as 1710 Yes +5C 3C 79
Bisoprolol for system suitability CRS
B1141000 Bleomycin sulfate 2 7 mg 1 See leaflet 0976,20702 Yes -20C 5C 79
Y0000434 Boldine 3 30 mg 1 See leaflet 1396, 1816 Yes +5C 3C 79
Y0001780 Boldo leaf dry extract HRS 1 550 mg 1 1816,1396 Yes -20C 5C 79
B1142000 Bordetella pertussis mouse antiserum BRP 1 0.5 mg 1 See leaflet See leaflet, Yes -20C 5C 90
20716
Y0001634 Brimonidine for system suitability 1 1.3 mg 1 2760 Yes +5C 3C 79
Y0001658 Brimonidine tartrate 1 5 mg 1 2760 Yes +5C 3C 79
B1143000 Bromazepam - * psy 4 60 mg 1 0778,0879 Yes +5C 3C 79
Y0000645 Bromazepam for system suitability - * psy 2 10 mg 1 0879 Yes +5C 3C 79
New B1145000 Bromhexine hydrochloride 4 200 mg 1 Batch 3 is valid until 31 March 2017 0706 Yes +5C 3C 79
Y0001757 Bromhexine for system suitability 1 15 mg 1 0706 Yes +5C 3C 79
B1150000 Bromocriptine mesilate 2 30 mg 1 0596 Yes -20C 5C 79
Y0000677 Bromocriptine mesilate for system suitability 1 5 mg 1 0596 Yes -20C 5C 79
B1152000 Bromperidol 1 100 mg 1 0616,1178 Yes +5C 3C 79
B1152050 Bromperidol decanoate 1 60 mg 1 1397,1431 Yes +5C 3C 79
B1153000 Brompheniramine maleate 1 100 mg 1 0977,1196 Yes +5C 3C 79
Y0000468 Brotizolam - * psy 1 10 mg 1 2197 Yes +5C 3C 79
Y0000470 Brotizolam impurity B 1 10 mg 1 2-bromo-4-(2-chlorophenyl)-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4] 2197 Yes +5C 3C 79
diazepine (desmethylbrotizolam)
Y0001196 Brucine 1 40 mg 1 see leaflet 2513,2514 Yes +5C 3C 79
B1157300 Budesonide 5 110 mg 1 See leaflet CHO ; Batch 4 is valid until 31 January 2017 1075 Yes +5C 3C 79
Y0001148 Budesonide for system suitability 1 10 mg 1 1075 Yes +5C 3C 79
B1156000 Bufexamac 1 100 mg 1 1179 Yes +5C 3C 79
Y0001729 Bufexamac impurity A 1 10 mg 1 2-(4-butoxyphenyl)acetic acid 1179 Yes +5C 3C 79
Y0001730 Bufexamac impurity B 1 15 mg 1 methyl 2-(4-butoxyphenyl)acetate 1179 Yes +5C 3C 79
B1157400 Buflomedil hydrochloride 2 100 mg 1 1398 Yes +5C 3C 79
Council of Europe, all rights reserved 2017 10 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0001731 Bufexamac impurity C 1 15 mg 1 butyl 2-(4-butoxyphenyl)acetate 1179 Yes +5C 3C 79
Y0001732 Bufexamac impurity D 1 10 mg 1 2-(4-butoxyphenyl)acetamide 1179 Yes +5C 3C 79
B1157410 Buflomedil impurity B 3 20 mg 1 1-(4-hydroxy-2,6-dimethoxyphenyl)-4-(pyrrolidin-1-yl)butan-1-one 1398 Yes +5C 3C 79
Y0001529 Buflomedil for peak identification 1 0.45 mg 1 1398 Yes +5C 3C 79
B1158000 Bumetanide 1 150 mg 1 1076 Yes +5C 3C 79
Y0000309 Bumetanide impurity A 1 5 mg 1 3-nitro-4-phenoxy-5-sulphamoylbenzoic acid 1076 Yes +5C 3C 79
Y0000310 Bumetanide impurity B 1 5 mg 1 3-amino-4-phenoxy-5-sulphamoylbenzoic acid 1076 Yes +5C 3C 79
B1160000 Bupivacaine hydrochloride 2 100 mg 1 0541, 2335 Yes +5C 3C 79
Y0000088 Bupivacaine impurity B 3 20 mg 1 (2RS)-N-(2,6-dimethylphenyl)piperidine-2-carboxamide 0541 Yes +5C 3C 79
Y0000089 Bupivacaine impurity E 3 20 mg 1 6-(butylamino)-N-(2,6-dimethylphenyl)hexanamide 0541 Yes +5C 3C 79
Y0001575 Bupivacaine impurity F 1 70 mg 1 2,6-dimethylaniline 0541 Yes +5C 3C 79
Y0001108 Buprenorphine - * psy 1 10 mg 1 1180 Yes +5C 3C 79
Y0001122 Buprenorphine for system suitability - * psy 2 10 mg 1 Batch 1 is valid until 31 October 2016 1180,1181 Yes +5C 3C 79
Y0001109 Buprenorphine hydrochloride - * psy 1 10 mg 1 1181 Yes +5C 3C 79
B1168000 Buserelin 2 2 mg 1 See leaflet CHNO 1077 Yes -20C 5C 79
Y0001814 Buserelin for NMR identification 1 2 mg 1 1077 Yes -20C 5C 79
Y0001740 Buserelin for peak identification 1 1 mg 1 1077 Yes -20C 5C 79
B1168020 D-His-Buserelin 2 0.5 mg 1 1077 Yes -20C 5C 79
Y0000131 Buspirone hydrochloride 1 5 mg 1 1711 Yes +5C 3C 79
Y0000471 Buspirone for system suitability 2 2.018 mg 1 1711 Yes +5C 3C 79
B1170000 Busulfan 3 50 mg 1 Batch 1 is valid until 30 September 2016 0542 Yes +5C 3C 79
Batch 2 is valid until 31 March 2017
Y0001487 Butyl methacrylate 1 100 mg 1 1975 Yes +5C 3C 79
Y0001304 Butyl methanesulfonate 1 30 L 1 20537,2053 Yes +5C 3C 79
8, 20539,
20540,2054
B1217000 Butyl parahydroxybenzoate 3 150 mg 1 See leaflet ; Batch 2 is valid until 31 December 2016 1
0881,1216 Yes +5C 3C 79
Y0001357 Butyl parahydroxybenzoate impurity E 1 15 mg 1 2-methylpropyl 4-hydroxybenzoate (iso-butyl parahydroxybenzoate) 0881 Yes +5C 3C 79
B1212000 Butylhydroxyanisole 4 60 mg 1 0880 Yes +5C 3C 79
B1215000 Butylhydroxytoluene 1 50 mg 1 Plastic additive 07 0581,30103, Yes +5C 3C 79
30105,3010
6, 30107
Y0000472 Cabergoline 2 160 mg 1 See leaflet 1773 Yes -20C 5C 79
C0100000 Caffeine 4 70 mg 1 See leaflet 0267,0268,1 Yes +5C 3C 79
504,2412
Y0000787 Caffeine for system suitability 4 10 mg 1 Batch 3 is valid until 31 August 2016 0267, 0268 Yes +5C 3C 79
New C0166000 Calcifediol 6 5 mg 1 See leaflet ; Batch 5 is valid until 30 June 2017 1295 Yes -20C 5C 150
C0166001 Calcifediol - reference spectrum 1 n/a 1 1295 79

Council of Europe, all rights reserved 2017 11 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0000499 Calcipotriol (anhydrous) - reference spectrum 1 n/a 1 2011 79
Y0000473 Calcipotriol monohydrate 2 10 mg 1 See leaflet CHO 2011,2284 Yes +5C 3C 79
Y0000474 Calcipotriol monohydrate - reference spectrum 1 n/a 1 2284 79
C0200000 Calcitonin (salmon) 11 1 mg 2 See leaflet 0471 Yes -20C 5C 79
Y0000632 Calcitonin-Gly 2 1 ml 1 About 0.9 mg per ml 0471 Yes -20C 5C 79
C0200010 N-acetyl-cys1-calcitonin 5 0.1 mg 1 See leaflet 0471 Yes -20C 5C 79
C0225000 Calcitriol 9 10 mg 1 See leaflet 0883 Yes -20C 5C 1000
C0226000 Calcitriol - reference spectrum 1 n/a 1 0883 79
C0249000 Calcium ascorbate - reference spectrum 1 n/a 1 1182 79
C0250000 Calcium folinate 6 130 mg 1 See leaflet 0978,1606 Yes +5C 3C 79
New C0299000 Calcium glucoheptonate 2 60 mg 1 Batch 1 is valid until 7 February 2017 1399 Yes +5C 3C 79
C0300000 Calcium gluconate 3 50 mg 1 Calcium digluconate ; Batch 2 is valid until 30 April 2017 0172,0658,0 Yes +5C 3C 79
979,1399,21
61,2162,216
4,2364
C0340000 Calcium levulinate dihydrate 1 250 mg 1 1296 Yes +5C 3C 79
C0350000 Calcium oxalate monohydrate 1 500 mg 1 See leaflet 20234 Yes +5C 3C 79
C0400000 Calcium pantothenate 4 50 mg 1 0470 Yes +5C 3C 79
C0405000 Camphor (racemic) 2 50 mg 1 0655,1400 Yes +5C 3C 79
Y0001388 Candesartan cilexetil 1 60 mg 1 2573 Yes +5C 3C 79
Y0001387 Candesartan cilexetil for peak identification 2 10 mg 1 Batch 1 is valid until 31 August 2016 2573 Yes +5C 3C 79
Y0001389 Candesartan cilexetil for system suitability 1 10 mg 1 2573 Yes +5C 3C 79
C0410000 Canrenone 4 15 mg 1 0688 Yes +5C 3C 79
Y0001858 Cape jasmine fruit for system suitability 1 260 mg 1 2565 Yes +5C 3C 79
Y0001642 Capecitabine 1 150 mg 1 See leaflet CHFNO 2762 Yes +5C 3C 79
Y0001643 Capecitabine impurity A 1 5 mg 1 4-amino-1-(5-deoxy--D-ribofuranosyl)-5-fluoropyrimidin-2(1H)-one (5- 2762 Yes +5C 3C 79
deoxy-5-fluorocytidine)
Y0001644 Capecitabine impurity B 1 5 mg 1 1-(5-deoxy--D-ribofuranosyl)-5-fluoropyrimidine-2,4(1H,3H)-dione (5- 2762 Yes +5C 3C 79
deoxy-5-fluorouridine)
Y0001645 Capecitabine impurity D 1 10 mg 1 (2RS)-2-methylbutyl [1-(5-deoxy--D-ribofuranosyl)-5-fluoro-2-oxo-1,2- 2762 Yes +5C 3C 79
dihydropyrimidin-4-yl]carbamate
C0426000 Caprylic acid 2 100 mg 1 1401,1471 Yes +5C 3C 79
Y0000671 Capsaicin 2 50 mg 1 See leaflet CHNO ; (E)-N-[(4-Hydroxy-3-methoxyphenyl)methyl]-8- 1859,2336,2 Yes +5C 3C 79
methylnon-6-enamide 337, 2529
C0430000 Captopril 2 10 mg 1 1079 Yes +5C 3C 79
Y0001219 Captopril impurity B 1 10 mg 1 See leaflet CHBrNO; (2S)1-[(2S)-3-bromo-2-methylpropanoyl] 1079 Yes +5C 3C 79
pyrrolidine-2-carboxylic acid

Council of Europe, all rights reserved 2017 12 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0001220 Captopril impurity C 1 10 mg 1 See leaflet CHOS; (2RS)-2-methyl-3-sulfanylpropanoic acid ; Batch 1 is 1079 Yes -20C 5C 79
valid until 21 January 2017
Y0001221 Captopril impurity D 1 10 mg 1 See leaflet CHBrO; (2RS)-3-bromo-2-methylpropanoic acid 1079 Yes +5C 3C 79
Y0000435 Captopril impurity E 1 10 mg 1 (2S)-1-(2-methylpropanoyl)pyrrolidine-2-carboxylic acid 1079 Yes +5C 3C 79
New Y0001450 Captopril impurity J 2 10 mg 1 See leaflet CHNOS; (2S)-1-[(2S)-3-(acetylsulfanyl)-2-methylpropanoyl] 1079 Yes +5C 3C 79
pyrrolidine-2-carboxylic acid (acetylcaptopril) ; Batch 1 is valid until 31 May
2017
Y0001182 Captopril for system suitability 2 20 mg 1 1079 Yes +5C 3C 79
Y0000113 Carbachol 1 50 mg 1 1971 Yes +5C 3C 79
C0450000 Carbamazepine 5 200 mg 1 See leaflet CHNO 0543 Yes +5C 3C 79
Y0000033 Carbamazepine impurity A 6 20 mg 1 10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide (10,11- 0543 Yes +5C 3C 79
dihydrocarbamazepine)
; Batch 5 is valid until 30 November 2016
C0451000 Carbasalate calcium - reference spectrum 1 n/a 1 1185 79
Y0001161 Carbasalate impurity B 1 5 mg 1 2-[[2-(acetyloxy)benzoyl]oxy]benzoic acid (acetylsalicylsalicylic acid) 1185 Yes +5C 3C 79
C0455000 Carbenicillin sodium 2 50 mg 1 0956 Yes -20C 5C 79
C0460000 Carbidopa 2 50 mg 1 0755 Yes +5C 3C 79
Y0001713 Carbidopa for system suitability 1 10 mg 1 0755 Yes +5C 3C 79
Y0001716 Carbidopa impurity mixture 1 0.008 mg 1 0755 Yes +5C 3C 79
C0465000 Carbimazole 2 120 mg 1 See leaflet CHNOS 0884 Yes +5C 3C 79
C0470000 Carbocisteine 2 60 mg 1 0885 Yes +5C 3C 79
C0499900 Carbon dioxide - reference spectrum 1 n/a 1 0375 79
C0550000 Carboplatin - reference spectrum 1 n/a 1 1081 79
Y0000475 Carboprost trometamol 1 40 mg 1 See leaflet CHNO 1712 Yes -20C 5C 79
Y0000536 Carboprost trometamol - reference spectrum 1 n/a 1 1712 79
Y0000035 Carisoprodol 1 50 mg 1 1689 Yes +5C 3C 79
Y0000036 Carisoprodol impurity A 2 10 mg 1 (2RS)-2-(hydroxymethyl)-2-methylpentyl(1-methylethyl)- 1689 Yes +5C 3C 79
carbamate
Y0001214 Carmellose 1 10 mg 1 2360 Yes +5C 3C 79
C0580004 Carmustine - reference spectrum 1 n/a 1 1187 79
C0580010 Carmustine impurity A 1 20 mg 1 1,3-bis(2-chloroethyl)urea 1187 Yes -20C 5C 79
Y0000846 Carprofen 1 30 mg 1 2201 Yes +5C 3C 79
Y0000884 Carprofen for system suitability 1 5 mg 1 2201 Yes +5C 3C 79
Y0000192 Carteolol hydrochloride - reference spectrum 1 n/a 1 1972 79
Y0000193 Carteolol for system suitability 1 30 mg 1 1972 Yes +5C 3C 79
Y0001427 Carvedilol 1 50 mg 1 1745 Yes +5C 3C 79
Y0000103 Carvedilol impurity C 2 15 mg 1 (2RS)-1-[benzyl[2-(2-methoxyphenoxy)ethyl]amino]-3-(9H- carbazol-4-yloxy) 1745 Yes +5C 3C 79
propan-2-ol

Council of Europe, all rights reserved 2017 13 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0001426 Carvedilol for system suitability 2 10 mg 1 1745 Yes +5C 3C 79
C0600000 Casein BRP 3 100000 mg 1 0350 Yes +5C 3C 131
C0630000 Cefaclor 3 450 mg 1 See leaflet CHClNOS 0986 Yes +5C 3C 79
C0640000 Delta-3-Cefaclor 4 20 mg 1 0986 Yes -20C 5C 79
C0650000 Cefadroxil 3 250 mg 1 see leaflet 0260,0577,0 Yes +5C 3C 79
813,2342
C0675000 Cefalexin monohydrate 4 150 mg 1 See leaflet 0708,0814 Yes +5C 3C 79
C0682000 Cefalotin sodium 3 170 mg 1 See leaflet 0987 Yes +5C 3C 79
Y0000505 Cefalotin for impurity B identification 1 10 mg 1 0987 Yes +5C 3C 79
C0682300 Cefamandole nafate 3 125 mg 1 See leaflet CHNNaOS 1402 Yes +5C 3C 79
Y0000240 Cefapirin sodium 2 100 mg 1 See leaflet CHNNaOS ; Batch 1 is valid until 31 October 2016 1650 Yes +5C 3C 79
C0682400 Cefatrizine propylene glycol 2 150 mg 1 see leaflet CHNOS 1403 Yes +5C 3C 79
C0682410 Cefatrizine impurity A 1 60 mg 1 acide (6R,7R)-7-amino-8-oxo-3-[[(1H-1,2,3-triazol-4-yl)sulfanyl]mthyl]-5- 1403 Yes +5C 3C 79
thia-1-azabicyclo[4.2.0]oct-2-ne-2-carboxylique (7-ACA triazole)
C0682800 Cefazolin 3 150 mg 1 See leaflet CHNOS 0988 Yes +5C 3C 79
Y0000633 Cefepime dihydrochloride monohydrate 3 150 mg 1 See leaflet ; Batch 2 is valid until 31 January 2017 2126 Yes +5C 3C 79
Y0001336 Cefepime impurity E 1 10 mg 1 (6R,7R)-7-amino-3-[(1-methylpyrrolidinio)methyl]-8-oxo-5- 2126 Yes -20C 5C 79
thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
Y0000634 Cefepime dihydrochloride monohydrate for system 2 15 mg 1 2126 Yes +5C 3C 79
suitability
New C0684000 Cefixime 4 200 mg 1 See leaflet CHNOS ; Batch 3 is valid until 30 June 2017 1188 Yes -20C 5C 79
C0684750 Cefoperazone dihydrate 2 100 mg 1 See leaflet CHNOS 1404 Yes +5C 3C 79
C0684800 Cefoperazone sodium - reference spectrum 1 n/a 1 1404 79
C0685000 Cefotaxime sodium 5 20 mg 1 0708,0989 Yes +5C 3C 79
Y0000420 Cefotaxime acid 2 20 mg 1 See leaflet CHNOS 0989 Yes +5C 3C 79
Y0000506 Cefotaxime for peak identification 1 10 mg 1 0989 Yes +5C 3C 79
C0688000 Cefoxitin sodium 3 100 mg 1 See leaflet CHNNaOS 0990 Yes +5C 3C 79
Y0001496 Cefoxitin for peak identification 1 15 mg 1 0990 Yes +5C 3C 79
Y0001305 Cefpodoxime proxetil 1 70 mg 1 See leaflet CHNOS 2341 Yes -20C 5C 79
Y0001318 Cefpodoxime proxetil for impurity H identification 1 10 mg 1 2341 Yes -20C 5C 79
Y0001306 Cefpodoxime proxetil for peak identification 1 10 mg 1 2341 Yes -20C 5C 79
Y0001371 Cefprozil 1 120 mg 1 See leaflet 2342 Yes +5C 3C 79
Y0001372 Cefprozil impurity A 1 20 mg 1 (2R)-2-amino-2-(4-hydroxyphenyl)acetic acid 2342 Yes +5C 3C 79
(p-hydroxyphenylglycine)
Y0001367 Cefprozil for peak identification 2 10 mg 1 Batch 1 is valid until 31 January 2017 2342 Yes +5C 3C 79
Y0001368 Cefprozil impurity mixture 2 10 mg 1 Batch 1 is valid until 30 April 2017 2342 Yes +5C 3C 79

Council of Europe, all rights reserved 2017 14 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
C0690000 Cefradine 4 300 mg 1 See leaflet 0167,0168,0 Yes +5C 3C 79
578,
0708,0814
Y0000568 Cefradine for peak identification 2 15 mg 1 0814 Yes +5C 3C 79
Y0001174 Cefradine impurity mixture 1 0.04 mg 1 0814 Yes +5C 3C 79
New C0690500 Ceftazidime 3 200 mg 1 See leaflet CHNOS ; Batch 2 is valid until 31 July 2017 1405, 2344 Yes +5C 3C 79
Y0001111 Ceftazidime for peak identification 2 13 mg 1 Batch 1 is valid until 30 November 2016 1405, 2344 Yes +5C 3C 79
C0691000 Ceftriaxone sodium 3 100 mg 1 See leaflet CHNNaOS 0991 Yes +5C 3C 79
C0692000 Ceftriaxone impurity A 4 10 mg 1 (6R,7R)-7-[[(2E)-(2-aminothiazol-4-yl)(methoxyimino)acetyl]amino]-3-[[(2- 0991 Yes +5C 3C 79
methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl]-8-
oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ((E)-isomer)
C0694990 Cefuroxime axetil 4 60 mg 1 See leaflet CHNOS 1300 Yes +5C 3C 79
C0695000 Cefuroxime sodium 4 70 mg 1 See leaflet CHNNaOS 0988,0992 Yes +5C 3C 79
Y0001445 Celecoxib 2 200 mg 1 See leaflet 2591 Yes +5C 3C 79
Y0001446 Celecoxib impurity A 2 10 mg 1 4-[5-(3-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl] 2591 Yes +5C 3C 79
benzenesulfonamide
Y0001447 Celecoxib impurity B 2 10 mg 1 4-[3-(4-methylphenyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl] 2591 Yes +5C 3C 79
benzenesulfonamide
Y0000311 Celiprolol hydrochloride 1 10 mg 1 1632 Yes +5C 3C 79
Y0000312 Celiprolol impurity I 1 0.02 mg 1 1-acetyl-1-(4-ethoxyphenyl)-3,3-diethylurea 1632 Yes +5C 3C 79
Y0000239 Celiprolol for peak identification 2 20 mg 1 1632 Yes +5C 3C 79
Y0000784 Cellulose acetate 1 40 mg 1 0887 Yes +5C 3C 79
Y0001585 Cellulose acetate butyrate 1 60 mg 1 1406 Yes +5C 3C 79
Y0001054 Cellulose acetate phthalate 1 10 mg 1 0314 Yes +5C 3C 79
Y0001764 Centella dry extract 1 150 mg 1 1498 Yes -20C 5C 79
C0700000 Cephaeline hydrochloride 4 15 mg 1 Batch 3 is valid until 31 March 2016 0081,0093, Yes +5C 3C 79
0094,1530,1
875
C0980650 Cetirizine dihydrochloride 4 100 mg 1 1084 Yes +5C 3C 79
C0980651 Cetirizine impurity A 5 10 mg 1 (RS)-1-[(4-chlorophenyl)phenylmethyl]piperazine 1084 Yes +5C 3C 79
Y0001197 Cetirizine for peak identification 2 1.01 mg 1 1084 Yes +5C 3C 79
C0984100 Cetostearyl isononanoate - reference spectrum 1 n/a 1 1085 79
C0990000 Cetyl alcohol 2 300 mg 1 See leaflet CHO 0540,0702,0 Yes +5C 3C 79
801,
0802,0847,0
969, 1411
Y0000073 Cetyl palmitate 15 1 60 mg 1 1906 Yes +5C 3C 79
New Y0000074 Cetyl palmitate 95 2 50 mg 1 Batch 1 is valid until 31 July 2017 1906 Yes +5C 3C 79
C1000000 Cetylpyridinium chloride 2 20 mg 1 0379 Yes +5C 3C 79

Council of Europe, all rights reserved 2017 15 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
C1050000 Chenodeoxycholic acid 3 125 mg 1 1189,1275 Yes +5C 3C 79
Y0000104 Chitosan hydrochloride 1 30 mg 1 1774 Yes +5C 3C 79
C1100000 Chlorambucil 1 100 mg 1 0137 Yes +5C 3C 79
Y0001298 Chlorambucil for system suitability 1 10 mg 1 0137 Yes +5C 3C 79
Y0001299 Chlorambucil with impurity G 1 10 mg 1 0137 Yes +5C 3C 79
New C1200000 Chloramphenicol 4 500 mg 1 Batch 3 is valid until 31 March 2017 0071,0473,0 Yes +5C 3C 79
709
C1300000 Chloramphenicol dipalmitate 1 100 mg 1 0473 Yes +5C 3C 79
C1350000 Chloramphenicol disodium disuccinate 3 25 mg 1 See leaflet CHClNNaO 0709 Yes +5C 3C 79
Y0001869 Chloramphenicol for peak identification 1 15 mg 1 0071 Yes +5C 3C 79
C1400000 Chloramphenicol palmitate isomer 1 100 mg 1 0473 Yes +5C 3C 79
C1425000 Chloramphenicol sodium succinate 2 30 mg 1 0709 Yes +5C 3C 79
C1435000 Chlorcyclizine hydrochloride 1 100 mg 1 1086 Yes +5C 3C 79
C1450000 Chlordiazepoxide - * psy 1 50 mg 2 0656,1974 Yes +5C 3C 79
C1500000 Chlordiazepoxide hydrochloride - * psy 1 100 mg 1 0474 Yes +5C 3C 79
Y0000476 Chlordiazepoxide impurity A 2 10 mg 1 7-chloro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one 4-oxide 0474,0656 Yes +5C 3C 79
C1510000 Chlorhexidine 4 50 mg 1 0658 Yes +5C 3C 79
C1520000 Chlorhexidine diacetate 2 10 mg 1 01/2015:0657 Yes +5C 3C 79
C1540000 Chlorhexidine dihydrochloride 2 50 mg 1 0659 Yes +5C 3C 79
Y0001545 Chlorhexidine for system suitability 1 15 mg 1 0658, 0657, Yes +5C 3C 79
0659
Y0001653 Chlormadinone acetate 1 120 mg 1 See leaflet 2702 Yes +5C 3C 79
Y0001656 Chlormadinone acetate impurity G 1 20 mg 1 3,20-dioxopregn-4-en-17-yl acetate 2702 Yes +5C 3C 79
Y0001638 Chlormadinone acetate for system suitability 1 10 mg 1 2702 Yes +5C 3C 79
Y0000569 Chlorogenic acid 2 25 mg 1 See leaflet CHO ; (1S,3R,4R,5R)-3-[(3,4-Dihydroxycinnamoyl)oxy]-1,4,5- 1821,1822,1 Yes +5C 3C 79
trihydroxycyclohexanecarboxylic acid 823,
1824,1866,1
897, 2389
C1650000 Chloroquine sulfate 3 200 mg 1 0544,0545 Yes +5C 3C 79
C1700000 Chlorothiazide 3 10 mg 1 0394 Yes +5C 3C 79
C1800000 Chlorphenamine maleate 2 20 mg 1 0386,0977,1 Yes +5C 3C 79
084, 1196
Y0000436 Chlorphenamine impurity A 4 0.01 mg 1 2-(4-chlorophenyl)-4-(dimethylamino)-2-[2-(dimethylamino) 0386 Yes +5C 3C 79
ethyl]butanenitrile
Y0000437 Chlorphenamine impurity C 2 10 mg 1 (3RS)-3-(4-chlorophenyl)-N-methyl-3-(pyridin-2-yl)propan-1-amine ; Batch 1 0386 Yes +5C 3C 79
is valid until 31 March 2016
C1900000 Chlorpromazine hydrochloride 1 200 mg 1 0475 Yes +5C 3C 79
Y0000507 Chlorpromazine impurity A 1 15 mg 1 3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1- 0475 Yes +5C 3C 79
amine S-oxide (chlorpromazine sulphoxide)
Council of Europe, all rights reserved 2017 16 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0000479 Chlorpromazine impurity D 1 10 mg 1 3-(2-chloro-10H-phenothiazin-10-yl)-N-methypropan-1-amine 0475 Yes +5C 3C 79
(desmethylchlorpromazine)
Y0000508 Chlorpromazine impurity E 1 10 mg 1 2-chloro-10H-phenothiazine 0475 Yes +5C 3C 79
Y0001449 Chlorpromazine impurity F 1 2 mg 1 3-(4-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine 0475 Yes +5C 3C 79
C1905000 Chlorpropamide 1 100 mg 1 1087 Yes +5C 3C 79
C1905020 Chlorpropamide impurity B 1 50 mg 1 1,3-Dipropylurea 1087 Yes +5C 3C 79
C1915000 Chlorprothixene hydrochloride 5 50 mg 1 See leaflet 0815,1365 Yes +5C 3C 79
C1950000 Chlortalidone 3 150 mg 1 See leaflet CHClNOS 0546 Yes +5C 3C 79
Y0000779 Chlortalidone for peak identification 3 1.017 mg 1 0546 Yes +5C 3C 79
C2000000 Chlortetracycline hydrochloride 5 100 mg 1 See leaflet 0173 Yes +5C 3C 79
Y0001451 Chlortetracycline for system suitability 2 10 mg 1 0173 Yes +5C 3C 79
C2100000 Cholecalciferol 9 500 mg 1 See leaflet; Vitamin D3 ; Batch 8 is valid until 28 February 2016 0072, 0574, Yes -20C 5C 79
0575, 0598,
1192, 1193,
2398
C2150000 Cholecalciferol for system suitability 7 1 mL 1 Batch 6 is valid until 31 May 2016 0072,0082,0 Yes -20C 5C 79
574,
0575,0598
C2155000 Cholesterol 4 100 mg 1 See leaflet 0593, 0993, Yes +5C 3C 79
2397
C2158000 Cholic acid 2 60 mg 1 1189 Yes +5C 3C 79
Y0000280 Chondroitin sulfate sodium 2 250 mg 1 See leaflet HO(CHNNaOS) 2064,2090 Yes +5C 3C 79
Y0000593 Chondroitin sulfate sodium (marine) 1 100 mg 1 2064 Yes +5C 3C 79
C2160000 Chymotrypsin BRP 2 100 mg 1 See leaflet 0476,0694 Yes +5C 3C 79
Y0001553 Ciclesonide 1 150 mg 1 See leaflet CHO 2703 Yes +5C 3C 79
Y0001554 Ciclesonide containing impurity A 1 15 mg 1 (2S)-2-cyclohexyl-11-hydroxy-3,20-dioxo-16H-[1,3]dioxolo[4,5:16,17] 2703 Yes +5C 3C 79
pregna-1,4-dien-21-yl 2-methylpropanoate (S-epimer of ciclesonide)
Y0001555 Ciclesonide impurity B 1 10 mg 1 (2'R)-2'-cyclohexyl-11,21-dihydroxy-16H-[1,3]dioxolo[4',5':16,17] 2703 Yes +5C 3C 79
pregna-1,4-diene-3,20-dione
Y0001556 Ciclesonide impurity C 1 10 mg 1 (2R)-2-[(1RS)-cyclohex-3-enyl]-11-hydroxy-3,20-dioxo-16H-[1,3] 2703 Yes +5C 3C 79
dioxolo[4,5:16,17]pregna-1,4-dien-21-yl 2-methylpropanoate
Y0000040 Ciclopirox 1 100 mg 1 1407 Yes +5C 3C 79
New C2162701 Ciclopirox impurity A 4 40 mg 1 [(5RS)-3-cyclohexyl-5-methyl-4,5-dihydro-1,2-oxazol-5-yl]acetic acid 1302,1407 Yes +5C 3C 79
; Batch 3 is valid until 31 July 2017
C2162702 Ciclopirox impurity B 3 20 mg 1 6-cyclohexyl-4-methyl-2H-pyran-2-one 1302,1407 Yes -20C 5C 79
C2162700 Ciclopirox olamine 2 150 mg 1 1302 Yes +5C 3C 79
C2163000 Ciclosporin 3 120 mg 1 See leaflet 0994 Yes +5C 3C 79
Y0000361 Ciclosporin for system suitability 1 5 mg 1 0994 Yes +5C 3C 79

Council of Europe, all rights reserved 2017 17 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
C2170000 Cilastatin sodium 2 10 mg 1 1408 Yes +5C 3C 79
Y0001651 Cilastatin for system suitability 1 1 5 mg 1 1408 Yes +5C 3C 79
Y0001652 Cilastatin for system suitability 2 1 5 mg 1 1408 Yes +5C 3C 79
C2174000 Cilazapril 1 50 mg 1 1499 Yes +5C 3C 79
C2174002 Cilazapril impurity A 1 25 mg 1 1,1-dimethylethyl (1S,9S)-9-[[(S)-1-(ethoxycarbonyl)-3-phenylpropyl] 1499 Yes +5C 3C 79
amino]-10-oxooctahydro-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxylate
C2174005 Cilazapril impurity D 1 10 mg 1 (1S,9S)-9-[[(R)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-10- 1499 Yes +5C 3C 79
oxooctahydro-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid
C2175000 Cimetidine 1 50 mg 1 0756 Yes +5C 3C 79
C2175500 Cimetidine hydrochloride 1 100 mg 1 1500 Yes +5C 3C 79
Y0001130 Cimetidine for peak identification 1 10 mg 1 0756, 1500 Yes +5C 3C 79
Y0001146 Cimetidine for system suitability 1 0.5085 mg 1 0756, 1500 Yes +5C 3C 79
C2177000 Cinchocaine hydrochloride 2 60 mg 1 1088 Yes +5C 3C 79
Y0000176 Cineole 2 180 mg 1 1973 Yes +5C 3C 79
C2180000 Cinnarizine 2 100 mg 1 0816 Yes +5C 3C 79
Y0000362 Ciprofibrate 1 5 mg 1 2013 Yes +5C 3C 79
Y0000363 Ciprofibrate for system suitability 1 5 mg 1 2013 Yes +5C 3C 79
Y0000198 Ciprofloxacin 1 20 mg 1 1089 Yes +5C 3C 79
C2190000 Ciprofloxacin hydrochloride 5 100 mg 1 See leaflet 0888,1353 Yes +5C 3C 79
Y0000199 Ciprofloxacin hydrochloride for peak identification 2 15 mg 1 0888,1089 Yes +5C 3C 79
C2190050 Ciprofloxacin impurity A 5 25 mg 1 7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid 0888,1089,2 Yes +5C 3C 79
(fluoroquinolonic acid) 229
; Batch 4 is valid until 31 December 2016
Y0001766 Cisatracurium besilate 1 170 mg 1 See leaflet 2763 Yes -20C 5C 79
Y0001768 Cisatracurium for peak identification 1 5 mg 1 2763 Yes -20C 5C 79
Y0001767 cisatracurium for system suitability 1 5 mg 1 2763 Yes -20C 5C 79
C2210000 Cisplatin 6 100 mg 1 See leaflet [PtCl(NH)] 0599 Yes +5C 3C 79
New Y0001018 Cisplatin impurity A 2 15 mg 1 trans-diamminedichloroplatinum(II) (transplatin), 0599 Yes +5C 3C 79
; Batch 1 is valid until 31 May 2017
Y0001019 Cisplatin impurity B 2 15 mg 1 See leaflet [PtCl(NH)]-; amminetrichloroplatinate(-) ; Batch 1 is valid until 30 0599 Yes +5C 3C 79
April 2016
Y0001008 Citalopram hydrobromide 1 5 mg 1 2288,2758,2 Yes +5C 3C 79
733
Y0001007 Citalopram hydrochloride 1 5 mg 1 2203 Yes +5C 3C 79
Y0000855 Citalopram for system suitability 3 0.065 mg 1 2203,2288 Yes +5C 3C 79
A1202000 Citric acid (anhydrous) 2 50 mg 1 0455 Yes +5C 3C 79
C2219000 Citric acid monohydrate 1 50 mg 1 0456 Yes +5C 3C 79
Y0000639 Cladribine 2 50 mg 1 See leaflet CHClNO ; Batch 1 is valid until 31 March 2016 2174 Yes +5C 3C 79

Council of Europe, all rights reserved 2017 18 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0000610 Cladribine impurity C 1 5 mg 1 2-chloro-7H-purin-6-amine (2-chloroadenine) 2174 Yes +5C 3C 79
Y0000609 Cladribine for peak identification 1 10 mg 1 2174 Yes +5C 3C 79
Y0000320 Clarithromycin 3 160 mg 1 See leaflet CHNO 1651 Yes +5C 3C 79
Y0000321 Clarithromycin for peak identification 2 40 mg 1 1651 Yes +5C 3C 79
Y0001193 Clazuril 1 10 mg 1 1714 Yes +5C 3C 79
Y0000269 Clazuril for system suitability 1 10 mg 1 1714 Yes +5C 3C 79
C2221000 Clebopride malate 1 100 mg 1 1303 Yes +5C 3C 79
C2223000 Clemastine fumarate 1 100 mg 1 1190 Yes +5C 3C 79
Y0001613 Clemastine for system suitability 1 0.165 mg 1 1190 Yes +5C 3C 79
C2248000 Clenbuterol hydrochloride 2 30 mg 1 1409 Yes +5C 3C 79
C2248010 Clenbuterol impurity B 2 10 mg 1 1-(4-amino-3,5-dichlorophenyl)-2-[(1,1-dimethylethyl)amino] ethanone 1409 Yes +5C 3C 79
C2250000 Clindamycin hydrochloride 5 200 mg 1 See leaflet ; Batch 4 is valid until 31 January 2017 0582 Yes +5C 3C 79
C2269000 Clindamycin phosphate 2 250 mg 1 see leaflet 0996 Yes +5C 3C 79
Y0001680 Clindamycin phosphate for system suitability 1 10 mg 1 0996 Yes +5C 3C 79
Y0000364 Clioquinol 1 5 mg 1 2111 Yes +5C 3C 79
Y0000205 Clobazam - reference spectrum 1 n/a 1 1974 79
Y0000241 Clobazam impurity A 1 10 mg 1 7-chloro-5-phenyl-1,5-dihydro-3H-1,5-benzodiazepine-2,4-dione 1974 Yes +5C 3C 79
Y0000559 Clobetasol propionate 2 50 mg 1 See leaflet CHClFO ; Batch 1 is valid until 31 December 2016 2127 Yes +5C 3C 79
Y0000571 Clobetasol impurity J 2 0.4 mg 1 (17R)-4'-chloro-5'-ethyl-9-fluoro-11-hydroxy-16-methylspiro 2127 Yes +5C 3C 79
[androsta-1,4-diene-17,2'(3'H)-furan]-3,3'-dione (17 alpha-spiro compound)
Y0000570 Clobetasol for peak identification 2 2 mg 1 2127 Yes +5C 3C 79
C2285000 Clobetasone butyrate 1 50 mg 1 1090 Yes +5C 3C 79
Y0001137 Clobetasone butyrate for system suitability 1 30 mg 1 1090 Yes +5C 3C 79
Y0000888 Clodronate disodium tetrahydrate 1 5 mg 1 1777 Yes +5C 3C 79
Y0000885 Clodronate impurity D 1 5 mg 1 (chloromethylene)bis(phosphonic acid) 1777 Yes +5C 3C 79
Y0000313 Clofazimine 1 150 mg 1 2054 Yes +5C 3C 79
Y0000358 Clofazimine for system suitability 1 10 mg 1 2054 Yes +5C 3C 79
C2300000 Clofibrate 1 0.5 ml 1 0318 Yes +5C 3C 79
C2320000 Clomifene citrate 2 50 mg 1 See leaflet CHClNO 0997,1046 Yes +5C 3C 79
C2332000 Clomifene citrate for performance test 1 50 mg 1 0997 Yes +5C 3C 79
C2360000 Clomipramine hydrochloride 1 100 mg 1 0889 Yes +5C 3C 79
Y0000132 Clomipramine impurity C 2 20 mg 1 3-(3-chloro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine ; Batch 0889 Yes +5C 3C 79
1 is valid until 28 February 2016
Y0000133 Clomipramine impurity D 2 10 mg 1 See leaflet CHClN; 3-(3,7-dichloro-10,11-dihydro-5H-dibenzo[b,f] 0889 Yes +5C 3C 79
azepin-5-yl)-N,N-dimethylpropan-1-amine
Y0000134 Clomipramine impurity F 1 5 mg 1 3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine 0889 Yes +5C 3C 79
C2385000 Clonazepam - * psy 1 50 mg 1 1974,0415 Yes +5C 3C 79

Council of Europe, all rights reserved 2017 19 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0000286 Clonazepam - reference spectrum 1 n/a 1 0890 79
C2385015 Clonazepam impurity B 2 5 mg 1 3-amino-4-(2-chlorophenyl)-6-nitroquinolin-2(1H)-one 0890 Yes +5C 3C 79
C2400000 Clonidine hydrochloride 1 100 mg 1 0477 Yes +5C 3C 79
Y0000801 Clonidine impurity B 1 20 mg 1 1-acetyl-2-[(2,6-dichlorophenyl)amino]-4,5-dihydro-1H-imidazole 0477 Yes +5C 3C 79
Y0000833 Clopamide 1 40 mg 1 1747 Yes +5C 3C 79
Y0000848 Clopamide for system suitability 1 10 mg 1 1747 Yes +5C 3C 79
Y0001852 Clopidogrel besilate 1 10 mg 1 2790 Yes +5C 3C 79
Y0001334 Clopidogrel for system suitability 2 100 mg 1 2531,2790,2 Yes +5C 3C 79
791
Y0001857 Clopidogrel hydrochloride 1 100 mg 1 see leaflet 2790,2791 Yes +5C 3C 79
Y0001333 Clopidogrel hydrogen sulfate 1 60 mg 1 2531 Yes +5C 3C 79
Y0001335 Clopidogrel impurity A 2 10 mg 1 (2S)-2-(2-chlorophenyl)-2-[6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]acetic 2531,2790,2 Yes +5C 3C 79
ac 791
Y0000392 Closantel sodium dihydrate 1 20 mg 1 1716 Yes +5C 3C 79
Y0000393 Closantel for system suitability 1 20 mg 1 1716 Yes +5C 3C 79
C2424400 Clostridia (multi-component) rabbit antiserum(for 1 1 mg 1 See leaflet 0362,0363,0 Yes -20C 5C 90
vaccines-vet.use)BRP 364, 0697
C2424550 Clostridium tetani guinea pig antiserum (for vaccines - 1 1 mg 3 See leaflet 20708 Yes -20C 5C 90
human use) BRP
C2424500 Clostridium tetani guinea pig antiserum (for vaccines - 1 1 mg 1 See leaflet See leaflet, Yes -20C 5C 90
vet. use) BRP 0697
C2425600 Clostridium tetani rabbit antiserum (for vaccines - vet. 1 1 mg 1 See leaflet See leaflet, Yes -20C 5C 90
use) BRP 0697
C2430000 Clotrimazole 4 100 mg 1 Batch 3 is valid until 28 February 2017 0757 Yes +5C 3C 79
Y0000818 Clotrimazole impurity E 2 15 mg 1 (2-chlorophenyl)phenylmethanone (2-chlorobenzophenone) 0757 Yes +5C 3C 79
Y0000849 Clotrimazole for peak identification 2 1.005 mg 1 0757 Yes +5C 3C 79
C2450000 Cloxacillin sodium 4 200 mg 1 see leaflet 0661, 0663, Yes +5C 3C 79
0668, 2260,
2346
C2460000 Clozapine 2 60 mg 1 1191 Yes +5C 3C 79
Y0000758 Clozapine for peak identification 2 0.41 mg 1 1191 Yes +5C 3C 79
Y0001472 Coagulation Factors V, VIII, XI and XIII plasma 1 1 mg 2 See leaflet 0903,1646,2 Yes -20C 5C 90
0740,20722
Y0000162 Cocaine hydrochloride - reference spectrum 1 n/a 1 0073 79
C2480000 Cocoyl caprylocaprate 1 40 mg 1 1411 Yes +5C 3C 79
Y0000722 Codeine - * narc 1 20 mg 1 See leaflet 0076,0777,1 Yes +5C 3C 79
839,1840,18
C2500000 Codeine - reference spectrum 1 n/a 1 41
0074,0075 79

Council of Europe, all rights reserved 2017 20 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0000334 Codeine impurity A 4 15 mg 1 7,8-didehydro-4,5-epoxy-3,6-dimethoxy-17-methylmorphinan 0074,0075,0 Yes +5C 3C 79
(methylcodeine) 076, 1412

C2500100 Codeine hydrochloride dihydrate - reference spectrum 1 n/a 1 1412 79


C2510000 Codergocrine mesilate 2 60 mg 1 1416,2060 Yes +5C 3C 79
Y0001500 Coix seed HRS 1 1300 mg 1 2454 Yes +5C 3C 79
C2580000 Colchicine 2 15 mg 1 0758 Yes +5C 3C 79
Y0000209 Colchicine for system suitability 2 10 mg 1 0758 Yes +5C 3C 79
Y0000374 Colestyramine 1 10 mg 1 1775 Yes +5C 3C 79
C2600000 Colistimethate sodium 2 20 mg 1 See leaflet 0319,20702 Yes +5C 3C 79
Y0000277 Colistin sulfate 4 25 mg 1 See leaflet 0320 Yes -20C 5C 79
C2700000 Colistin sulfate for microbiological assay 2 25 mg 1 See leaflet; For microbiological assay only 0320 Yes -20C 5C 79
C2725000 Copovidone - reference spectrum 1 n/a 1 0891 79
Y0001748 Copper tetramibi tetrafluoroborate 1 15 mg 1 2547 Yes -20C 5C 79
C2800000 Cortisone acetate 6 250 mg 1 0321,0736,0 Yes +5C 3C 79
767
Y0001307 Costunolide 1 10 mg 1 See leaflet CHO 1797 Yes -20C 5C 79
C2900000 Cotton wool standard for neps 1 1000 mg 1 0036 Yes +5C 3C 79
Y0000438 Coumarin 1 110 mg 1 See leaflet CHO 2120 Yes +5C 3C 79
Y0001053 Crospovidone 1 5 mg 1 0892 Yes +5C 3C 79
C2970000 Crotamiton 3 100 mg 1 see leaflet CHNO 1194 Yes -20C 5C 79
C2970005 Crotamiton impurity A 5 35 mg 1 See leaflet; N-ethyl-N-(2-methylphenyl)but-3-enamide 1194 Yes -20C 5C 79
Y0001061 Cyanidin chloride 3 25 mg 1 See leaflet CHClO ; Batch 2 is valid until 31 July 2016 2394 Yes +5C 3C 79
C3000000 Cyanocobalamin 5 20 mg 1 Vitamin B12 0269,0270,0 Yes +5C 3C 79
547,
0710,1505
C3090000 Cyclizine hydrochloride 1 50 mg 1 1092 Yes +5C 3C 79
Y0000886 Cyclizine impurity A 1 15 mg 1 1-methylpiperazine 1092 Yes +5C 3C 79
Y0000887 Cyclizine impurity B 1 15 mg 1 diphenylmethanol (benzhydrol) 1092 Yes +5C 3C 79
C3200000 Cyclobenzaprine hydrochloride 1 100 mg 1 0408,0464 Yes +5C 3C 79
C3230000 Cyclohexa-1,4-dienylglycine 3 15 mg 1 (2R)-amino(cyclohexa-1,4-dienyl)acetic acid (d-dihydrophenylglycine) 0814 Yes -20C 5C 79
C3245000 Cyclopentolate hydrochloride 2 50 mg 2 1093 Yes +5C 3C 79
Y0001088 Cyclopentolate for system suitability 2 20 mg 1 1093 Yes +5C 3C 79
C3250000 Cyclophosphamide 3 50 mg 1 Batch 2 is valid until 28 February 2016 0711 Yes +5C 3C 79
C3280000 Cyproheptadine hydrochloride 2 15 mg 1 0817,0846 Yes +5C 3C 79
Y0001095 Cyproheptadine impurity C 1 5 mg 1 5-(1-methylpiperidin-4-yl)-5H-dibenzo[a,d][7]annulen-5-ol 0817 Yes +5C 3C 79
C3283000 Cyproterone acetate 2 30 mg 1 1094 Yes +5C 3C 79
Y0001390 Cyproterone acetate for peak identification 1 5 mg 1 1094 Yes +5C 3C 79

Council of Europe, all rights reserved 2017 21 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0001223 Cyproterone impurity mixture 2 0.01 mg 1 Batch 1 is valid until 30 November 2016 1094 Yes +5C 3C 79
C3290000 Cysteine hydrochloride monohydrate 2 100 mg 1 0895 Yes +5C 3C 79
C3300000 Cystine 2 100 mg 1 0998 Yes +5C 3C 79
C3350000 Cytarabine 2 150 mg 1 Batch 1 is valid until 31 July 2016 0760 Yes +5C 3C 79
Y0000733 Dacarbazine 1 20 mg 1 1691 Yes +5C 3C 79
Y0000734 Dacarbazine impurity A 2 20 mg 1 See leaflet CHNO; 3,7-dihydro-4H-imidazo[4,5-d]-1,2,3-triazin-4-one (2- 1691 Yes +5C 3C 79
azahypoxanthine)
Y0000735 Dacarbazine impurity B 1 10 mg 1 See leaflet; 5-amino-1H-imidazole-4-carboxamide 1691 Yes +5C 3C 79
D0070000 Dalteparin sodium 3 250 mg 1 1195 Yes +5C 3C 79
Y0000600 Danaparoid sodium 2 10.5 mg 1 See leaflet 2090 Yes +5C 3C 79
D0100000 Dapsone 2 100 mg 1 0077 Yes +5C 3C 79
D0125000 Daunorubicin hydrochloride 4 120 mg 1 See leaflet CHClNO 0662 Yes +5C 3C 79
D0120000 Daunorubicinone 3 10 mg 1 Daunorubicin aglycone 0662 Yes +5C 3C 79
D0160000 Deferoxamine mesilate 2 30 mg 1 0896 Yes +5C 3C 79
D0201000 Dehydrohexetidine 2 50 mg 1 2-ethyl-N-[[1-(2-ethylhexyl)-4-methyl-4,5-dihydro-1H-imidazol-4-yl]methyl] 1221 Yes +5C 3C 79
hexan-1-amine
Y0000611 Dembrexine hydrochloride monohydrate 1 10 mg 1 2169 Yes +5C 3C 79
Y0001707 Demeclocycline for system suitability 1 10 mg 1 0176 Yes +5C 3C 79
D0300000 Demeclocycline hydrochloride 4 100 mg 1 see leaflet 0211,0210,0 Yes +5C 3C 79
176,
0173,1654
Y0000228 Demethylflumazenil - reference spectrum 1 n/a 1 1917 79
D0406200 Deptropine citrate 1 60 mg 1 1308 Yes +5C 3C 79
D0430000 Dequalinium chloride 1 50 mg 1 1413 Yes +5C 3C 79
D0431000 Dequalinium chloride for performance test 1 50 mg 1 1413 Yes +5C 3C 79
Y0001321 Dermatan sulfate and over-sulfated chondroitin sulfate 2 1 mL 1 See leaflet ; Batch 1 is valid until 28 February 2016 0332,0333 Yes -20C 5C 79
D0480000 Desacetylvinblastine 1 1 mg 2 1276 Yes -80C 10C 79
Y0000879 Desflurane - reference spectrum 1 n/a 1 1666 79
Y0000807 Desflurane impurity A 2 1 mL 1 1,1'-oxybis(1,2,2,2-tetrafluoroethane) 1666 Yes +5C 3C 79
D0500000 Desipramine hydrochloride 1 100 mg 1 0481 Yes +5C 3C 79
D0600000 Deslanoside 2 150 mg 1 See leaflet CHO 0482 Yes +5C 3C 79
Y0001584 Desloratadine 2 100 mg 1 See leaflet 2570 Yes +5C 3C 79
D0630000 Desmethylmetrifonate 2 25 mg 1 1133 Yes +5C 3C 79
Y0001582 Desloratadine for system suitability 1 5 mg 1 2570 Yes +5C 3C 79
New D0650000 Desmopressin 9 1 mg 1 See leaflet CHNOS ; Batch 8 is valid until 30 June 2017 0712 Yes -20C 5C 79
Y0000509 Desogestrel 1 50 mg 1 See leaflet CHO 1717 Yes +5C 3C 79
Y0000510 Desogestrel for system suitability 2 10 mg 1 1717 Yes +5C 3C 79

Council of Europe, all rights reserved 2017 22 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
D0400000 Desoxycortone acetate 2 100 mg 1 0322, 1327 Yes +5C 3C 79
Y0000001 Detomidine hydrochloride 2 100 mg 1 1414 Yes +5C 3C 79
D0660020 Detomidine impurity B 1 20 mg 1 (RS)-(1-benzyl-1H-imidazol-5-yl)(2,3-dimethylphenyl)methanol 1414 Yes +5C 3C 79
D0700000 Dexamethasone 5 50 mg 1 0312,0388,0 Yes +5C 3C 79
548,
0768,1376,2
237,0549
Y0001593 Dexamethasone for peak identification 1 10 mg 1 0388 Yes +5C 3C 79
Y0001177 Dexamethasone for system suitability 2 10 mg 1 0388 Yes +5C 3C 79
D0710000 Dexamethasone acetate 4 100 mg 2 Batch 3 is valid until 31 May 2017 0548,0933,0 Yes +5C 3C 79
975, 2237
Y0001842 Dexamethasone acetate for peak identification 1 10 mg 1 0548 +5C 3C 79
Y0001169 Dexamethasone acetate impurity E 1 0.013 mg 1 9-fluoro-11,17-dihydroxy-16-methyl-3,20-dioxopregn-4-en-21-yl acetate 0548 Yes +5C 3C 79

Y0000538 Dexamethasone isonicotinate 1 10 mg 1 2237 Yes +5C 3C 79


Y0000511 Dexamethasone isonicotinate for impurity C identification 1 10 mg 1 2237 Yes +5C 3C 79
D0718000 Dexamethasone pivalate 1 50 mg 1 1327 Yes +5C 3C 79
D0720000 Dexamethasone sodium phosphate 6 130 mg 1 See leaflet 0549,0735,0 Yes +5C 3C 79
810
Y0001477 Dexamethasone sodium phosphate for peak 1 10 mg 1 0549 Yes +5C 3C 79
identification
D0720800 Dexchlorpheniramine maleate 1 60 mg 1 1196 Yes +5C 3C 79
D0730000 Dexpanthenol 5 5 mg 1 0761 Yes +5C 3C 79
D0731000 Dextran 1 25 mg 1 0999,1000,1 Yes +5C 3C 79
001
D0731005 Dextran 1 1 50 mg 1 See leaflet; Average molecule mass : 930-1000 1506 Yes +5C 3C 79
Fraction with less than 3 glucose units : 8.0 to 10.5%
Fraction with more than 9 glucose units : 10.0 to 12.5%
D0733000 Dextran 4 for calibration 1 50 mg 1 See leaflet 20239 Yes +5C 3C 79
D0734000 Dextran 10 for calibration 1 50 mg 1 See leaflet 20239 Yes +5C 3C 79
D0735000 Dextran 40 for calibration 1 50 mg 1 See leaflet 20239 Yes +5C 3C 79
D0738000 Dextran 40 for performance test 1 50 mg 1 20239 Yes +5C 3C 79
D0739000 Dextran 60/70 for performance test 1 50 mg 1 20239 Yes +5C 3C 79
D0736000 Dextran 70 for calibration 1 50 mg 1 See leaflet 20239 Yes +5C 3C 79
D0737000 Dextran 250 for calibration 1 50 mg 1 See leaflet 20239 Yes +5C 3C 79
D0732000 Dextran Vo 1 10 mg 1 20239 Yes +5C 3C 79
Y0000744 Dextranomer 1 50 mg 1 2238 Yes +5C 3C 79
D0740000 Dextromethorphan hydrobromide 4 100 mg 1 0020 Yes +5C 3C 79
Y0000261 Dextromethorphan impurity A 2 5 mg 1 ent-3-methoxymorphinan 0020 Yes +5C 3C 79
Y0001058 Dextropropoxyphene hydrochloride - * narc 1 10 mg 1 0713 Yes +5C 3C 79
Council of Europe, all rights reserved 2017 23 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0001150 Dextropropoxyphene for system suitability - * narc 1 5 mg 1 0713 Yes +5C 3C 79
Y0001595 Diacerein 1 150 mg 1 See leaflet CHO 2409 Yes +5C 3C 79
Y0001596 Diacerein impurity B 1 20 mg 1 see leaflet; 1,8-dihydroxy-3-(hydroxymethyl)-anthracene-9,10-dione (aloe- 2409 Yes +5C 3C 79
emodin)
Y0001597 Diacerein impurity mixture 1 0.014 mg 1 2409 Yes -20C 5C 79
Y0000454 Diacetylfluorescein 1 100 mg 1 See leaflet 1213 Yes +5C 3C 79
D0940000 Diazepam - * psy 1 30 mg 1 0022 Yes +5C 3C 79
Y0000596 Diazepam for system suitability - * psy 2 0.5 mg 1 0022 Yes +5C 3C 79
D0950000 Diazoxide 1 50 mg 1 0550 Yes +5C 3C 79
D0970000 Dibenzocycloheptene 3 20 mg 1 Batch 2 is valid until 31 August 2016 0817 Yes +5C 3C 79
D1000000 Dibenzosuberone 2 30 mg 1 0464,0817,0 Yes +5C 3C 79
941
Y0000480 Dibrompropamidine diisetionate 1 10 mg 1 2300 Yes +5C 3C 79
Y0000481 Dibrompropamidine for system suitability 1 20 mg 1 2300 Yes +5C 3C 79
D1010000 Dibutyl phthalate 1 1 ml 1 0762 Yes +5C 3C 79
Y0001620 2,4-dichlorobenzyl alcohol 1 250 mg 1 See leaflet CHClO 2410 Yes +5C 3C 79
Y0001621 2,4-Dichlorobenzyl alcohol impurity A 1 25 mg 1 (2,5-dichlorophenyl)methanol 2410 Yes +5C 3C 79
Y0001622 2,4-Dichlorobenzyl alcohol impurity C 1 25 mg 1 (3,4-dichlorophenyl)methanol 2410 Yes +5C 3C 79
Y0000275 Dichlorodiaminocyclohexaneplatinum 5 15 mg 1 Batch 4 is valid until 31 October 2016 2017 Yes +5C 3C 79
Y0000264 Diclazuril for veterinary use - reference spectrum 1 n/a 1 1718 79
Y0000259 Diclazuril for system suitability 1 20 mg 1 1718 Yes +5C 3C 79
D1039990 Diclofenac potassium 3 70 mg 1 Batch 2 is valid until 31 May 2016 1508 Yes +5C 3C 79
S0765000 Diclofenac sodium 4 100 mg 1 1002,1281 Yes +5C 3C 79
New D1040000 Diclofenac impurity A 9 0.005 mg 1 1-(2,6-dichlorophenyl)-1,3-dihydro-2H-indol-2-one ; Batch 8 is valid until 30 1281 Yes +5C 3C 79
June 2017
Y0001635 Diclofenac for system suitability 2 1 mg 1 Batch 1 is valid until 31 August 2016 1002,1508 Yes +5C 3C 79
D1050000 Dicloxacillin sodium 5 250 mg 1 See leaflet CHClNNaOS 0661, 0663, Yes -20C 5C 79
0668, 2346
D1060000 Dicycloverine hydrochloride 2 100 mg 1 1197 Yes +5C 3C 79
Y0001864 Dicycloverine for system suitability 1 15 mg 1 1197 Yes +5C 3C 79
Y0000439 Didanosine 1 10 mg 1 2200 Yes +5C 3C 79
Y0000441 Didanosine impurity A 1 10 mg 1 1,7-dihydro-6H-purin-6-one (hypoxanthine) 2200 Yes +5C 3C 79
Y0000442 Didanosine impurity G 1 10 mg 1 9-(2,3-dideoxy--D-glycero-pentofuranosyl)-9H-purin-6-amine (2',3'- 2200 Yes +5C 3C 79
dideoxyadenosine)
Y0000440 Didanosine for system suitability 1 10 mg 1 2200 Yes +5C 3C 79
D1200000 Dienestrol 3 150 mg 1 See leaflet CHO 0484 Yes +5C 3C 79
Y0001785 Dienogest 1 80 mg 1 See leaflet CHNO 2732 Yes +5C 3C 79
Y0001782 Dienogest for system suitability 1 10 mg 1 2732 Yes +5C 3C 79
Council of Europe, all rights reserved 2017 24 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
D1410000 Diethyl phthalate 1 1 ml 1 0897 Yes +5C 3C 79
D1300000 Diethylcarbamazine citrate 2 250 mg 1 See leaflet CHNO 0271 Yes +5C 3C 79
Y0000217 Diethylene glycol (monoethyl ether) - reference spectrum 1 n/a 1 1198 79
D1500000 Diethylstilbestrol 1 100 mg 1 See leaflet CHO 0484 Yes +5C 3C 79
D1600000 Diethylstilbestrol dimethyl ether 1 10 mg 1 0484 Yes +5C 3C 79
D1700000 Diethylstilbestrol monomethyl ether 1 10 mg 1 0484 Yes +5C 3C 79
Y0001423 Difloxacin hydrochloride 1 60 mg 1 2239 Yes +5C 3C 79
Y0001429 Difloxacin impurity G 1 15 mg 1 7-chloro-6-fluoro-1-(4-fluorophenyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic 2239 Yes +5C 3C 79
acid
D1750000 Diflunisal 1 30 mg 1 0864 Yes +5C 3C 79
D1800000 Digitoxin 4 200 mg 1 See leaflet CHO ; Batch 3 is valid until 31 May 2016 0078,0117 Yes +5C 3C 79
Y0000640 Digoxigenin 3 10 mg 1 See leaflet 0079 Yes +5C 3C 79
D1900000 Digoxin 7 30 mg 1 See leaflet CHO 0079 Yes +5C 3C 79
Y0000554 Digoxin for peak identification 1 10 mg 1 0079 Yes +5C 3C 79
D1940001 Dihydralazine sulfate (hydrated) - reference spectrum 1 n/a 1 1310 79
Y0000232 Dihydralazine for system suitability 1 10 mg 1 1310 Yes +5C 3C 79
Y0000216 Dihydrocodeine hydrogen tartrate - reference spectrum 1 n/a 1 1776 79
Y0000053 17 alpha-dihydroequilin 1 10 mg 1 See leaflet 1512 Yes -20C 5C 79
D1945000 Dihydroergocristine mesilate 3 250 mg 1 1416,2060 Yes +5C 3C 79
D1950000 Dihydroergotamine mesilate 4 50 mg 1 0551 Yes +5C 3C 79
Y0000831 Dihydroergotamine for peak identification 1 10 mg 1 0551 Yes +5C 3C 79
D1952000 Dihydroergotamine tartrate 2 150 mg 1 0600 Yes +5C 3C 79
D1954000 Dihydrostreptomycin sulfate 5 25 mg 1 See leaflet CHNOS ; Batch 4 is valid until 31 March 2016 0485 Yes -20C 5C 79
Y0000544 Dihydrotachysterol 2 30 mg 1 See leaflet CHO 2014 Yes -20C 5C 79
Y0000482 Dihydrotachysterol for system suitability 1 5 mg 1 2014 Yes -20C 5C 79
D1980000 Diltiazem hydrochloride 5 300 mg 1 1004 Yes +5C 3C 79
Y0001439 Diltiazem impurity F 2 15 mg 1 (2S,3S)-5-[2-(dimethylamino)ethyl]-3-hydroxy-2-(4-methoxyphenyl)-2,3- 1004 Yes +5C 3C 79
dihydro-1,5-benzothiazepin-4(5H)-one ; Batch 1 is valid until 31 March 2017
Y0001141 Diltiazem for system suitability 2 10 mg 1 Replaces Diltiazem impurity A CRS 1004 Yes +5C 3C 79
D2000000 Dimenhydrinate 1 100 mg 1 0601 Yes +5C 3C 79
Y0001103 Dimenhydrinate for peak identification 2 1 mg 1 Batch 1 is valid until 30 April 2017 0601 Yes +5C 3C 79
Y0000234 N,N-Dimethylacetamide - reference spectrum 1 n/a 1 1667 79
D2050000 Dimethyl sulfoxide 3 1 mL 1 0763 Yes +5C 3C 79
Y0001489 2-(Dimethylamino)ethyl methacrylate 1 50 mg 1 1975 Yes +5C 3C 79
New Y0001879 (25R)-spirost-5-en-3-one 1 10 mg 1 2890 Yes +5C 3C 79
D2200000 Dimeticone 4 200 mg 1 See leaflet 0138,1470 Yes +5C 3C 79
D2205000 Dimetindene maleate 1 50 mg 1 1417 Yes +5C 3C 79
Council of Europe, all rights reserved 2017 25 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
D2255000 Dinoprost trometamol 1 60 mg 1 See leaflet CHNO 1312 Yes -20C 5C 79
D2250000 Dinoprostone 2 100 mg 1 See leaflet CHO 1311 Yes -20C 5C 79
D2250015 Dinoprostone impurity C 2 10 mg 1 (E)-7-[(1R,2R,3R)-3-hydroxy-2-[(E)-(3S)-3-hydroxyoct-1-enyl]-5- 1311,1488 Yes -20C 5C 240
oxocyclopentyl]hept-5-enoic acid (5-trans-PGE2; (5E)-PGE2)
New Y0001871 Diosgenin 1 15 mg 1 see leaflet CHO 2890 Yes +5C 3C 79
Y0000094 Diosmin 4 70 mg 1 See leaflet 1611 Yes +5C 3C 79
Y0000095 Diosmin for system suitability 2 5 mg 1 1611 Yes +5C 3C 79
D2600000 Diphenhydramine hydrochloride 1 100 mg 1 0023,0601 Yes +5C 3C 79
Y0000135 Diphenhydramine impurity A 4 10 mg 1 2-(diphenylmethoxy)-N-methylethanamine 0023,0601 Yes +5C 3C 79
Y0001415 Diphenoxylate hydrochloride - * narc 1 15 mg 1 0819 Yes +5C 3C 79
D2630000 Diphenoxylate hydrochloride - reference spectrum 1 n/a 1 0819 79
Y0001430 Diphenoxylate for system suitability - * narc 1 10 mg 1 0819 Yes +5C 3C 79
Y0000258 Diphtheria toxin BRP 1 1 ml 1 See leaflet See leaflet, Yes +5C 3C 90
0443
D2700000 Diphtheria vaccine (adsorbed) BRP 4 32 mg 1 See leaflet See leaflet, Yes -20C 5C 90
20706
Y0000376 Dipivefrine hydrochloride 1 100 mg 1 See leaflet CHClNO 1719 Yes +5C 3C 79
Y0000394 Dipivefrine for system suitability 1 10 mg 1 1719 Yes +5C 3C 79
D2750100 Dipotassium clorazepate - reference spectrum 1 n/a 1 0898 79
D2800000 Diprophylline 1 100 mg 1 0486 Yes +5C 3C 79
D2850000 Dipyridamole 1 50 mg 1 1199 Yes +5C 3C 79
Y0000802 Dipyridamole for peak identification 2 2.04 mg 1 1199 Yes +5C 3C 79
D2880000 Dirithromycin 1 100 mg 1 See leaflet CHNO 1313 Yes +5C 3C 79
D2900000 Disodium edetate 1 100 mg 1 0232 Yes +5C 3C 79
D2920000 Disopyramide 1 100 mg 1 1006 Yes +5C 3C 79
D2922000 Disopyramide phosphate 1 100 mg 1 1005 Yes +5C 3C 79
D2950000 Disulfiram 1 100 mg 1 0603 Yes +5C 3C 79
D2953000 Dithranol 3 55 mg 1 1007 Yes +5C 3C 79
D2953025 Dithranol impurity C 4 15 mg 1 See leaflet; 4,4',5,5'-tetrahydroxy-9,9'-bianthracenyl-10,10'(9H,9'H)-dione 1007 Yes +5C 3C 79
D2953050 Dithranol impurity D 4 20 mg 1 1-hydroxyanthracen-9(10H)-one 1007 Yes +5C 3C 79
D2954000 Dobutamine hydrochloride 1 100 mg 1 1200 Yes +5C 3C 79
Y0001239 Dobutamine impurity mixture 1 0.1 mg 1 1200 Yes -20C 5C 79
New Y0001133 Docetaxel trihydrate 3 160 mg 1 See leaflet CHNO.3HO ; Batch 2 is valid until 31 July 2017 2449, 2593 Yes +5C 3C 79
Y0001155 Docetaxel for system suitability 2 10 mg 1 2449,2593 Yes +5C 3C 79
Y0001452 Docetaxel impurity E 1 15 mg 1 5,20-epoxy-4-(acetyloxy)-1,7,10,13-tetrahydroxy-9-oxotax-11-en-2-yl 2593 Yes +5C 3C 79
benzoate (10-desacetyl-baccatin III)
D2954600 Docosahexaenoic acid ethyl ester 5 150 mg 1 See leaflet ; Batch 4 is valid until 31 July 2016 20429 Yes -20C 5C 79

Council of Europe, all rights reserved 2017 26 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0001567 Docusate sodium 1 10 mg 1 1418 Yes +5C 3C 79
Y0000365 Dodecyl gallate 1 30 mg 1 2078 Yes +5C 3C 79
D2955000 Domperidone 3 120 mg 1 1009 Yes +5C 3C 79
D2957000 Domperidone maleate 1 150 mg 1 1008 Yes +5C 3C 79
D2960000 Dopamine hydrochloride 2 20 mg 1 0664,1200 Yes +5C 3C 79
Y0000612 Dopexamine dihydrochloride 1 10 mg 1 1748 Yes +5C 3C 79
Y0000613 Dopexamine impurity B 1 10 mg 1 2-methoxy-4-[2-[[6-[(2-phenylethyl)amino]hexyl]amino]ethyl]phenol 1748 Yes -20C 5C 79
Y0000614 Dopexamine impurity F 1 10 mg 1 4-chloro-5-[2-[[6-[(2-phenylethyl)amino]hexyl]amino]ethyl]benzene-1,2-diol 1748 Yes -20C 5C 79
Y0000726 Dorzolamide hydrochloride 1 50 mg 1 2359 Yes +5C 3C 79
Y0000727 Dorzolamide impurity A 2 5 mg 1 (4R,6R)-4-(ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2- 2359 Yes +5C 3C 79
sulphonamide 7,7-dioxide
Y0000750 Dorzolamide for system suitability 1 5 mg 1 2359 Yes +5C 3C 79
D2962000 Dosulepin hydrochloride 1 100 mg 1 1314 Yes +5C 3C 79
D2962005 Dosulepin impurity A 2 30 mg 1 (E)-3-(5-oxo-54-dibenzo[b,e]thiepin-11(6H)-ylidene)-N,N- 1314 Yes +5C 3C 79
dimethylpropan-1-amine
D2963000 Doxapram hydrochloride 1 50 mg 1 1201 Yes +5C 3C 79
Y0000208 Doxapram impurity B 2 10 mg 1 (4RS)-1-ethyl-4-[2-[(2-hydroxyethyl)amino]ethyl]-3,3-diphenylpyrolidin-2- 1201 Yes +5C 3C 79
one ; Batch 1 is valid until 31 May 2016
Y0000553 Doxazosin mesilate 1 60 mg 1 See leaflet 2125 Yes +5C 3C 79
Y0000551 Doxazosin impurity D 1 10 mg 1 6,7-dimethoxyquinazoline-2,4(1H,3H)-dione 2125 Yes +5C 3C 79
Y0000552 Doxazosin impurity F 2 15 mg 1 2-chloro-6,7-dimethoxyquinazolin-4-amine 2125 Yes +5C 3C 79
Y0000838 Doxepin hydrochloride 1 5 mg 1 1096 Yes +5C 3C 79
Y0000851 Doxepin for system suitability 1 1 mg 1 1096 Yes +5C 3C 79
D2975000 Doxorubicin hydrochloride 7 150 mg 1 See leaflet CHClNO ; Batch 6 is valid until 30 September 2016 0714,0662,1 Yes -20C 5C 79
590
D3000000 Doxycycline hyclate 6 50 mg 1 see leaflet ; Batch 5 is valid until 31 March 2016 0272, 0820 Yes +5C 3C 79
Y0001714 Doxycycline for system suitability 2 10 mg 1 Batch 1 is valid until 31 March 2016 0272,0820 Yes +5C 3C 79
Y0001562 Doxylamine hydrogen succinate 1 60 mg 1 1589 Yes +5C 3C 79
Y0000163 Doxylamine hydrogen succinate - reference spectrum 1 n/a 1 1589 79
Y0001492 Doxylamine for system suitability 3 110 mg 1 Batch 2 is valid until 31 December 2016 1589 Yes +5C 3C 79
D3100000 Droperidol 3 150 mg 1 1008,1009,1 Yes +5C 3C 79
010, 1172
Y0001105 Drospirenone 1 60 mg 1 See leaflet CHO 2404 Yes +5C 3C 79
Y0001115 Drospirenone impurity E 1 0.06 mg 1 3-oxo-6,7,15,16-tetrahydro-3H,3H dicyclopropa[6,7:15,16]pregn-4- 2404 Yes +5C 3C 79
ene-21,17-carbolactone (17-epidrospirenone)

Y0001718 Drospirenone for peak identification 1 10 mg 1 2404 Yes +5C 3C 79

Council of Europe, all rights reserved 2017 27 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0001453 Duloxetine hydrochloride 2 120 mg 1 See leaflet CHClNOS ; Batch 1 is valid until 31 March 2016 2594 Yes +5C 3C 79
Y0001455 Duloxetine impurity A 2 10 mg 1 (3R)-N-methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine 2594 Yes +5C 3C 79
Y0001454 Duloxetine for system suitability 1 40 mg 1 2594 Yes +5C 3C 79
Y0001598 Dutasteride 1 150 mg 1 See leaflet 2641 Yes +5C 3C 79
Y0001603 Dutasteride for system suitability 1 10 mg 1 2641 Yes +5C 3C 79
Y0001004 Dydrogesterone 1 50 mg 1 See leaflet CHO 2357 Yes +5C 3C 79
Y0001005 Dydrogesterone impurity A 1 6 mg 1 9,10-pregna-4,6,8(14)-triene-3,20-dione 2357 Yes +5C 3C 79

Y0001006 Dydrogesterone impurity B 1 5 mg 1 pregna-4,6-diene-3,20-dione 2357 Yes +5C 3C 79


Y0000249 Ebastine - reference spectrum 1 n/a 1 2015 79
Y0000247 Ebastine impurity C 1 10 mg 1 4-(diphenylmethoxy)piperidine 2015 Yes +5C 3C 79
Y0000248 Ebastine impurity D 1 10 mg 1 1-[4-(1,1-dimethylethyl)phenyl]-4-(4-hydroxypiperidin-1-yl)butan-1-one 2015 Yes +5C 3C 79
Y0001236 Econazole 1 10 mg 1 2049 Yes +5C 3C 79
Y0000254 Econazole for system suitability 1 20 mg 1 0665,2049 Yes +5C 3C 79
E0050000 Econazole nitrate 3 100 mg 1 0513,0665,0 Yes +5C 3C 79
921, 0935,
1017,1018
Y0001738 Edrophonium chloride 1 10 mg 1 2106 Yes +5C 3C 79
E0085000 Eicosapentaenoic acid ethyl ester 4 200 mg 1 See leaflet CHO 20429 Yes -20C 5C 79
Y0000537 Emedastine difumarate 1 10 mg 1 2242 Yes +5C 3C 79
Y0000512 Emedastine impurity E 1 10 mg 1 1-(2-ethoxyethyl)-2-(hexahydro-1H-1,4-diazepin-1-yl)-1H-benzimidazole 2242 Yes +5C 3C 79
E0100000 Emetine hydrochloride 2 100 mg 1 0081,0093, Yes +5C 3C 79
0094,1530,1
875
Y0001837 Emodin 1 15 mg 1 see leaflet CHO 2724 Yes +5C 3C 79
E0109000 Enalapril maleate 3 15 mg 1 Batch 2 is valid until 31 May 2016 1420 Yes +5C 3C 79
E0110000 Enalapril for system suitability 2 10 mg 1 Batch 1 is valid until 31 August 2016 1420 Yes +5C 3C 79
Y0001853 Enalapril impurity mixture A 1 0.06 mg 1 1420 Yes +5C 3C 79
Y0001829 Enalapril impurity G 1 15 mg 1 (2S)-2-[[(1S)-3-cyclohexyl-1-(ethoxycarbonyl)propyl]amino]propanoic acid 1420 +5C 3C 79
Y0000615 Enalaprilat dihydrate 1 100 mg 1 1749 Yes +5C 3C 79
Y0000678 Enalaprilat impurity G 1 0.005 mg 1 (2SR)-2-[(3SR,8aRS)-3-methyl-1,4-dioxohexahydropyrrolo[1,2-a] pyrazin-2 1749 Yes +5C 3C 79
(1H)-yl]-4-phenylbutanoic acid
Y0000629 Enalaprilat for system suitability 1 10 mg 1 1749 Yes +5C 3C 79
E0150000 Endotoxin standard BRP 5 10 mg 1 See leaflet 20614, 20630 Yes -20C 5C 79
Y0000136 Enilconazole 1 60 mg 1 1720 Yes +5C 3C 79
Y0000137 Enilconazole impurity E 1 20 mg 1 (1RS)-1-(2,4-dichlorophenyl)-2-(-1H-imidazol-1-yl)ethanol 1720 Yes +5C 3C 79
E0180000 Enoxaparin sodium 5 200 mg 1 1097 Yes +5C 3C 79
E0180500 Enoxolone 2 220 mg 1 Batch 1 is valid until 28 February 2016 1511 Yes +5C 3C 79

Council of Europe, all rights reserved 2017 28 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0001259 Enrofloxacin 1 5 mg 1 2229 Yes +5C 3C 79
Y0001160 Enrofloxacin for system suitability 1 10 mg 1 2229 Yes +5C 3C 79
Y0001249 Entacapone 1 160 mg 1 See leaflet CHNO 2574 Yes +5C 3C 79
Y0001250 Entacapone impurity A 1 10 mg 1 (2Z)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide 2574 Yes +5C 3C 79
Y0001800 Entecavir monohydrate 1 160 mg 1 see leaflet CHNO,HO 2815 Yes +5C 3C 79
New Y0001802 Entecavir impurity F 2 10 mg 1 Batch 1 is valid until 31 May 2017 2815 Yes +5C 3C 79
Y0001801 Entecavir for system suitability 1 1 mg 1 2815 Yes +5C 3C 79
E0200000 Enterokinase BRP 2 200 mg 1 Batch 1 is valid until 30 June 2016 0350 Yes +5C 3C 79
E0300000 Ephedrine hydrochloride - * Drug Precursor 3 150 mg 1 See leaflet 0487,0488,0 Yes +5C 3C 79
489,1367,24
E0305000 Ephedrine hydrochloride (racemic) - * Drug Precursor 1 50 mg 1 51
0715 Yes +5C 3C 79
New E0400000 4-Epianhydrotetracycline hydrochloride 7 25 mg 1 See leaflet ; Batch 6 is valid until 31 July 2017 0210,0211,1 Yes +5C 3C 79
654
Y0001139 Epinastine hydrochloride 1 20 mg 1 2411 Yes +5C 3C 79
Y0001128 Epinastine for system suitability 1 10 mg 1 2411 Yes +5C 3C 79
E0550000 Epirubicin hydrochloride 6 100 mg 1 See leaflet CHClNO 0662,0714,1 Yes -20C 5C 79
590
E0600000 4-Epitetracycline hydrochloride 9 30 mg 1 Batch 8 is valid until 30 June 2016 0210,0211,1 Yes +5C 3C 79
654
Y0001704 Eplerenone 1 75 mg 1 see leaflet CHO 2765 Yes +5C 3C 79
Y0001706 Eplerenone for peak identification 1 10 mg 1 2765 Yes +5C 3C 79
Y0001705 Eplerenone for system suitability 1 10 mg 1 2765 Yes +5C 3C 79
P1609010 trans-Epoxyphytomenadione 3 5 mg 1 1036 Yes +5C 3C 79
E0850010 Eq Influenza Subtype 1 Strain A/eq/Newmarket/77 2 1 mg 3 See leaflet; Common standard OIE See leaflet, Yes -20C 5C 90
Horse Antiserum BRP Strain A/eq/Newmarket/77 0249
E0850021 Eq Influenza Subtype 2 American-like/Newmarket 2 1 mg 3 See leaflet; Common standard OIE See leaflet, Yes -20C 5C 90
Horse Antiserum BRP Strain A/eq/Newmarket/1/93 0249
Y0000712 Eq Influenza Subtype 2 American-like/South Africa 1 1 mg 3 See leaflet See leaflet, Yes -20C 5C 90
Horse Antiserum BRP 0249
E0850022 Eq Influenza Subtype 2 European-like/Newmarket 2 1 mg 3 See leaflet; Common standard OIE See leaflet, Yes -20C 5C 90
Horse Antiserum BRP Strain A/eq/Newmarket/2/93 0249
Y0000052 Equilin 1 15 mg 1 See leaflet CHO 1512 Yes -20C 5C 79
Y0001325 Equisetum palustre 1 200 mg 1 1825 Yes +5C 3C 79
E0900000 Ergocalciferol 9 150 mg 1 See leaflet; Vitamin D2 ; Batch 8 is valid until 30 June 2016 0082,0574,0 Yes -20C 5C 79
575,
0598,1192,1
193, 2398
Y0001375 Ergocalciferol for system suitability 1 10 mg 1 0082 Yes -20C 5C 79
E1000000 Ergometrine maleate - * Drug Precursor 2 50 mg 1 0223 Yes +5C 3C 79

Council of Europe, all rights reserved 2017 29 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
E1100000 Ergosterol 6 20 mg 1 See leaflet CHO ; Batch 5 is valid until 30 June 2016 0082 Yes -20C 5C 79
Y0001851 Ergotamine for system suitability - * Drug precursor 1 10 mg 1 0224 Yes -20C 5C 79
E1200000 Ergotamine tartrate - * Drug Precursor 2 100 mg 1 0224, 0551 Yes +5C 3C 79
Y0000051 Erysipelas ELISA coating antigen BRP 1 0.4 mg 1 See leaflet See leaflet, Yes -20C 5C 90
0064
Y0000177 Erythritol 1 1000 mg 1 See leaflet CHO 1803 Yes +5C 3C 79
E1400000 Erythromycin estolate 1 100 mg 1 0552 Yes +5C 3C 79
E1500000 Erythromycin ethylsuccinate 2 10 mg 1 0274 Yes +5C 3C 79
E1500800 Erythromycin stearate 1 50 mg 1 0490 Yes +5C 3C 79
Y0001848 Erythromycin lactobionate 1 15 mg 1 1098 Yes +5C 3C 79
Y0001912 Erythromycin A 4 250 mg 1 see leaflet 0179, 0274, Yes -20C 5C 79
0293, 0490,
0552, 1098
E1310000 Erythromycin B 4 50 mg 1 See leaflet 0179,0274,0 Yes -20C 5C 79
490,
0552,1098
Y0001849 Erythromycin stearate for impurity S identification 1 15 mg 1 0490 Yes +5C 3C 79
E1320000 Erythromycin C 5 50 mg 1 See leaflet 0179,0274,0 Yes -20C 5C 79
490,
0552,1098
Y0001845 Erythromycin ethylsuccinate for impurity P identification 1 15 mg 1 0274 Yes +5C 3C 79
Y0001846 Erythromycin for impurity M identification 1 15 mg 1 0179 Yes -20C 5C 79
E1300000 Erythromycin for microbiological assay 5 100 mg 1 See leaflet ; Batch 4 is valid until 30 November 2016 20702 Yes -20C 5C 79
Y0001847 Erythromycin for system suitability 1 15 mg 1 0179, 0552, Yes -20C 5C 79
0274, 1098,
0490
E1515000 Erythropoietin BRP 4 15 mg 1 see leaflet 1316 Yes -20C 5C 500
Y0001725 Erythropoietin for physicochemical tests 1 0.1 mg 3 1316 Yes -20C 5C 500
Y0001844 Escitalopram 1 10 mg 1 2758 Yes +5C 3C 79
Y0001797 Escitalopram for system suitability 1 15 mg 1 2733 Yes +5C 3C 79
Y0001796 Escitalopram oxalate 1 10 mg 1 2733 Yes +5C 3C 79
Y0001611 Esculetin 1 25 mg 1 See leaflet CHO 2452 Yes +5C 3C 79
Y0001612 Esculin 1 25 mg 1 See leaflet CHO 2452 Yes +5C 3C 79
Y0000324 Esketamine hydrochloride - reference spectrum 1 n/a 1 1742 79
Y0000338 Esketamine impurity D - * narc 1 10 mg 1 (2R)-2-(2-chlorophenyl)-2-(methylamino)cyclohexanone ((R)-ketamine) 1742 Yes +5C 3C 79
Y0001660 Esomeprazole magnesium dihydrate 1 15 mg 1 2787 Yes +5C 3C 79
Y0001028 Esomeprazole magnesium trihydrate 2 5 mg 1 2372 Yes +5C 3C 79
Y0000749 Essential oil 2 1000 mg 1 Batch 1 is valid until 31 March 2016 2098 Yes +5C 3C 79
E1600000 Estradiol benzoate 2 250 mg 1 0139 Yes +5C 3C 79
Council of Europe, all rights reserved 2017 30 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0000852 Estradiol benzoate for system suitability 1 10 mg 1 0139 Yes +5C 3C 79
E1620000 Estradiol hemihydrate 3 100 mg 1 0821,1203 Yes +5C 3C 79
Y0000314 Estradiol for peak identification 2 10 mg 1 Batch 1 is valid until 30 November 2016 0821 Yes +5C 3C 79
Y0000046 Estradiol valerate 2 120 mg 1 See leaflet CHO ; Batch 1 is valid until 31 March 2016 1614 Yes +5C 3C 79
Y0001823 Estradiol valerate for system suitability 2 10 mg 1 1614 +5C 3C 79
E1680000 Estriol 3 50 mg 1 Batch 2 is valid until 31 March 2017 1203 Yes +5C 3C 79
E1680005 Estriol impurity A 2 20 mg 1 See leaflet; estra-1,3,5(10),9(11)-tetraene-3,16,17-triol (9,11- 1203 Yes +5C 3C 79
didehydroestriol)
E1700000 Estrone 5 20 mg 1 See leaflet 1512,0140 Yes +5C 3C 79
E1800000 Etacrynic acid 1 100 mg 1 0457 Yes +5C 3C 79
Y0001263 Etacrynic acid for system suitability 1 10 mg 1 0457 Yes +5C 3C 79
E1830000 Etamsylate 2 10 mg 1 1204 Yes +5C 3C 79
E1840000 Ethacridine lactate monohydrate 1 50 mg 1 1591 Yes +5C 3C 79
E1850000 Ethambutol hydrochloride 3 250 mg 1 0553 Yes +5C 3C 79
Y0000803 Ethambutol for system suitability 2 10 mg 1 Batch 1 is valid until 31 October 2016 0553 Yes +5C 3C 79
A1202800 Ethanol (anhydrous) - reference spectrum 1 n/a 1 1318 79
E1860100 Ethanol 96% - reference spectrum 1 n/a 1 1317 79
E1900000 Ethinylestradiol 5 200 mg 1 See leaflet 0140, 0821, Yes +5C 3C 79
0940, 0926
Y0001124 Ethinylestradiol for system suitability 2 1.0124 mg 1 0140 Yes +5C 3C 79
E2000000 Ethionamide 1 100 mg 1 0141 Yes +5C 3C 79
Y0001686 Ethionamide for system suitability 1 10 mg 1 0141 Yes +5C 3C 79
E2150000 Ethosuximide 1 30 mg 1 0764 Yes +5C 3C 79
E2250000 Ethosuximide impurity A 4 30 mg 1 (2RS)-2-ethyl-2-methylbutanedioic acid 0764 Yes +5C 3C 79
E2195000 Ethyl acetate - reference spectrum 1 n/a 1 0899 79
Y0000617 Ethyl indole-3-carboxylate 1 10 mg 1 2102 Yes +5C 3C 79
E2425000 Ethyl parahydroxybenzoate 3 150 mg 1 See leaflet CHO 0409,0431,0 Yes +5C 3C 79
900,
1262,1263,2
134
Y0001633 Ethylcellulose 1 100 mg 1 0822 Yes +5C 3C 79
E2202000 1-N-Ethylgaramine sulfate 3 50 mg 1 See leaflet 1351 Yes +5C 3C 79
New E2205500 1,1'-Ethylidenebistryptophan 7 0.002 mg 2 See leaflet CHNO ; Batch 5 is valid until 30 June 2017 1272,1383 Yes +5C 3C 79
E2300000 Ethylmorphine hydrochloride - reference spectrum 1 n/a 1 0491 79
E2400000 Ethylnicotinamide 1 150 mg 1 0233 Yes +5C 3C 79
Y0000572 Etidronate disodium 1 10 mg 1 1778 Yes +5C 3C 79
E2450000 Etifenin 1 25 mg 2 0585 Yes +5C 3C 79

Council of Europe, all rights reserved 2017 31 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
E2451000 Etilefrine hydrochloride 2 75 mg 1 1205 Yes +5C 3C 79
E2451010 Etilefrine impurity A 1 20 mg 1 2-(ethylamino)-1-(3-hydroxyphenyl)ethanone (etilefrone) 1205 Yes +5C 3C 79
E2470000 Etodolac 1 60 mg 1 1422 Yes +5C 3C 79
E2470050 Etodolac impurity H 1 10 mg 1 2-(7-ethyl-1H-indol-3-yl)ethanol 1422 Yes +5C 3C 79
Y0000768 Etodolac for peak identification 2 0.41 mg 1 Batch 1 is valid until 31 May 2016 1422 Yes +5C 3C 79
E2499900 Etofenamate 1 40 mg 1 1513 Yes +5C 3C 79
E2499914 Etofenamate impurity G 2 25 mg 1 2-hydroxyethyl 2-[[3-(trifluoromethyl)phenyl]amino]-benzoate 1513 Yes +5C 3C 79
E2499901 Etofenamate for peak identification 2 20 mg 1 1513 Yes +5C 3C 79
E2500000 Etofylline 1 100 mg 1 0486 Yes +5C 3C 79
E2503000 Etomidate 2 50 mg 1 1514 Yes +5C 3C 79
E2503004 Etomidate impurity B 1 25 mg 1 methyl 1-[(1RS)-1-phenylethyl]-1H-imidazole-5-carboxylate (metomidate) 1514 Yes +5C 3C 79
E2600000 Etoposide 7 150 mg 1 See leaflet 0823 Yes +5C 3C 79
Y0001365 Etoposide for system suitability 1 10 mg 1 0823 Yes +5C 3C 79
Y0001747 Exemestane 1 70 mg 1 see lealet CHO 2766 Yes +5C 3C 79
Y0001605 Eucommia bark HRS 1 2100 mg 1 2412 Yes +5C 3C 79
E5000000 Eugenol 2 500 l 1 1100 Yes +5C 3C 79
Y0001756 Exemestane for system suitability 1 10 mg 1 2766 Yes +5C 3C 79
F0005000 Famotidine 2 100 mg 1 1012 Yes +5C 3C 79
Y0000409 Famotidine impurity D 2 10 mg 1 3-[[[2-[(diaminomethylene)amino]thiazol-4-yl]methyl]sulphanyl]propanamide 1012 Yes +5C 3C 79
Y0000382 Famotidine for system suitability 2 15 mg 1 1012 Yes +5C 3C 79
Y0000556 Febantel 2 150 mg 1 See leaflet 2176 Yes +5C 3C 79
Y0000660 Febantel for system suitability 1 10 mg 1 2176 Yes +5C 3C 79
Y0000731 Felbinac 1 10 mg 1 2304 Yes +5C 3C 79
Y0000732 Felbinac impurity A 1 20 mg 1 4-acetyl biphenyl 2304 Yes +5C 3C 79
F0030000 Felodipine 2 120 mg 1 1013 Yes +5C 3C 79
Y0000415 Felypressin 1 0.994 mg 1 See leaflet CHNOS 1634 Yes -20C 5C 79
F0040000 Fenbendazole 3 150 mg 1 1208,1458 Yes +5C 3C 79
F0040010 Fenbendazole impurity A 1 20 mg 1 methyl(1-benzimidazol-2-yl)carbamate 1208 Yes +5C 3C 79
F0040020 Fenbendazole impurity B 1 25 mg 1 methyl (5-chloro-1H-benzimidazol-2-yl)carbamate 1208 Yes +5C 3C 79
F0041000 Fenbufen 1 100 mg 1 1209 Yes +5C 3C 79
F0048000 Fenofibrate 3 100 mg 1 See leaflet CHClO 1322 Yes +5C 3C 79
F0048005 Fenofibrate impurity A 4 15 mg 1 (4-chlorophenyl)(4-hydroxyphenyl)methanone 1322 Yes +5C 3C 79
F0048010 Fenofibrate impurity B 4 10 mg 1 2[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoic acid (fenofibric acid) 1322 Yes +5C 3C 79
F0048035 Fenofibrate impurity G 4 25 mg 1 1-methylethyl 2-[[2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoyl] 1322 Yes +5C 3C 79
oxy]-2-methylpropanoate
F0050000 Fenoterol hydrobromide 3 50 mg 1 0901 Yes +5C 3C 79

Council of Europe, all rights reserved 2017 32 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0000756 Fenoterol for peak identification 1 1.2 mg 1 0901 Yes +5C 3C 79
F0054990 Fentanyl - reference spectrum 1 n/a 1 1210 79
F0055000 Fentanyl citrate - reference spectrum 1 n/a 1 1103 79
Y0001509 Fentanyl for system suitability - * narc 2 15 mg 1 1210,1103 Yes +5C 3C 79
F0060000 Fenticonazole nitrate 1 50 mg 1 1211 Yes +5C 3C 79
F0060040 Fenticonazole impurity D 2 0.01 mg 1 ()-1-[2-(2,4-dichlorophenyl)-2-hydroxyethyl]-3-[4-(phenylsufanyl)benzyl] 1211 Yes +5C 3C 79
imidazolium nitrate
F0100000 Ferrous gluconate 1 100 mg 1 0493 Yes +5C 3C 79
Y0001013 Ferulic acid 1 20 mg 1 See leaflet CHO 1834,2558 Yes +5C 3C 79
Y0000789 Fexofenadine hydrochloride 1 60 mg 1 See leaflet CHClNO 2280 Yes +5C 3C 79
Y0000751 Fexofenadine impurity A 2 5 mg 1 2-[4-[4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butanoyl]phenyl]-2- 2280 Yes +5C 3C 79
methylpropanoic acid ; Batch 1 is valid until 28 February 2017
Y0000752 Fexofenadine impurity B 1 0.01 mg 1 2-[3-[(1RS)-1-hydroxy-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butyl] 2280 Yes +5C 3C 79
phenyl]-2-methylpropanoic acid
Y0000753 Fexofenadine impurity C 1 5 mg 1 (1RS)-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]-1-[4-(1-methylethyl) 2280 Yes +5C 3C 79
phenyl]butan-1-ol
Y0001173 Filgrastim 2 0.2 mL 1 See leaflet 2206 Yes -80C 10C 79
Y0000090 Finasteride 3 120 mg 1 See leaflet 1615 Yes +5C 3C 79
Y0001604 Finasteride for peak identification 1 15 mg 1 1615 Yes +5C 3C 79
Y0000736 Flavoxate hydrochloride 1 10 mg 1 1692 Yes +5C 3C 79
Y0000737 Flavoxate impurity A 1 10 mg 1 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylic acid 1692 Yes +5C 3C 79
Y0000738 Flavoxate impurity B 1 10 mg 1 ethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate 1692 Yes +5C 3C 79
F0120000 Flecainide acetate 2 10 mg 1 1324 Yes +5C 3C 79
F0120005 Flecainide impurity A 4 20 mg 1 (8aRS)-3-[2,5-bis(2,2,2-trifluoroethoxy)phenyl]-1,5,6,7,8,8a- 1324 Yes +5C 3C 79
hexahydroimidazo[1,5-a]pyridine
; Batch 3 is valid until 31 March 2017
F0120010 Flecainide impurity B 1 25 mg 1 (RS)-(piperidin-2-yl)methanamine 1324 Yes +5C 3C 79
Y0001274 Flecainide for system suitability 1 10 mg 1 1324 Yes +5C 3C 79
Y0001606 Fleeceflower root HRS 1 300 mg 1 2433 Yes +5C 3C 79
Y0000138 Flubendazole 1 25 mg 1 1721 Yes +5C 3C 79
Y0000139 Flubendazole for system suitability 1 20 mg 1 1721 Yes +5C 3C 79
Y0000892 Flucloxacillin magnesium octahydrate 1 5 mg 1 2346 Yes +5C 3C 79
Y0000889 Flucloxacillin impurity C 1 5 mg 1 (2S,5R,6R)-6-amino-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2- 2346 Yes +5C 3C 79
carboxylic acid (6-aminopenicillanic acid)
Y0000890 Flucloxacillin impurity D 1 5 mg 1 3-(2-chloro-6-fluorophenyl)-5-methylisoxazole-4-carboxylic acid 2346 Yes +5C 3C 79
Y0000891 Flucloxacillin impurity E 1 5 mg 1 (2S,5R,6R)-6-[[[(2S,5R,6R)-6-[[[3-(2-chloro-6-fluorophenyl)-5- 2346 Yes -20C 5C 79
methylisoxazol-4-yl]carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo
[3.2.0]hept-2-yl]carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo
[3.2.0]heptane-2-carboxylic acid (6-APA flucloxacillin amide)

Council of Europe, all rights reserved 2017 33 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
F0150000 Flucloxacillin sodium 8 250 mg 1 See leaflet CHClFNNaOS ; Batch 7 is valid until 30 April 2017 0661,0663,0 Yes -20C 5C 79
668,2346
Y0000557 Fluconazole 2 50 mg 1 2287 Yes +5C 3C 79
Y0000573 Fluconazole impurity B 3 10 mg 1 See leaflet; 2-[2-fluoro-4-(1H-1,2,4-triazol-1-yl)phenyl]-1,3-bis(1H-1,2,4 - 2287 Yes +5C 3C 79
triazol-1-yl)propan-2-ol
Y0000574 Fluconazole impurity C 3 5 mg 2 1,1'-(1,3-phenylene)di-1H-1,2,4-triazole ; Batch 2 is valid until 31 August 2016 2287 Yes +5C 3C 79
Y0000558 Fluconazole for peak identification 1 10 mg 1 2287 Yes +5C 3C 79
F0175000 Flucytosine 2 50 mg 1 Batch 1 is valid until 31 August 2016 0766 Yes +5C 3C 79
Y0001262 Flucytosine for system suitability 1 0.3 mg 1 0766 Yes +5C 3C 79
Y0000419 Fludarabine phosphate 3 120 mg 1 see leaflet 1781 Yes +5C 3C 79
Y0001536 Fludarabine for system suitability 1 15 mg 1 1781 Yes +5C 3C 79
F0180000 Fludrocortisone acetate 2 100 mg 1 0767 Yes +5C 3C 79
F0188000 Flumazenil - reference spectrum 1 n/a 1 1326 79
Y0000335 Flumazenil impurity B 2 5 mg 1 ethyl 8-hydroxy-5-methyl-6-oxo-5,6-dihydro-4H-imidazo[1,5-a][1,4] 1326 Yes +5C 3C 79
benzodiazepine-3-carboxylate
F0189000 Flumequine 1 60 mg 1 1517 Yes +5C 3C 79
F0189020 Flumequine impurity B 2 0.1 mg 1 ethyl(RS)-9-fluoro-5-methyl-1-oxo-6,7-dihydro-1H,5H-benzo[i,j] 1517 Yes +5C 3C 79
quinolizine-2-carboxylate
New F0188500 Flumetasone pivalate 2 100 mg 1 Batch 1 is valid until 31 May 2017 1327 Yes +5C 3C 79
F0189900 Flunarizine dihydrochloride 3 100 mg 1 0816 Yes +5C 3C 79
Y0000265 Flunarizine dihydrochloride - reference spectrum 1 n/a 1 1722 79
Y0000266 Flunarizine dihydrochloride for system suitability 1 20 mg 1 1722 Yes +5C 3C 79
F0190000 Flunitrazepam - * psy 2 100 mg 1 Batch 1 is valid until 30 April 2016 1280 Yes +5C 3C 79
Y0000169 Flunitrazepam - reference spectrum 1 n/a 1 0717 79
Y0000443 Flunixin meglumine 1 10 mg 1 1696 Yes +5C 3C 79
Y0000444 Flunixin impurity B 1 10 mg 1 2-methyl-3-(trifluoromethyl)aniline 1696 Yes +5C 3C 79
Y0000445 Flunixin impurity C 2 55 mg 1 ethyl 2-chloropyridine-3-carboxylate 1696 Yes +5C 3C 79
F0200000 Fluocinolone acetonide 5 110 mg 1 see leaflet 0494 Yes +5C 3C 79
Y0001711 Fluocinolone acetonide for peak identification 1 10 mg 1 0494 Yes +5C 3C 79
Y0001710 Fluocinolone acetonide for system suitability 1 10 mg 1 0494 Yes +5C 3C 79
F0230000 Fluocortolone pivalate 1 100 mg 1 1212 Yes +5C 3C 79
Y0000796 Fluorescein 1 120 mg 1 See leaflet CHO 2348 Yes +5C 3C 79
Y0000804 Fluorescein impurity C 1 0.01 mg 1 2-(2,4-dihydroxybenzoyl)benzoic acid 2348 Yes +5C 3C 79
F0245000 Fluoresceine sodium - reference spectrum 1 n/a 1 1213 79
F0250000 Fluorouracil 3 40 mg 1 Batch 2 is valid until 30 November 2016 0611,0766 Yes +5C 3C 79
Y0000762 Fluorouracil impurity A 1 10 mg 1 pyrimidine-2,4,6(1H,3H,5H)-trione (barbituric acid) 0611 Yes +5C 3C 79
Y0000763 Fluorouracil impurity B 1 15 mg 1 dihydropyrimidine-2,4,5(3H)-trione (isobarbituric acid or 5-hydroxyuracil) 0611 Yes +5C 3C 79

Council of Europe, all rights reserved 2017 34 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0000764 Fluorouracil impurity C 1 10 mg 1 pyrimidine-2,4(1H,3H)-dione (uracil) 0611 Yes +5C 3C 79
Y0000765 Fluorouracil impurity F 1 10 mg 1 2-ethoxy-5-fluoropyrimidin-4(1H)-one (2-ethoxy-5-fluorouracil) 0611 Yes +5C 3C 79
New Y0000791 Fluorouracil impurity mixture 2 0.0002 mg 1 Batch 1 is valid until 30 June 2017 0611 Yes +5C 3C 79
F0253000 Fluoxetine hydrochloride 5 250 mg 1 See leaflet 1104 Yes +5C 3C 79
F0253020 Fluoxetine impurity B 6 10 mg 1 N-methyl-3-phenylpropan-1-amine 1104 Yes +5C 3C 79
F0253030 Fluoxetine impurity C 4 5 mg 1 (3RS)-N-methyl-3-phenyl-3-[3-(trifluoromethyl)phenoxy]propan-1-amine 1104 Yes +5C 3C 79
Y0000064 Flupentixol dihydrochloride 1 100 mg 1 See leaflet 1693 Yes +5C 3C 79
Y0000067 Flupentixol impurity D 2 15 mg 1 2-[2-[4-[3-[(EZ)-2-(trifluoromethyl)-9H-thioxanthen-9-ylidene]propyl] 1693 Yes +5C 3C 79
piperazin-1-yl]ethoxy]ethanol
Y0000078 Flupentixol impurity F 2 25 mg 1 See leaflet CHFNOS; mixture of 2-[4-[(E)-3-[(9RS)-2- 1693 Yes +5C 3C 79
(trifluoromethyl)-9H-thioxanthen-9-yl]prop-2-enyl]piperazin-1-yl]ethanol and
2-[4-[(Z)-3-[(9RS)-2-(trifluoromethyl)-9H-thioxanthen-9-yl]prop-2-enyl]
piperazin-1-yl]ethanol
F0260000 Fluphenazine decanoate 3 100 mg 1 Batch 2 is valid until 31 January 2017 1014,1015 Yes +5C 3C 79
F0280000 Fluphenazine dihydrochloride 2 50 mg 1 0904,1014 Yes +5C 3C 79
Y0000708 Fluphenazine impurity mixture 1 0.07 mg 1 0904 Yes +5C 3C 79
Y0000009 Fluphenazine enantate 3 100 mg 1 Batch 2 is valid until 31 January 2017 1014,1015 Yes +5C 3C 79
Y0000298 Fluphenazine octanoate 4 20 mg 1 1014,1015 Yes +5C 3C 79
Y0000299 Fluphenazine sulfoxide 2 15 mg 1 Batch 1 is valid until 31 December 2016 0904,1014,1 Yes +5C 3C 79
015
Y0000211 Flurazepam monohydrochloride - reference spectrum 1 n/a 1 0905 79
F0285200 Flurbiprofen 1 50 mg 1 1519 Yes +5C 3C 79
F0285202 Flurbiprofen impurity A 2 25 mg 1 (2RS)-2-(biphenyl-4-yl)propanoic acid 1519 Yes +5C 3C 79
Y0000236 Fluspirilene 1 20 mg 1 1723 Yes +5C 3C 79
Y0000375 Fluspirilene impurity C 1 10 mg 1 8-[4,4-bis(4-fluorophenyl)butyl]-3-(hydroxymethyl)-1-phenyl-1,3,8- 1723 Yes +5C 3C 79
triazaspiro[4.5]decan-4-one
F0285600 Flutamide 2 100 mg 1 See leaflet 1423 Yes +5C 3C 79
Y0001591 Flutamide for system suitability 1 10 mg 1 1423 Yes +5C 3C 79
Y0000284 Fluticasone propionate 4 100 mg 1 See leaflet CHFOS ; Batch 3 is valid until 31 October 2016 1750 Yes +5C 3C 79
Y0001754 Fluticasone propionate for impurity C identification 1 5 mg 1 1750 +5C 3C 79
Y0000221 Fluticasone impurity D 3 5 mg 1 6,9-difluoro-11-hydroxy-16-methyl-17- 1750 Yes +5C 3C 79
[(methylsulfanyl)carbonyl]-3-oxoandrosta-1,4-dien-17-yl
propanoate
Y0001755 Fluticasone propionate for impurity G identification 1 5 mg 1 1750 Yes +5C 3C 79
F0290000 Flutrimazole 1 100 mg 1 1424 Yes +5C 3C 79
F0290010 Flutrimazole impurity B 1 60 mg 1 (RS)-(2-fluorophenyl)(4-fluorophenyl)phenylmethanol 1424 Yes +5C 3C 79
Y0001090 Fluvastatin sodium 1 110 mg 1 2333 Yes +5C 3C 79
Y0001082 Fluvastatin for system suitability 1 0.5 mg 1 2333 Yes +5C 3C 79
Y0000854 Fluvoxamine maleate 1 5 mg 1 1977 Yes +5C 3C 79
Council of Europe, all rights reserved 2017 35 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0000853 Fluvoxamine for system suitability 1 1.004 mg 1 1977 Yes +5C 3C 79
Y0000916 Fluvoxamine impurity D 1 10 mg 1 5-methoxy-1-[4-(trifluoromethyl)phenyl]pentan-1-one 1977 Yes +5C 3C 79
Y0000386 Foeniculin for peak identification 1 100 mg 1 Anise oil 0804 Yes +5C 3C 79
F0300000 Folic acid 8 300 mg 2 See leaflet CHNO 0067 Yes +5C 3C 79
Y0001242 Folic acid impurity A 1 15 mg 1 (2S)-2-[(4-aminobenzoyl)amino]pentanedioic acid (N-(4-aminobenzoyl)-L- 0067 Yes +5C 3C 79
glutamic acid)
Y0001243 Folic acid impurity D 3 70 mg 1 4-[[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino]benzoic acid 0067 Yes +5C 3C 79
(pteroic acid)
Y0001629 Follitropin 1 0.2 mL 1 See leaflet 2285, 2286 Yes -20C 5C 79
Y0001627 Follitropin for peptide mapping and glycan analysis 1 0.5 mL 1 2285 Yes -20C 5C 79
F0372000 Formoterol fumarate dihydrate 2 10 mg 1 1293,1724 Yes +5C 3C 79
Y0000339 Formoterol for impurity I identification 2 10 mg 1 Batch 1 is valid until 31 March 2016 1724 Yes +5C 3C 79
Y0000340 Formoterol fumarate for system suitability 2 10 mg 1 Batch 1 is valid until 31 March 2016 1724 Yes +5C 3C 79
F0380000 Formylfolic acid 3 30 mg 1 See leaflet CHNO; 10-Formylfolic acid 0978,1606 Yes -20C 5C 79
F0389000 Foscarnet sodium hexahydrate 1 50 mg 1 1520 Yes +5C 3C 79
F0389004 Foscarnet impurity B 1 10 mg 1 disodium (ethoxyoxydophosphanyl)formate 1520 Yes +5C 3C 79
Y0001222 Foscarnet impurity D 1 50 mg 1 ethyl (diethoxyphosphoryl)formate 1520 Yes +5C 3C 79
Y0001213 Foscarnet impurity mixture 1 0.012 mg 1 1520 Yes +5C 3C 79
Y0000782 Fosfomycin calcium 1 10 mg 1 1328 Yes +5C 3C 79
F0399950 Fosfomycin sodium - reference spectrum 1 n/a 1 1329 79
F0400000 Fosfomycin trometamol 3 1500 mg 1 See leaflet 1425 Yes +5C 3C 79
Y0001227 Fosinopril sodium 1 60 mg 1 1751 Yes +5C 3C 79
Y0001228 Fosinopril impurity A 1 5 mg 1 (2S,4S)-4-cyclohexyl-1-[[(R)-hydroxy(4-phenylbutyl)phosphoryl]acetyl] 1751 Yes +5C 3C 79
pyrrolidine-2-carboxylic acid
Y0001229 Fosinopril impurity B 1 5 mg 1 (2RS,4RS)-4-cyclohexyl-1-[[(RS)-[(1SR)-2-methyl-1-(1-oxopropoxy) 1751 Yes +5C 3C 79
propoxy](4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid
Y0001230 Fosinopril impurity C 1 10 mg 1 mixture of (2S,4S)-4-cyclohexyl-1-[[(S)-[(1S)-2-methyl-1-(1-oxopropoxy) 1751 Yes +5C 3C 79
propoxy](4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid and
(2S,4S)-4-cyclohexyl-1-[[(R)-[(1R)-2-methyl-1-(1-oxopropoxy)propoxy](4-
phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid
Y0001231 Fosinopril impurity D 1 10 mg 1 (2S,4R)-4-cyclohexyl-1-[[(R)-[(1S)-2-methyl-1-(1-oxopropoxy)propoxy](4- 1751 Yes +5C 3C 79
phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid
Y0001232 Fosinopril impurity I 1 5 mg 1 [(RS)-[(1SR)-2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphoryl] 1751 Yes +5C 3C 79
acetic acid
Y0001233 Fosinopril impurity K 1 5 mg 1 (2S,4S)-4-cyclohexyl-1-(2,2-dimethyl-1-oxopropyl)pyrrolidine-2-carboxylic 1751 Yes +5C 3C 79
acid
Y0001212 Fosinopril impurity mixture 1 0.02 mg 1 1751 Yes +5C 3C 79
F0450000 Framycetin sulfate 7 25 mg 2 See leaflet ; Batch 6 is valid until 28 February 2017 0180,0197,2 Yes -20C 5C 79
0702

Council of Europe, all rights reserved 2017 36 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
F0550000 Fructose 1 100 mg 1 0188, 0924 Yes +5C 3C 79
Y0001399 Fulvestrant 1 120 mg 1 See leaflet CHFOS 2443 Yes +5C 3C 79
Y0001413 Fulvestrant for system suitability 1 40 mg 1 2443 Yes +5C 3C 79
F0600000 Fumaric acid 3 120 mg 1 0365,0902,1 Yes +5C 3C 79
190
F0700000 Furosemide 2 100 mg 1 0391,2185 Yes +5C 3C 79
F0702000 Furosemide impurity A 4 5 mg 1 2-chloro-4-[(furan-2-ylmethyl)amino]-5-sulfamoylbenzoic acid 0391 Yes +5C 3C 79
Y0001493 Furosemide for peak identification 2 10 mg 1 Batch 1 is valid until 31 May 2016 0391 Yes +5C 3C 79
Y0001411 Fusidic acid 1 10 mg 1 0798 Yes -20C 5C 79
Y0001394 Fusidic acid for peak identification 1 5 mg 1 0798,0848 Yes -20C 5C 79
Y0001384 Fusidic acid impurity mixture 2 0.048 mg 1 0798,0848 Yes -20C 5C 79
Y0001280 Gabapentin 2 300 mg 1 See leaflet CHNO ; Batch 1 is valid until 31 December 2016 2173 Yes +5C 3C 79
Y0001281 Gabapentin impurity A 1 20 mg 1 2-azaspiro[4.5]decan-3-one 2173 Yes +5C 3C 79
Y0001348 Gabapentin impurity B 2 20 mg 1 (1-cyanocyclohexyl)acetic acid 2173 Yes -20C 5C 79
Y0001349 Gabapentin impurity D 1 10 mg 1 [1-[(3-oxo-2-azaspiro[4.5]dec-2-yl)methyl]cyclohexyl]acetic acid 2173 Yes +5C 3C 79
Y0001803 Gadobutrol monohydrate 1 210 mg 1 See leaflet CHGdNO,HO 2735 Yes +5C 3C 79
Y0001804 Gadobutrol for peak identification 1 20 mg 1 2735 Yes +5C 3C 79
G0049000 Galactitol 2 50 mg 1 1381 Yes +5C 3C 79
G0050000 Galactose 3 100 mg 1 See leaflet CH0 ; Batch 2 is valid until 30 June 2016 1215 Yes +5C 3C 79
Y0001279 Galantamine hydrobromide 1 10 mg 1 2366 Yes +5C 3C 79
Y0001190 Galantamine natural for system suitability 1 10 mg 1 2366 Yes +5C 3C 79
Y0001201 Galantamine racemic mixture 1 10 mg 1 2366 Yes +5C 3C 79
New Y0001191 Galantamine synthetic for system suitability 2 5 mg 1 Batch 1 is valid until 30 June 2017 2366 Yes +5C 3C 79
G0150000 Gammacyclodextrin 2 60 mg 1 See leaflet CHO 1070,1487 Yes +5C 3C 79
Y0001129 Ganciclovir 1 220 mg 1 1752 Yes +5C 3C 79
Y0001144 Ganciclovir impurity mixture 1 0.005 mg 1 1752 Yes +5C 3C 79
Y0001813 Gefitinib 1 100 mg 1 See leaflet CHClFNO 2866 Yes +5C 3C 79
Y0001809 Gefitinib for system suitability 1 0.351 mg 1 2866 Yes +5C 3C 79
Y0000675 Gemcitabine hydrochloride 1 50 mg 1 See leaflet 2306 Yes +5C 3C 79
Y0000676 Gemcitabine impurity A 1 20 mg 1 4-aminopyrimidin-2(1H)-one (cytosine) 2306 Yes +5C 3C 79
Y0001682 Gemcitabine impurity C 1 5 mg 1 1-(2-deoxy-2,2-difluoro--D-erythro-pentofuranosyl)pyrimidin-2,4(1H,3H)- 2306 Yes +5C 3C 79
dione (2-deoxy-2,2-difluorouridine) (-uridine)
Y0000513 Gemfibrozil 1 5 mg 1 1694 Yes +5C 3C 79
Y0000514 Gemfibrozil for system suitability 2 0.196 mg 1 1694 Yes +5C 3C 79
Y0001835 Geniposide 1 15 mg 1 See leaflet CHO 2565 Yes +5C 3C 79
G0200000 Gentamicin sulfate 14 25 mg 2 see leaflet ; Batch 9 is valid until 28 February 2017 0331,20702 Yes -20C 5C 79

Council of Europe, all rights reserved 2017 37 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0001363 Gentamicin for peak identification 2 10 mg 1 Batch 1 is valid until 31 March 2016 0331 Yes -20C 5C 79
Y0001112 Gestodene 2 100 mg 1 see leaflet 1726 Yes +5C 3C 79
Y0001116 Gestodene impurity I 1 0.01 mg 1 13-ethyl-17-hydroxy-5-methoxy-18,19-dinor-5,17-pregn-15-en-20-yn-3- 1726 Yes +5C 3C 79
one (5-methoxy-gestodene)
Y0001110 Gestodene for system suitability 1 10 mg 1 1726 Yes +5C 3C 79
Y0001012 Ginkgo dry extract for peak identification 2 150 mg 1 1827 Yes -20C 5C 79
Y0001010 Ginkgolic Acids 2 20 mg 1 See leaflet 1827 Yes -20C 5C 79
Y0001029 Ginseng dry extract HRS 1 500 mg 1 2356 Yes -20C 5C 79
Y0001347 Ginsenoside Rb1 1 30 mg 1 See leaflet CHO 2356 Yes +5C 3C 79
G0300000 Gitoxin 3 30 mg 1 Batch 2 is valid until 31 July 2016 0078,2168 Yes +5C 3C 79
G0325000 Glibenclamide 3 100 mg 1 0718 Yes +5C 3C 79
G0325010 Glibenclamide impurity A 4 10 mg 1 5-chloro-2-methoxy-N-[2-(4-sulfamoylphenyl)ethyl]benzamide 0718 Yes +5C 3C 79
; Batch 3 is valid until 28 February 2017
Y0000242 Glibenclamide impurity B 3 10 mg 1 methyl [[4-[2-[(5-chloro-2-methoxybenzoyl)amino]ethyl]phenyl]sulphonyl] 0718 Yes +5C 3C 79
carbamate ; Batch 2 is valid until 31 December 2016
Y0001511 Glibenclamide for peak identification 1 30 mg 1 0718 Yes +5C 3C 79
Y0001406 Glucosamine hydrochloride 1 15 mg 1 2446 Yes +5C 3C 79
G0326000 Gliclazide 2 20 mg 1 1524 Yes +5C 3C 79
G0326004 Gliclazide impurity B 3 25 mg 1 2-nitroso-octahydrocyclopenta[c]pyrrole 1524 Yes +5C 3C 79
G0326012 Gliclazide impurity F 5 50 mg 1 1-(hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-[(2-methylphenyl) sulphonyl] 1524 Yes +5C 3C 79
urea
Y0001685 Glucosamine sulfate potassium chloride 1 10 mg 1 2708 Yes +5C 3C 79
Y0000515 Glimepiride 2 110 mg 1 See leaflet 2223 Yes +5C 3C 79
Y0001742 Glimepiride for impurity A identification 1 5 mg 1 2223 Yes +5C 3C 79
Y0000516 Glimepiride for system suitability 4 0.012 mg 1 Batch 3 is valid until 28 February 2017 2223 Yes +5C 3C 79
G0340000 Glipizide 1 50 mg 1 0906 Yes +5C 3C 79
G0342000 Glipizide impurity A 1 10 mg 1 5-methyl-N-[2-(4-sulfamoylphenyl)ethyl]pyrazine-2-carboxamide 0906 Yes +5C 3C 79

Y0000523 Glipizide impurity C 1 10 mg 1 ethyl [2-[4-[(cyclohexylcarbamoyl)sulfamoyl]phenyl]ethyl] carbamate 0906 Yes +5C 3C 79


Y0000643 Glipizide impurity D 1 10 mg 1 6-methyl-N-[2-(4-sulphamoylfenyl)ethyl]pyrazine-2-carboxamide 0906 Yes +5C 3C 79
Y0001140 Glipizide impurity mixture 1 0.002 mg 1 0906 Yes +5C 3C 79
Y0001407 Glucosamine sulfate sodium chloride 1 15 mg 1 2447 Yes +5C 3C 79
Y0001381 Glucosamine for system suitability 1 40 mg 1 2446,2447,2 Yes +5C 3C 79
708
Y0001745 Glucose monohydrate 1 750 mg 1 See leaflet CHO,HO 0177,0178,0 Yes +5C 3C 79
209
G0355000 Glutamic acid 2 50 mg 1 0750,0797,1 Yes +5C 3C 79
445, 2076

Council of Europe, all rights reserved 2017 38 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0000517 Glutathione 1 10 mg 1 1670 Yes +5C 3C 79
G0360000 Glutethimide - * psy 1 50 mg 1 1291 Yes +5C 3C 79
G0400000 Glycerol (85 per cent) - reference spectrum 1 n/a 1 0496,0497 79
Y0001391 Glycerol formal 1 20 mg 2 1671 Yes +5C 3C 79
Y0000794 Glycerol monocaprylate 1 400 mg 1 2213 Yes +5C 3C 79
Y0000795 Glycerol monocaprylocaprate 2 500 mg 1 2392 Yes +5C 3C 79
G0400006 Glycerol monolinoleate 1 2000 mg 1 1429 Yes +5C 3C 79
G0400007 Glycerol mono-oleate 2 2500 mg 1 1430 Yes +5C 3C 79
G0400008 Glycerol monostearate 40-55 4 2000 mg 1 Batch 3 is valid until 31 March 2017 0495 Yes +5C 3C 79
Y0001786 Glyceryl trinitrate for system suitability 1 0.5 mL 1 1331 Yes +5C 3C 79
G0400100 Glyceryl trinitrate solution 3 0.5 mL 1 1331,1355 Yes +5C 3C 79
G0400101 Glyceryl trinitrate - reference spectrum 1 n/a 1 1331 79
G0450000 Glycine 3 50 mg 1 0614, 0813 Yes +5C 3C 79
Y0001308 Glycopyrronium bromide 1 10 mg 1 1783 Yes +5C 3C 79
Y0001358 Glycopyrronium impurity N 1 10 mg 1 See leaflet CHBrNO; (3RS)-3-[(2RS)-(2-cyclopentyl-2-hydroxy-2- 1783 Yes +5C 3C 79
phenylacetyl)oxy]-1,1-dimethylpyrrolidinium
Y0000433 Ammonium glycyrrhizate 2 70 mg 1 1772 Yes +5C 3C 79
Y0001309 Glycopyrronium for peak identification 1 10 mg 1 1783 Yes +5C 3C 79
G0460000 Glycyrrhizate (monoammonium) 4 300 mg 1 see leaflet 0277, 2378 Yes +5C 3C 79
G0525000 Gonadorelin 5 5 mg 1 See leaflet CHNO 0827 Yes -20C 5C 79
Y0000125 Goserelin 3 2 mg 1 See leaflet CHNO ; Batch 2 is valid until 30 November 2016 1636 Yes -20C 5C 79
Y0000126 Gosereline - reference spectrum 1 n/a 1 1636 79
Y0001473 Goserelin for NMR identification 1 14 mg 1 1636 Yes -20C 5C 79
Y0000194 Goserelin validation mixture 2 1 mg 1 Supplied with the Ph. Eur. reference chromatogram 1636 Yes -20C 5C 79
Y0000019 4-D-Ser-goserelin 1 0.1 mg 1 1636 Yes -20C 5C 79
G0550000 Gramicidin 1 250 mg 1 See leaflet 0907,1662,2 Yes +5C 3C 79
0702
Y0000396 Granisetron hydrochloride 2 120 mg 1 See leaflet 1695 Yes +5C 3C 79
Y0000477 Granisetron impurity A 3 1 mg 1 2-methyl-N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-2H- 1695 Yes +5C 3C 79
indazole-3-carboxamide
Y0000478 Granisetron impurity B 3 1 mg 1 N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3- 1695 Yes +5C 3C 79
carboxamide
Y0000395 Granisetron impurity E 3 15 mg 2 (1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine 1695 Yes +5C 3C 79
G0600000 Griseofulvin 2 50 mg 1 0182 Yes +5C 3C 79
Y0000619 Guaiacol 2 1500 mg 1 See leaflet CHO 1978 Yes +5C 3C 79
G0700000 Guaifenesin 1 100 mg 1 0615 Yes +5C 3C 79
Y0000117 Halofantrine hydrochloride 1 125 mg 1 See leaflet CHClFNO 1979 Yes +5C 3C 79

Council of Europe, all rights reserved 2017 39 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0000118 Halofantrine impurity C 1 10 mg 1 [1,3-dichloro-6-(trifluoromethyl)phenantren-9-yl]methanol 1979 Yes +5C 3C 79
H0100000 Haloperidol 2 60 mg 1 0616,1178 Yes +5C 3C 79
Y0001518 Haloperidol for peak identification 2 20 mg 1 0616 Yes +5C 3C 79
Y0001517 Haloperidol for system suitability 1 25 mg 1 0616 Yes +5C 3C 79
H0100100 Haloperidol decanoate 1 60 mg 1 1397,1431 Yes +5C 3C 79
H0150000 Halothane - reference spectrum 2 n/a 1 0393 79
Y0000673 Harpagoside 1 1.03 mg 1 See leaflet CHO 1095, 1871 Yes +5C 3C 79
H0200000 Heparin sodium BRP 3 2 ml 1 See leaflet 0569, 20705 Yes +5C 3C 79
Y0001283 Heparin sodium for NMR identification 1 30 mg 1 0333 Yes +5C 3C 79
Y0001287 Heparin calcium for NMR identification 1 30 mg 1 0332 Yes +5C 3C 79
Y0001282 Heparin for physico-chemical analysis 2 300 mg 1 0332, 0333 Yes +5C 3C 79
H0185000 Heparin Low-Molecular-Mass for assay BRP 9 1 mg 5 See leaflet ; Batch 8 is valid until 31 March 2016 0828 Yes +5C 3C 90
H0190000 Heparin Low-Molecular-Mass for calibration CRS 3 25 mg 1 See leaflet 0828 Yes +5C 3C 90
H0205010 Hepatitis A vaccine (inactivated, adsorbed) Type B BRP 2 0.5 ml 3 See leaflet; Please contact us for information on the type needed for your use See leaflet, Yes +5C 3C 90
20714
Y0001192 Hepatitis A Vaccine (Inactivated, Non-Adsorbed) BRP 2 1 mL 1 To be stored below -50C 20714,1526, Yes -80C 10C 90
1935, 1107
Y0001624 Hepatitis A virus Coating Reagent for ELISA - BRR 1 1 mL 1 Yes -20C 5C 79
Y0001623 Set of Hepatitis A virus Detection Antibodies for ELISA - 3 275 L 1 See leaflet 20714 Yes -20C 5C 79
BRR
Y0001872 Hepatitis A virus RNA for NAT testing BRP 1 45 mg 5 See leaflet 1646 Yes -20C 5C 242
Y0000389 Hepatitis B vaccine (rDNA) BRP method A (thiomersal 2 0.5 ml 2 See leaflet; Ph. Eur. BRPs are established in the context of specific methods. See leaflet, Yes +5C 3C 90
free) The method used to establish this BRP (refer to leaflet) is no longer available. 20715
Reference to the BRP has therefore been removed from the relevant
monograph and general chapter of the Ph. Eur. and upon depletion of stocks
this BRP will not be replaced. Users are encouraged to find alternative
reference material to address their future needs.
H0210010 Hepatitis B vaccine (rDNA) BRP method B 2 1 ml 2 See leaflet; Ph. Eur. BRPs are established in the context of specific methods. See leaflet, Yes +5C 3C 90
The method used to establish this BRP (refer to leaflet) is no longer available. 1056
Reference to the BRP has therefore been removed from the relevant
monograph and general chapter of the Ph. Eur. and upon depletion of stocks
this BRP will not be replaced. Users are encouraged to find alternative
reference material to address their future needs.
H0215000 Hepatitis C Virus RNA for NAT testing BRP 1 40 mg 5 See leaflet; For plasma pool testing by NAT See leaflet, Yes -20C 5C 242
20621
Y0001873 Hepatitis E virus RNA for NAT testing BRP 1 45 mg 1 See leaflet 1646 Yes -20C 5C 79
Y0000063 Heptaminol hydrochloride 1 150 mg 1 1980 Yes +5C 3C 79
Y0000057 Heptaminol impurity A 2 20 mg 1 See leaflet CHN; (2RS)-6-methylhept-5-en-2-amine 1980 Yes +5C 3C 79
Y0001203 Hesperidin 1 20 mg 1 See leaflet CHO 2430 Yes +5C 3C 79
H0330000 Hexamidine diisetionate 2 20 mg 1 1436 Yes +5C 3C 79

Council of Europe, all rights reserved 2017 40 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
H0325000 Hexetidine 2 100 mg 1 1221 Yes +5C 3C 79
H0420000 Hexylresorcinol 1 100 mg 1 1437 Yes +5C 3C 79
Y0001746 Hexylresorcinol for system suitability 1 1 mg 1 1437 Yes -20C 5C 79
H0500000 Hide powder 4 500 mg 1 20814 Yes +5C 3C 79
Y0001779 Histamine 1 15 mg 1 2671 Yes -20C 5C 79
H0600000 Histamine dihydrochloride 3 250 mg 1 Batch 2 is valid until 30 April 2017 0143 Yes +5C 3C 79
H0750000 Histidine 3 25 mg 1 0911 Yes +5C 3C 79
H0755000 Histidine hydrochloride monohydrate 2 100 mg 1 0910,2671 Yes +5C 3C 79
H0800000 Homatropine hydrobromide 1 100 mg 1 0500,0720 Yes +5C 3C 79
H0830000 Homatropine methylbromide 1 25 mg 1 0720 Yes +5C 3C 79
H0837000 L-Homocysteine thiolactone hydrochloride - reference 1 n/a 1 1617 79
spectrum
Y0001383 Homatropine methylbromide for system suitability 1 5 mg 1 0720 Yes +5C 3C 79
Y0001290 Honokiol 1 20 mg 1 See leaflet CHO 2567,2568 Yes -20C 5C 79
H0900000 Human albumin for electrophoresis BRP 3 50 mg 1 See leaflet ; Batch 2 is valid until 31 March 2017 0255 Yes -20C 5C 79
Y0000219 Human anti-D immunoglobulin BRP 1 40 mg 1 See leaflet See leaflet, Yes -20C 5C 90
20713
Y0000667 Human coagulation factor VII concentrate BRP 2 25 mg 2 See leaflet See leaflet, Yes -20C 5C 79
20710
Y0001663 Human coagulation factor VIIa (rDNA) 1 42 mg 1 See leaflet 2534 Yes -20C 5C 79
H0920000 Human coagulation factor VIII concentrate BRP 5 37 mg 3 See leaflet ; Batch 4 is valid until 31 May 2016 20704 Yes -20C 5C 90
H0920500 Human coagulation factor IX concentrate BRP 3 30 mg 3 See leaflet; Common standard with FDA and WHO (4th IS) ; Batch 2 is valid 2.7.11 Yes -20C 5C 90
until 31 October 2016
Y0001659 Human coagulation factor IX (rDNA) 1 10 mg 1 see leaflet 2522 Yes -20C 5C 79
Y0000191 Human glucagon 2 2.94 mg 2 See leaflet CHNOS 1635 Yes -20C 5C 79
H0950000 Human hepatitis A immunoglobulin BRP 1 10 mg 3 See leaflet See leaflet, Yes -20C 5C 90
0338, 0769,
1646
Y0001414 Human Hepatitis B immunoglobulin BRP 1 100 mg 1 See leaflet 0722, 1016 Yes -20C 5C 90
Y0001504 Human immunoglobulin BRP (ACA and Molecular size) 1 6000 mg 1 See leaflet, Yes +5C 3C 90
0338, 0918
Y0001512 Human Immunoglobulin BRP (Fc Function and 2 5000 mg 1 See leaflet ; Batch 1 is valid until 30 September 2016 See leaflet, Yes +5C 3C 90
Molecular size) 0338, 0918
Y0000488 Human immunoglobulin (molecular size) BRP 1 700 mg 3 Each vial contains 0.7 gram of immunoglobulin G See leaflet, Yes +5C 3C 90
0338,
0918,1928
H1000000 Human immunoglobulin for electrophoresis BRP 3 50 mg 1 See leaflet 0338,0918 Yes +5C 3C 79
H1005000 Human Plasma Pools for NAT validation 1 3502 mg 1 Set of 103 plasma pool samples See leaflet, Yes -20C 5C 400
20621

Council of Europe, all rights reserved 2017 41 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
H1100000 Human rabies immunoglobulin BRP 1 170 mg 3 See leaflet See leaflet, Yes -20C 5C 90
0723
H1110000 Human tetanus immunoglobulin BRP 1 87 mg 1 See leaflet 0398 Yes -20C 5C 90
Y0000502 Human vaccinia immunoglobulin 1 1 ml 3 See leaflet See leaflet Yes -20C 5C 270
H1115000 Hyaluronidase BRP 2 50 mg 1 See leaflet ; Batch 1 is valid until 31 October 2016 0912 Yes +5C 3C 79
H1120000 Hydralazine hydrochloride 1 20 mg 1 0829 Yes +5C 3C 79
New Y0001151 Hydrastine hydrochloride 2 25 mg 1 See leaflet CHClNO ; Batch 1 is valid until 31 May 2017 1831,2500 Yes -20C 5C 79
H1200000 Hydrochlorothiazide 7 300 mg 1 See leaflet CHClNOS 0394 Yes +5C 3C 79
Y0001494 Hydrochlorothiazide for peak identification 3 10 mg 1 Batch 2 is valid until 30 November 2016 0394 Yes +5C 3C 79
Y0000646 Hydrocodone hydrogen tartrate 2.5-hydrate - * narc 1 10 mg 1 1784 Yes +5C 3C 79
Y0000710 Hydrocodone for peak identification - * narc 1 10 mg 1 1784 Yes +5C 3C 79
H1300000 Hydrocortisone 8 100 mg 1 0335 Yes +5C 3C 79
Y0001092 Hydrocortisone for peak identification 2 5 mg 1 0335 Yes +5C 3C 79
H1400000 Hydrocortisone acetate 9 125 mg 1 See leaflet 0321,0334,0 Yes +5C 3C 79
335,
0734,0767
Y0001482 Hydrocortisone acetate for peak identification 2 15 mg 1 Batch 1 is valid until 30 November 2016 0334 Yes +5C 3C 79
H1425000 Hydrocortisone hydrogen succinate 2 100 mg 1 0768 Yes -20C 5C 79
H1426000 Hydrogenated wool fat 1 250 mg 1 0969 Yes +5C 3C 79
Y0000446 Hydromorphone hydrochloride - * narc 1 10 mg 1 2099 Yes +5C 3C 79
B0650000 Hydrous benzoyl peroxide - reference spectrum 1 n/a 1 0704 79
H1428000 Hydroxocobalamin 1 10 mg 1 0913,0914,0 Yes -20C 5C 79
915
Y0000119 Hydroxycarbamide 2 360 mg 1 See leaflet 1616 Yes +5C 3C 79
Y0001841 Hydroxychloroquine for system suitability 1 15 mg 1 2849 Yes +5C 3C 79
New Y0001839 Hydroxychloroquine sulfate 1 70 mg 1 see leaflet CHClNO.HSO 2849 Yes +5C 3C 79
H1429400 Hydroxyethyl salicylate 1 125 mg 1 1225 Yes +5C 3C 79
Y0001322 Hydroxyethyl starch (high Mw) 1 800 mg 1 See leaflet 1785 Yes +5C 3C 79
Y0001277 Hydroxyethyl starch (medium MW) 1 1200 mg 1 See leaflet 1785 Yes +5C 3C 79
H1430000 D-alpha-(4-Hydroxy-phenyl)glycine 1 50 mg 1 (2R)-2-amino-2-(4-hydroxyphenyl)acetic acid - Cefadroxyl impurity A 0813 Yes +5C 3C 79
H1429700 4-Hydroxyphenoxymethylpenicillin potassium 3 20 mg 1 See leaflet CHKNOS; The reference standard H1429700 will be deleted 0148,0149 Yes -20C 5C 79
from monographs 01/2008:0148 and 01/2008:0149 on 2017/04/01 and
replaced by the reference standard Y0001868. ; Batch 3 is valid until 31
March 2017
Y0000186 Hydroxypropylbetadex 2 200 mg 1 1804 Yes +5C 3C 79
Y0001720 Hydroxypropylcellulose 1 150 mg 1 0337, 2083 Yes +5C 3C 79
Y0001798 Low-substituted hydroxypropylcellulose 1 100 mg 1 2083 Yes +5C 3C 79
H1435000 Hydroxyzine hydrochloride 3 600 mg 1 0916,1086 Yes +5C 3C 79

Council of Europe, all rights reserved 2017 42 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0000011 Hymecromone 1 100 mg 1 1786 Yes +5C 3C 79
Y0000012 Hymecromone impurity A 1 25 mg 1 benzene-1,3-diol (resorcinol) 1786 Yes +5C 3C 79
Y0000013 Hymecromone impurity B 2 25 mg 1 7-hydroxy-2-methyl-4H-1-benzopyran-4-one. 1786 Yes +5C 3C 79
Y0000483 Hyoscine 1 10 mg 1 2167 Yes +5C 3C 79
Y0000484 Hyoscine impurity A 1 15 mg 1 (1R,2R,4S,5S,7s)-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl 2167 Yes +5C 3C 79
(2S)-3-hydroxy-2-phenylpropanoate (norhyoscine)
H1450000 Hyoscine butylbromide 2 20 mg 1 0737 Yes +5C 3C 79
Y0000447 Hyoscine butylbromide impurity E 1 10 mg 1 (1R,2R,4S,5S,7s)-9-butyl -3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl (2S)-3- 0737 Yes +5C 3C 79
hydroxy-2-phenylpropanoate (N-butylhyoscine)
H1500000 Hyoscine hydrobromide 1 50 mg 1 0106,0500 Yes +5C 3C 79
Y0000448 Hyoscine hydrobromide impurity B 1 10 mg 1 (1R,2R,4S,5S,7s)-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl (2S)-3-hydroxy-2- 0106 Yes +5C 3C 79
phenylpropanoate (norhyoscine)
H1600000 Hyoscyamine sulfate 1 100 mg 1 0501, 2489 Yes +5C 3C 79
Y0000449 Hyoscyamine impurity E 1 10 mg 1 (1R,3r,5S)-8-azabicyclo[3.2.1]oct-3-yl (2S)-3-hydroxy-2-phenylpropanoate 0501 Yes +5C 3C 79
(norhyoscyamine)
Y0000915 Hypromellose phthalate 1 10 mg 1 347 Yes +5C 3C 79
I0020000 Ibuprofen 5 250 mg 1 0721 Yes +5C 3C 79
B1220000 Ibuprofen impurity B 9 1.15 mL 1 See leaflet; (2RS)-2-(4-Butylphenyl)propanoic acid 0721 Yes +5C 3C 79
Y0000140 Ibuprofen impurity F 2 5 mg 1 3-[4-(2-methylpropyl)phenyl]propanoic acid 0721 Yes +5C 3C 79
Y0000881 Ibuprofen for peak identification 7 0.09 mg 1 Batch 5 is valid until 31 March 2016 0721 Yes +5C 3C 79
Batch 6 is valid until 31 March 2017
I0050000 Idoxuridine 1 50 mg 1 0669 Yes +5C 3C 79
I0060000 Ifosfamide 1 50 mg 1 See leaflet CHClNOP 1529 Yes +5C 3C 79
I0060100 Ifosfamide - reference spectrum 1 n/a 1 1529 79
I0060002 Ifosfamide impurity A 4 100 mg 2 3-[(2-chloroethyl)amino]propyl dihydrogen phosphate 1529 Yes -20C 5C 79
I0060004 Ifosfamide impurity B 2 40 mg 1 bis[3-[(2-chloroethyl)amino]propyl] dihydrogen diphosphate 1529 Yes +5C 3C 79
I0060010 Ifosfamide impurity E 1 20 mg 2 3-chloro-N-(2-chloroethyl)propan-1-amine 1529 Yes +5C 3C 79
I0060012 Ifosfamide impurity F 2 10 mg 1 (RS)-2-chloro-3-(2-chloroethyl)-1,3,2-oxazaphosphinane 2-oxide 1529 Yes +5C 3C 79
New Y0001691 Imatinib mesilate 2 120 mg 1 see leaflet CHNSO ; Batch 1 is valid until 31 May 2017 2736 Yes +5C 3C 79
Y0001695 Imatinib impurity A 1 0.03 mg 1 (2E)-3-(dimethylamino)-1-(pyridin-3-yl)prop-2-ene-1-one 2736 Yes -20C 5C 79
Y0001693 Imatinib impurity F 3 10 mg 1 4-methyl-N3-[4-(pyridin-3-yl)pyrimidin-2-yl]benzene-1,3-diamine 2736 Yes +5C 3C 79
; Batch 2 is valid until 31 July 2016
Y0001694 Imatinib impurity H 1 130 mg 1 1-(pyridin-3-yl)ethan-1-one 2736 Yes +5C 3C 79
Y0001692 Imatinib for system suitability 1 5 mg 1 2736 Yes +5C 3C 79
I0086000 Imidazole 2 60 mg 1 0757,1424, Yes +5C 3C 79
2270
I0090000 Imipenem 3 70 mg 1 See leaflet 1226 Yes -20C 5C 79

Council of Europe, all rights reserved 2017 43 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
I0100000 Imipramine hydrochloride 2 50 mg 1 0029, 0408, Yes +5C 3C 79
0889,1787
Y0001689 Immunoglobulin (anti-A, anti-B antibodies test) 1 50 mg 1 20620 Yes -20C 5C 90
Negative control
Y0001688 Immunoglobulin (anti-A, anti-B antibodies test) Positive 1 46 mg 1 20620 Yes -20C 5C 90
control
Y0000893 Imipramine for system suitability 1 10 mg 1 0029 Yes +5C 3C 79
Y0001153 Immunoglobulin for anti-A, anti-B antibodies limit test 1 45 mg 1 20620 Yes -20C 5C 90
BRP
Y0000540 Immunoglobulin panel for anti-D antibodies test BRP 1 2000 mg 1 See leaflet, Yes -20C 5C 90
20626
Y0001205 Imperatorin 1 20 mg 1 See leaflet CHO 2556 Yes +5C 3C 79
I0150000 Indapamide 5 150 mg 1 See leaflet CHClNOS 1108 Yes +5C 3C 79
Y0001828 Indapamide Impurity C 1 25 mg 1 (2RS)-2-methyl-2,3-dihydro-1H-indol-1-amine 1108 Yes +5C 3C 79
I0150020 Indapamide impurity B 4 5 mg 1 4-chloro-N-(2-methyl-1H-indol-1-yl)-3-sulfamoylbenzamide 1108 Yes +5C 3C 79
Y0001752 Indigo 1 15 mg 1 see leaflet CHNO 2727 Yes +5C 3C 79
Y0000788 Indinavir 1 100 mg 1 see leaflet 2214 Yes +5C 3C 79
Y0000880 Indinavir sulfate - reference spectrum 1 n/a 1 2214 79
Y0000746 Indinavir for system suitability 1 20 mg 1 2214 Yes +5C 3C 79
New I0200000 Indometacin 3 70 mg 1 Batch 2 is valid until 18 January 2017 0092,0922,1 Yes +5C 3C 79
686
Y0001640 Indometacine impurity mixture 1 0.002 mg 1 0092 Yes +5C 3C 79
Y0000349 Insulin aspart 2 8 mg 1 See leaflet 2084 Yes -20C 5C 90
I0305000 Insulin (bovine) 3 7.99 mg 1 See leaflet CHNOS 0854,1637 Yes -20C 5C 90
Y0001542 Insulin glargine 1 15 mg 1 See leaflet 2571 Yes -20C 5C 79
Y0001544 Insulin glargine for peak identification 1 3.2 mg 1 2571 Yes -20C 5C 79
I0310000 Insulin (human) 4 8 mg 1 see leaflet 0838, 0854, Yes -20C 5C 90
1637, 1638
Y0000348 Insulin lispro 2 5.75 mg 1 See leaflet CHNOS 2085 Yes -20C 5C 90
I0320000 Insulin (porcine) 4 9 mg 1 See leaflet CHNOS; For qualitative use see insulin porcine for system 0854,1638 Yes -20C 5C 90
suitability CRS Y0001717
Y0001717 Insulin porcine for system suitability 2 9 mg 1 For intended use: see leaflet. 0838,0854,1 Yes -20C 5C 79
637, 1638
I0320301 Interferon alfa-2b 6 200 L 1 About 9.74 mg per mL 1110 Yes -80C 10C 90
Y0001101 Interferon beta-1a 3 0.6 mL 1 See leaflet 1639 Yes -80C 10C 90
I0320330 Interferon gamma-1b 2 0.5 mL 2 about 1 mg per ml 1440 Yes -80C 10C 90
Y0001664 Interferon gamma-1b for system suitability 1 0.6 mg 1 1440 Yes -20C 5C 79
New I0328000 Iobenguane sulfate 3 25 mg 1 See leaflet ; Batch 2 is valid until 31 May 2017 1111,1112,11 Yes +5C 3C 79
13,2351

Council of Europe, all rights reserved 2017 44 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0000839 Iobenguane sulfate - reference spectrum 1 n/a 1 2351 79
Y0001294 Iodixanol 1 60 mg 1 2215 Yes +5C 3C 79
Y0001292 Iodixanol impurity C 1 10 mg 1 5-[acetyl[3-[[3,5-bis[(2,3-dihydroxypropyl)carbamoyl]-2,4,6-triiodophenyl] 2215 Yes +5C 3C 79
amino]-2-hydroxypropyl]amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-
triiodobenzene-1,3-dicarboxamide
Y0001291 Iodixanol impurity E 1 10 mg 1 5-[acetyl[3-[acetyl[3-carbamoyl-5-[(2,3-dihydroxypropyl)carbamoyl]-2,4,6- 2215 Yes +5C 3C 79
triiodophenyl]amino]-2-hydroxypropyl]amino]-N,N'-bis(2,3-
dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide
Y0001293 Iodixanol impurity H 1 10 mg 1 5-[acetyl[3-[acetyl[3-[[3-[3-[acetyl[3,5-bis[(2,3-dihydroxypropyl) 2215 Yes +5C 3C 79
carbamoyl]-2,4,6-triiodophenyl]amino]-2-hydroxypropoxy]-2-hydroxypropyl]
carbamoyl]-5-[(2,3-dihydroxypropyl)carbamoyl]-2,4,6-triiodophenyl]
amino]-2-hydroxypropyl]amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-
triiodobenzene-1,3-dicarboxamide
I0320800 Iohexol 2 150 mg 1 Batch 1 is valid until 31 May 2016 1114 Yes +5C 3C 79
I0320810 Iohexol impurity A 1 50 mg 1 5-(acetylamino)-N,N-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3- 1114 Yes +5C 3C 79
dicarboxamide
I0320820 Iohexol impurity J 1 125 mg 1 5-amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3- 1114,2215 Yes +5C 3C 79
dicarboxamide
Y0000672 Iohexol for peak identification 1 10 mg 1 1114 Yes +5C 3C 79
I0329000 Iopamidol 1 50 mg 1 1115 Yes +5C 3C 79
I0329010 Iopamidol impurity A 2 15 mg 1 5-amino-N,N-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-2,4,6- 1115, 1754 Yes +5C 3C 79
triiodobenzene-1,3-dicarboxamide
; Batch 1 is valid until 31 October 2016
Y0000406 Iopamidol impurity H 1 10 mg 1 4-chloro-N,N-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[[(2S)-2- 1115 Yes +5C 3C 79
hydroxypropanoyl]amino]-2,6-diiodobenzene-1,3-dicarboxamide
I0330000 Iopanoic acid 1 100 mg 1 0700 Yes +5C 3C 79
Y0001297 Iopentol 1 10 mg 1 2215 Yes +5C 3C 79
Y0001020 Iopromide 1 100 mg 1 See leaflet CHINO 1753 Yes +5C 3C 79
Y0001077 Iopromide impurity A 1 0.125 mg 1 5-amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-N-methylbenzene-1,3- 1753 Yes +5C 3C 79
dicarboxamide
Y0001021 Iopromide for system suitability 1 1 5 mg 1 1753 Yes +5C 3C 79
Y0001022 Iopromide for system suitability 2 1 5 mg 1 1753 Yes +5C 3C 79
Y0000555 Iotrolan 1 100 mg 1 See leaflet 1754 Yes +5C 3C 79
Y0000658 Iotrolan for system suitability 1 5 mg 1 1754 Yes +5C 3C 79
Y0000141 Ioxaglic acid 2 125 mg 1 2009 Yes +5C 3C 79
Y0000142 Ioxaglic acid impurity A 1 20 mg 1 3-amino-5-[(2-hydroxyethyl)carbamoyl]-2,4,6-triiodobenzoic acid 2009 Yes +5C 3C 79
I0360000 Ipratropium bromide 5 120 mg 1 0919 Yes +5C 3C 79
I0361000 Ipratropium impurity B 3 10 mg 1 (1R,3r,5S,8s)-3-[[(2RS)-3-hydroxy-2-phenylpropanoyl]oxy]-8-methyl-8-(1- 0919 Yes +5C 3C 79
methylethyl)-8-azoniabicyclo[3.2.1]octane

Council of Europe, all rights reserved 2017 45 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0000276 Ipratropium impurity A 2 15 mg 1 (1R,3r,5S,8r)-3-hydroxy-8-methyl-8-(1-methylethyl)-8-azoniabicyclo[3.2.1] 0919 Yes +5C 3C 79
octane
Y0001166 Irbesartan 1 60 mg 1 2465 Yes +5C 3C 79
Y0001156 Irbesartan impurity A 3 10 mg 1 1-(pentanoylamino)-N-[[2-(1H-tetrazol-5-yl)[1,1-biphenyl]-4-yl]methyl] 2465 Yes +5C 3C 79
cyclopentane-1-carboxamide
Y0001831 Irinotecan for peak identification 1 1 mg 1 2675 Yes +5C 3C 79
Y0001830 Irinotecan for system suitability 1 1 1.51 mg 1 2675 Yes +5C 3C 79
Y0001833 Irinotecan for system suitability 2 1 10 mg 1 2675 Yes +5C 3C 79
Y0001832 Irinotecan hydrochloride trihydrate 1 170 mg 1 see leaflet CHClNO,3HO 2675 Yes +5C 3C 79
Y0001616 Irisflorentin 1 15 mg 1 See leaflet CHO 2561 Yes +5C 3C 79
I0375000 Isoconazole 1 200 mg 1 1018 Yes +5C 3C 79
I0380000 Isoconazole nitrate 1 200 mg 1 1017 Yes +5C 3C 79
I0400000 Isoemetine hydrobromide 1 25 mg 1 0081 Yes +5C 3C 79
Y0000858 Isoflurane 2 1.4 mL 1 1666 Yes +5C 3C 79
Y0000037 Isoflurane - reference spectrum 1 n/a 1 1673 79
I0460000 Isoleucine 2 30 mg 1 Batch 1 is valid until 28 February 2016 0770 Yes +5C 3C 79
I0465000 Isomalt 5 3000 mg 1 See leaflet 1531 Yes +5C 3C 79
Y0000070 Isomaltooligosaccharide 1 0.9 mg 1 1506 Yes +5C 3C 79
I0500000 Isoniazid 1 100 mg 1 0146 Yes +5C 3C 79
I0599990 Isoprenaline hydrochloride 1 50 mg 1 1332 Yes +5C 3C 79
Y0001577 Isoprenaline impurity A 1 15 mg 1 1-(3,4-dihydroxyphenyl)-2-[(1-methylethyl)amino]ethanone 1332 Yes +5C 3C 79
I0600000 Isoprenaline sulfate 3 510 mg 1 0502 Yes +5C 3C 79
Y0001728 Isopropyl alcohol 1 100 mg 1 0970 Yes +5C 3C 79
I0725000 Isopropyl hexadecanoate 2 100 mg 1 See leaflet CHO 0839 Yes +5C 3C 79
New Y0001907 Isopropyl isostearate 1 0.5 mL 1 2867 Yes +5C 3C 79
I0750000 Isopropyl tetradecanoate 4 2 ml 1 See leaflet CHO 0725 Yes +5C 3C 79
Y0001568 Isoquercitroside 1 15 mg 1 See leaflet CHO 2528 Yes +5C 3C 79
Y0001836 Isorhynchophylline 1 15 mg 1 see leaflet 2729 Yes -20C 5C 79
I0775000 Isosorbide dinitrate 4 350 mg 1 See leaflet CHNO ; Batch 3 is valid until 28 February 2017 1117,1118 Yes +5C 3C 79
I0775010 Isosorbide mononitrate 4 150 mg 1 See leaflet CHNO; Isosorbide-5-nitrate. Can only be sent by road. 1117,1118 Yes +5C 3C 79
I0775020 Isosorbide-2-nitrate 3 50 mg 1 1117,1118 Yes +5C 3C 79
I0800000 Isotretinoin 5 50 mg 1 Batch 4 is valid until 31 May 2016 0693,1019 Yes +5C 3C 79
Y0001218 Isotretinoin for peak identification 2 10 mg 1 Batch 1 is valid until 30 April 2016 1019 Yes +5C 3C 79
I0900000 Isoxsuprine hydrochloride 1 50 mg 1 1119 Yes +5C 3C 79
Y0000366 Isradipine 1 125 mg 1 See leaflet CHNO 2110 Yes +5C 3C 79
Y0000367 Isradipine impurity D 1 5 mg 1 methyl 1-methylethyl 4-(2,1,3-benzoxadiazol-4-yl) 2110 Yes +5C 3C 79
-2,6-dimethylpyridine-3,5-dicarboxylate
Council of Europe, all rights reserved 2017 46 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
I7000000 Itraconazole 3 20 mg 1 1335 Yes +5C 3C 79
Y0001100 Itraconazole for system suitability 2 25 mg 1 1335 Yes +5C 3C 79
I8000010 Ivermectin 2 150 mg 1 See leaflet 1336 Yes +5C 3C 79
Y0001592 Ivy leaf dry extract HRS 1 70 mg 1 See leaflet 2148 Yes -20C 5C 79
Y0000041 Josamycin 2 150 mg 1 See leaflet 1982,1983,2 Yes -20C 5C 79
0702
Y0001315 Josamycin for peak identification 1 25 mg 1 1983 Yes +5C 3C 79
Y0000042 Josamycin propionate 3 150 mg 1 See leaflet ; Batch 2 is valid until 31 January 2017 1982,1983,2 Yes -20C 5C 79
0702
K0100000 Kanamycin B sulfate 3 20 mg 1 0032,0033,0 Yes +5C 3C 79
645
K0200000 Kanamycin monosulfate 3 150 mg 1 See leaflet CHNOS,HO 0032,0033,0 Yes +5C 3C 79
053,
0485,0645,1
289,
1290,20702
Y0000450 Ketamine hydrochloride - * narc 1 10 mg 1 1020 Yes +5C 3C 79
K0551000 Ketamine impurity A 2 50 mg 1 1-(2-chloro-N-methylbenzimidoyl)cyclopentanol 1020,1742 Yes +5C 3C 79
Y0000246 Ketobemidone hydrochloride - reference spectrum 1 n/a 1 1746 79
Y0000244 Ketobemidone impurity B 1 5 mg 1 1-[4-(3-hydroxyphenyl)-1-methylpiperidin-4-yl]ethanone 1746 Yes +5C 3C 79
Y0000245 Ketobemidone impurity C 1 5 mg 1 1-[4-(3-hydroxyphenyl)piperidin-4-yl]propan-1-one 1746 Yes +5C 3C 79
K0600000 Ketoconazole 2 150 mg 1 0921,1270 Yes +5C 3C 79
K2000000 Ketoprofen 2 50 mg 1 0922,1157,1 Yes +5C 3C 79
209
K2000010 Ketoprofen impurity A 5 10 mg 1 1-(3-benzoylphenyl)ethanone 0922 Yes +5C 3C 79
New K2000015 Ketoprofen impurity C 4 15 mg 1 3-[(1RS)-1-carboxyethyl]benzoic acid ; Batch 3 is valid until 31 May 2017 0922 Yes +5C 3C 79
Y0000486 Ketorolac trometamol 1 10 mg 1 1755 Yes +5C 3C 79
Y0000626 Ketorolac trometamol for peak identification 2 5 mg 1 1755 Yes +5C 3C 79
Y0001619 Ketotifen hydrogen fumarate 1 10 mg 1 1592 Yes +5C 3C 79
Y0000161 Ketotifen impurity G 5 0.0225 mg 1 4-(1-methylpiperidin-4-ylidene)-4H-benzo(4,5)cyclohepta(1,2-b) 1592 Yes +5C 3C 79
thiophen-9,10-dione ; Batch 4 is valid until 28 February 2016
Y0001617 Ketotifen for peak identification 1 15 mg 1 1592 Yes +5C 3C 79
Y0001200 Kudzuvine root dry extract 1 200 mg 1 See leaflet 2434,2483 Yes -20C 5C 79
L0050000 Labetalol hydrochloride 2 120 mg 1 See leaflet CHClNO 0923 Yes +5C 3C 79
Y0001548 Labetalol impurity A 1 10 mg 1 mixture of 4 stereoisomers of 2-hydroxy-5-[1-hydroxy-2-[(1-methyl-3- 0923 Yes +5C 3C 79
phenylpropyl)amino]ethyl]benzoic acid
L0129000 Lactitol monohydrate 2 60 mg 1 See leaflet CHO 1337 Yes +5C 3C 79
Y0000257 Lactobionic acid 1 100 mg 1 1647 Yes +5C 3C 79
A1206000 Lactose (anhydrous) 2 30 mg 1 Batch 1 is valid until 31 July 2016 1061 Yes +5C 3C 79

Council of Europe, all rights reserved 2017 47 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0001750 Lactose monohydrate 1 100 mg 1 0187 Yes +5C 3C 79
L0130000 Lactulose 4 3000 mg 1 See leaflet 0924,1230 Yes +5C 3C 79
Y0001510 Lactulose for peak identification 1 2600 mg 1 0924 Yes +5C 3C 79
Y0000425 Lamivudine 1 150 mg 1 See leaflet CHNOS 2217 Yes +5C 3C 79
Y0000518 Lamivudine for system suitability 1 1 10 mg 1 2217 Yes +5C 3C 79
Y0000426 Lamivudine for system suitability 2 2 10.3 mg 1 2217 Yes +5C 3C 79
Y0001030 Lamotrigine 1 10 mg 1 1756 Yes +5C 3C 79
Y0001032 Lamotrigine impurity E 1 15 mg 1 2,3-dichlorobenzoic acid 1756 Yes +5C 3C 79
Y0001031 Lamotrigine for peak identification 1 20 mg 1 1756 Yes +5C 3C 79
Y0001085 Lamotrigine for system suitability 2 10 mg 1 1756 Yes +5C 3C 79
Y0000773 Lansoprazole 1 60 mg 1 2219 Yes +5C 3C 79
Y0000774 Lansoprazole for peak identification 2 1.01 mg 1 2219 Yes +5C 3C 79
Y0001765 Laudanosine 1 15 mg 1 2763 Yes +5C 3C 79
Y0001474 Lauric acid 1 1500 mg 1 see leaflet 1848, 2579 Yes +5C 3C 79
Y0000654 Leflunomide 1 100 mg 1 See leaflet 2330 Yes +5C 3C 79
Y0000487 Leflunomide impurity A 2 25 mg 1 4-(trifluoromethyl)aniline 2330 Yes +5C 3C 79
Y0000674 Leflunomide for peak identification 1 1 mg 1 2330 Yes +5C 3C 79
Y0000685 Letrozole 1 70 mg 1 See leaflet CHN 2334 Yes +5C 3C 79
L0375000 Leucine 2 50 mg 1 0771,0874 Yes +5C 3C 79
L0376000 Leuprorelin 5 1 mg 1 See leaflet CHNO 1442 Yes -20C 5C 79
L0376001 Leuprorelin - reference spectrum 1 n/a 1 1442 79
Y0000048 Levamisole - reference spectrum 1 n/a 1 1728 79
L0380000 Levamisole hydrochloride 1 50 mg 1 0726 Yes +5C 3C 79
Y0000047 Levamisole hydrochloride for system suitability 5 15 mg 1 0726,1728 Yes +5C 3C 79
Y0001253 Levetiracetam 3 120 mg 1 See leaflet ; Batch 2 is valid until 31 March 2017 2535 Yes +5C 3C 79
Y0001254 Levetiracetam impurity A 3 10 mg 1 (2RS)-2-(2-oxopyrrolidin-1-yl)butanoic acid ; Batch 2 is valid until 31 March 2535 Yes +5C 3C 79
2016
Y0001255 Levetiracetam impurity B 2 15 mg 1 (2Z)-2-(2-oxopyrrolidin-1-yl)but-2-enamide 2535 Yes +5C 3C 79
Y0001256 Levetiracetam impurity C 2 15 mg 1 pyridin-2-ol 2535 Yes +5C 3C 79
Y0001257 Levetiracetam impurity D 3 15 mg 1 (2R)-2-(2-oxopyrrolidin-1-yl)butanamide ((R)-etiracetam) ; Batch 2 is valid 2535 Yes +5C 3C 79
until 31 May 2016
L0390000 Levocabastine hydrochloride 1 125 mg 1 1484 Yes +5C 3C 79
Y0001636 Levocabastine for system suitability 1 1 5.028 mg 1 1484 Yes +5C 3C 79
Y0001637 Levocabastine for system suitability 2 1 5.005 mg 1 1484 Yes +5C 3C 79
L0399900 Levocarnitine 3 125 mg 1 Batch 2 is valid until 28 February 2016 1339 Yes +5C 3C 79
L0399905 Levocarnitine impurity A 4 50 mg 1 (E)- or (Z)-4-(trimethylammonio)but-2-enoate ; Batch 3 is valid until 30 April 1339 Yes +5C 3C 79
2016

Council of Europe, all rights reserved 2017 48 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
New L0400000 Levodopa 3 20 mg 1 Batch 2 is valid until 31 May 2017 0038 Yes +5C 3C 79
L0420000 Levodropropizine 1 60 mg 1 1535 Yes +5C 3C 79
L0420002 Levodropropizine impurity A 3 25 mg 1 (2R)-3-(4-phenylpiperazin-1-yl)propan-1,2-diol (dextrodropropizine) 1535 Yes +5C 3C 79
Y0001033 Levodropropizine impurity B 1 50 mg 1 1-phenylpiperazine 1535 Yes +5C 3C 79
Y0001048 Levodropropizine impurity C 1 300 mg 1 [(2RS)-oxiran-2-yl]methanol (glycidol) 1535 Yes -20C 5C 79
L0500000 Levomepromazine hydrochloride 1 100 mg 1 0505 Yes +5C 3C 79
L0505000 Levomepromazine maleate 1 50 mg 1 0925 Yes +5C 3C 79
L0551000 Levonorgestrel 2 30 mg 1 0926 Yes +5C 3C 79
Y0001379 Levonorgestrel impurity B 2 15 mg 1 13-ethyl-17-hydroxy-18,19-dinor-17-pregn-5(10)-en-20-yn-3-one 0926 Yes +5C 3C 79

Y0001431 Levonorgestrel for system suitability 1 2 10 mg 1 0926 Yes +5C 3C 79


Y0001618 Levonorgestrel for system suitability 2 1 10 mg 1 0926 Yes +5C 3C 79
L0570000 Levothyroxine sodium 4 100 mg 1 see leaflet 0401,0728 Yes -20C 5C 79
Y0001382 Levothyroxine for peak identification 1 10 mg 1 0401 Yes -20C 5C 79
L0595000 Lidocaine 2 10 mg 1 0727 Yes +5C 3C 79
L0600000 Lidocaine hydrochloride 3 40 mg 1 0227,1242,1 Yes +5C 3C 79
363
L0650000 Lincomycin hydrochloride 4 100 mg 1 See leaflet 0582,0583,0 Yes +5C 3C 79
996
Y0001393 Lincomycin hydrochloride for system suitability 2 10 mg 1 0583 Yes -20C 5C 79
L0700000 Liothyronine sodium 8 60 mg 1 See leaflet 0401,0728 Yes -20C 5C 79
Y0000860 Liothyronine for peak identification 1 0.0046 mg 1 0728 Yes -20C 5C 79
L0702000 Lisinopril dihydrate 2 50 mg 1 1120 Yes +5C 3C 79
Y0001234 Lisinopril impurity F 2 0.01 mg 1 (2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-cyclohexylpropyl]amino] 1120 Yes +5C 3C 79
hexanoyl]pyrrolidine-2-carboxylic acid (cyclohexyl analogue)
Y0001701 Lisinopril for peak identification 1 10 mg 1 1120 Yes +5C 3C 79
Y0001709 Lisinopril for system suitability A 1 10 mg 1 1120 Yes +5C 3C 79
L0720000 Lithium clavulanate 8 125 mg 1 See leaflet; 1 mg of CHLiNO corresponds to 1.157 mg of CHKNO ; Batch 1140,1653 Yes +5C 3C 79
6 is valid until 31 January 2017
L0720800 Lithocholic acid 2 60 mg 1 1189,1275 Yes +5C 3C 79
Y0000112 Lobeline hydrochloride 1 50 mg 1 1988 Yes +5C 3C 79
L0745000 Lomustine 2 50 mg 1 0928 Yes +5C 3C 79
Y0001438 Long pepper for system suitability HRS 1 600 mg 1 2477, 2453 Yes +5C 3C 79
L0750000 Loperamide hydrochloride 2 50 mg 1 0921,0929,1 Yes +5C 3C 79
729
Y0000322 Loperamide hydrochloride for system suitability 2 15 mg 1 0929 Yes +5C 3C 79
Y0000341 Loperamide oxide monohydrate 1 20 mg 1 1729 Yes +5C 3C 79
Y0001498 Lopinavir 1 200 mg 1 See leaflet CHNO 2615 Yes +5C 3C 79

Council of Europe, all rights reserved 2017 49 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0001506 Lopinavir for peak identification 1 10 mg 1 2615 Yes +5C 3C 79
Y0001505 Lopinavir for system suitability 1 10 mg 1 2615 Yes +5C 3C 79
Y0000688 Loratadine 4 60 mg 1 Batch 3 is valid until 31 August 2016 2124 Yes +5C 3C 79
Y0000604 Loratadine impurity F 1 10 mg 1 ethyl 4-[(11RS)-8-chloro-11-fluoro-6,11-dihydro-5H-benzo[5,6]cyclohepta 2124 Yes +5C 3C 79
[1,2-b]pyridin-11-yl]piperidine-1-carboxylate
Y0000605 Loratadine impurity H 2 50 mg 1 ethyl 4-oxopiperidine-1-carboxylate ; Batch 1 is valid until 30 November 2016 2124 Yes +5C 3C 79
Y0000603 Loratadine for system suitability 2 15 mg 1 Batch 1 is valid until 31 December 2016 2124 Yes +5C 3C 79
L0750500 Lorazepam - * psy 2 15 mg 1 1121 Yes +5C 3C 79
Y0000718 Lorazepam impurity D 2 10 mg 1 (5RS)-7-chloro-5-(2-chlorophenyl)-4,5-dihydro-1H-1,4-benzodiazepine-2,3- 1121 Yes +5C 3C 79
dione
Y0000576 Lorazepam for system suitability - * psy 2 0.8 mg 1 1121 Yes +5C 3C 79
Y0001062 Losartan potassium 2 50 mg 1 Batch 1 is valid until 30 April 2017 2232 Yes +5C 3C 79
Y0001072 Losartan impurity D 3 10 mg 1 2-butyl-4-chloro-1H-imidazole-5-carbaldehyde 2232 Yes +5C 3C 79
Y0001076 Losartan for system suitability 3 0.0015 mg 1 2232 Yes +5C 3C 79
New L0790000 Lovastatin 4 60 mg 1 See leaflet CHO ; Batch 3 is valid until 31 July 2017 1538,1563 Yes -20C 5C 79
Y0001136 Lovastatin for peak identification 1 20 mg 1 1538 Yes -20C 5C 79
Y0001284 Lufenuron 1 140 mg 1 See leaflet CHClFNO 2177 Yes +5C 3C 79
Y0001261 Lufenuron for peak identification 1 0.4028 mg 1 2177 Yes +5C 3C 79
Y0001265 Lufenuron impurity G 1 15 mg 1 2,5-dichloro-4-[[[(2,6-difluorophenyl)carbonyl]carbamoyl]amino]phenyl 2177 Yes +5C 3C 79
phenyl carbonate
L0800000 Lynestrenol 1 50 mg 1 0558 Yes +5C 3C 79
Y0001034 Lynestrenol for peak identification 1 20 mg 1 0558 Yes +5C 3C 79
Y0000397 Lysine acetate 2 60 mg 1 2114 Yes +5C 3C 79
L0900000 Lysine hydrochloride 3 50 mg 1 0930, 1654 Yes +5C 3C 79
Y0001369 Macrogol 30 dipolyhydroxystearate 1 100 mg 1 2584 Yes +5C 3C 79
Y0000745 Macrogol 40 sorbitol heptaoleate 1 20 mg 1 2396 Yes +5C 3C 79
Y0001684 High-molecular-mass macrogol CRS 1 10 mg 1 2444 Yes +5C 3C 79
Y0001157 Macrogol polyvinyl alcohol grafted copolymer 1 400 mg 1 2523 Yes +5C 3C 79
M0088000 Magnesium aspartate dihydrate 1 60 mg 1 1445 Yes +5C 3C 79
Y0001289 Magnolol 1 20 mg 1 See leaflet CHO 2567,2568 Yes -20C 5C 79
M0120000 Malathion 3 250 mg 1 See leaflet CHOPS 1343 Yes -20C 5C 79
M0120005 Malathion impurity A 3 15 mg 1 see leaflet; diethyl (2RS)-2-[(methoxy)(methylsulfanyl)-S-phosphinothioyl] 1343 Yes -20C 5C 79
butanedioate (isomalathion)
M0120010 Malathion impurity B 3 10 mg 1 diethyl (2RS)-2-(dimethoxy-S-phosphinothioyl)-butanedioate (maloxon) 1343 Yes -20C 5C 79
M0100000 Maleic acid 2 100 mg 1 0365,0925 Yes +5C 3C 79
Y0000143 Malic acid - reference spectrum 1 n/a 1 2080 79
M0160000 Maltitol 4 1200 mg 1 See leaflet CHO 1235,1236 Yes +5C 3C 79

Council of Europe, all rights reserved 2017 50 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0001751 Mangiferin 1 15 mg 1 see leaflet CHO 2661 Yes +5C 3C 79
M0200000 Mannitol 5 1200 mg 1 See leaflet CHO 0435,0559,1 Yes +5C 3C 79
381, 1531
M0206000 Maprotiline hydrochloride 1 100 mg 1 1237 Yes +5C 3C 79
M0206040 Maprotiline impurity D 1 25 mg 1 3-(9,10-ethanoanthracen-9(10H)-yl)-N-methylprop-2-en-1-amine 1237 Yes +5C 3C 79
(dehydromaprotiline)
Y0000819 Marbofloxacin 1 10 mg 1 2233 Yes +5C 3C 79
Y0000820 Marbofloxacin for peak identification 1 20 mg 1 2233 Yes +5C 3C 79
M0210000 Measles vaccine (live) BRP 1 400 mg 1 See leaflet; One sale unit is composed of a bag of 5 vials. The unit quantity of 1057,0213,2 Yes -20C 5C 90
each vial is 80 mg. 442
M0215000 Mebendazole 1 20 mg 1 1208,1254, Yes +5C 3C 79
0845
Y0000144 Mebendazole for system suitability 1 20 mg 1 0845 Yes +5C 3C 79
Y0001086 Mebrofenin 1 120 mg 1 2393 Yes +5C 3C 79
M0220000 Meclozine dihydrochloride 2 150 mg 1 0622 Yes +5C 3C 79
Y0001310 Meclozine impurity B 1 15 mg 1 (RS)-(4-chlorophenyl)phenylmethanol 0622 Yes +5C 3C 79
Y0001311 Meclozine impurity H 1 15 mg 1 1-[(RS)-(4-chlorophenyl)phenylmethyl]piperazine 0622 Yes +5C 3C 79
Y0001770 Medronate for radiochemical purity testing 1 5 mg 1 0641 Yes +5C 3C 79
M0240000 Medronic acid 2 20 mg 1 2350 Yes +5C 3C 79
Y0001107 Medronic acid impurity A 2 60 L 1 see leaflet CHOP; Tris(1-methylethoxy)phosphane ; Batch 1 is valid until 28 2350 Yes -20C 5C 79
February 2016
Y0001106 Medronic acid impurity B 1 40 l 1 Tetrakis(1-methylethyl)methylenediphosphonate 2350 Yes -20C 5C 79
M0250000 Medroxyprogesterone acetate 3 100 mg 1 0673 Yes +5C 3C 79
Y0001484 Medroxyprogesterone acetate for peak identification 1 25 mg 1 0673 Yes +5C 3C 79
Y0000598 Medroxyprogesterone acetate for system suitability 2 10 mg 1 Batch 1 is valid until 31 March 2016 0673 Yes -20C 5C 79
M0252600 Mefenamic acid 2 50 mg 1 1240 Yes +5C 3C 79
Y0001081 Mefenamic acid impurity A 1 100 mg 1 2,3-dimethylaniline 1240 Yes +5C 3C 79
M0253000 Mefloquine hydrochloride 2 100 mg 1 1241 Yes +5C 3C 79
Y0001514 Megestrol acetate 1 120 mg 1 See leaflet CHO 1593 Yes +5C 3C 79
Y0001594 Megestrol acetate for impurity K identification 1 0.01 mg 1 1593 Yes +5C 3C 79
Y0001507 Megestrol acetate for peak identification 1 25 mg 1 1593 Yes +5C 3C 79
Y0001524 Megestrol acetate for system suitability 1 50 mg 1 1593 Yes +5C 3C 79
Y0001209 Meglumine 1 10 mg 1 2055 Yes +5C 3C 79
Y0001670 Meldonium dihydrate 1 10 mg 1 2624 Yes +5C 3C 79
Y0001671 Meldonium impurity A 1 25 mg 1 N,N-dimethylmethanaminium 2624 Yes +5C 3C 79
Y0001672 Meldonium impurity B 1 25 mg 1 1,1,1-trimethylhydrazin-1-ium 2624 Yes +5C 3C 79
Y0001673 Meldonium impurity C 1 25 mg 1 see leaflet CHNOBr; 2-(3-methoxy-3-oxopropyl)-1,1,1- 2624 Yes +5C 3C 79
trimethylhydrazin-1-ium
Council of Europe, all rights reserved 2017 51 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0001674 Meldonium impurity D 1 25 mg 1 see leaflet CHNOBr; 2-(3-ethoxy-3-oxopropyl)-1,1,1-trimethylhydrazin-1- 2624 Yes +5C 3C 79
ium
Y0001675 Meldonium impurity E 1 25 mg 1 see leaflet CHBrNO; 1,1,1-trimethyl-2-[3-(1-methylethoxy)-3-oxopropyl] 2624 Yes +5C 3C 79
hydrazin-1-ium
Y0001676 Meldonium impurity F 1 25 mg 1 see leaflet CHNO; 1,1-dimethyl-4,5-dihydro-1H-pyrazol-1-ium-3-olate 2624 Yes +5C 3C 79
Y0001080 Meloxicam 1 50 mg 1 2373 Yes +5C 3C 79
Y0001035 Meloxicam impurity A 2 5 mg 1 ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide 2373 Yes +5C 3C 79
Y0001036 Meloxicam impurity B 2 5 mg 1 5-methylthiazol-2-amine 2373 Yes +5C 3C 79
Y0001037 Meloxicam impurity C 3 10 mg 1 N-[(2Z)-3,5-dimethylthiazol-2(3H)-ylidene]-4-hydroxy-2-methyl-2H-1,2- 2373 Yes +5C 3C 79
benzothiazine-3-carboxamide 1,1-dioxide
Y0001039 Meloxicam impurity D 3 5 mg 1 N-[(2Z)-3-ethyl-5-methylthiazol-2(3H)-ylidene]-4-hydroxy-2-methyl-2H-1,2- 2373 Yes +5C 3C 79
benzothiazine-3-carboxamide 1,1-dioxide
Y0001158 Melphalan hydrochloride 2 100 mg 1 see leaflet ; Batch 1 is valid until 28 February 2017 1698 Yes +5C 3C 79
Y0001513 Melphalan - reference spectrum 1 1 uc 1 1698 79
Y0001457 Melphalan for system suitability 1 10 mg 1 1698 Yes +5C 3C 79
M0300000 Menadione 1 100 mg 1 0507 Yes +5C 3C 79
M0350000 Menthol 5 150 mg 1 Batch 4 is valid until 31 May 2016 0619,0623 Yes +5C 3C 79
M0370000 Mepivacaine hydrochloride 1 100 mg 1 1242 Yes +5C 3C 79
M0370020 Mepivacaine impurity B 1 60 mg 1 (RS)-N-(2,6-dimethylphenyl)piperidine-2-carboxamide 1242 +5C 3C 79
M0400000 Meprobamate - * psy 1 100 mg 1 0407,1689 Yes +5C 3C 79
M0500000 Mepyramine maleate 1 1000 mg 1 0278 Yes +5C 3C 79
Y0000679 Mepyramine impurity A 1 10 mg 1 N-(4-methoxybenzyl)pyridin-2-amine 0278 Yes +5C 3C 79
Y0000680 Mepyramine impurity C 1 10 mg 1 pyridin-2-amine 0278 Yes +5C 3C 79
Y0001252 Meropenem trihydrate 1 110 mg 1 See leaflet 2234 Yes +5C 3C 79
Y0000297 Mesalazine 2 125 mg 1 1699,1993 Yes +5C 3C 79
Y0001563 Mesalazine impurity A 1 15 mg 1 4-aminophenol 1699 Yes +5C 3C 79
Y0001569 Mesalazine impurity C 1 15 mg 1 2-aminophenol 1699 Yes +5C 3C 79
Y0001574 Mesalazine for system suitability 4 10 mg 1 Batch 2 is valid until 31 March 2016 1699 Yes +5C 3C 79
Batch 3 is valid until 31 October 2016
Y0001040 Mesityl oxide 1 100 mg 1 2358 +5C 3C 79
Y0000337 Mesna - reference spectrum 1 n/a 1 1674 79
Y0000316 Mesna impurity C 1 10 mg 1 2-(acetylsulfanyl)ethanesulfonic acid 1674 Yes +5C 3C 79
Y0000317 Mesna impurity D 1 10 mg 1 2,2'-(disulfanediyl)bis(ethanesulfonic acid) 1674 Yes +5C 3C 79
Y0000227 Meso-rich exametazime 1 0.5 mg 1 1925 Yes +5C 3C 79
Y0000097 Mesterolone 2 120 mg 1 See leaflet CHO 1730 Yes +5C 3C 79
Y0000096 Mesterolone impurity A 1 30 mg 1 17-hydroxy-1-methylandrost-4-en-3-one 1730 Yes +5C 3C 79

M0600000 Mestranol 1 100 mg 1 0509 Yes +5C 3C 79

Council of Europe, all rights reserved 2017 52 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0000301 Metacresol - reference spectrum 1 n/a 1 2077 79
M0600900 Metamizole sodium 4 10 mg 1 1346 Yes +5C 3C 79
M0600905 Metamizole impurity A 4 15 mg 1 4-(formylamino)-1,5-dimethyl-2-phenyl-2,3-dihydro-1H-pyrazol-3-one 1346 Yes +5C 3C 79
Y0001481 Metamizole impurity E 3 0.01 mg 1 [(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino] 1346 Yes +5C 3C 79
methanesulfonic acid (4-N-desmethylmetamizole).
M0605000 Metformin hydrochloride 3 50 mg 1 0931 Yes +5C 3C 79
Y0001590 Metformin impurity A 1 25 mg 1 Cyanoguanidine 0931 Yes +5C 3C 79
Y0001600 Metformin impurity F 2 2 mL 1 N-methylmethanamine (dimethylamine) 0931 Yes +5C 3C 79
Y0001820 Methacrylic acid - methylmethacrylate copolymer (1:1) 1 120 mg 1 1127 Yes +5C 3C 79
Y0001821 Methacrylic acid - methylmethacrylate copolymer (1:2) 1 120 mg 1 1130 Yes +5C 3C 79
Y0000770 Methacrylic acid-ethyl acrylate copolymer (1:1) - type A 1 200 mg 1 1128 Yes +5C 3C 79
Y0000323 Methacrylic acid-ethyl acrylate copolymer (1:1) - type B 1 200 mg 1 1128 Yes +5C 3C 79
M0610030 Methacrylic acid-ethylacrylate copolymer (1:1), 1 n/a 1 1129 79
dispersion 30%-ref.sp
M0800000 Methadone hydrochloride - reference spectrum 1 n/a 1 0408,1787 79
Y0000428 Methanol - reference spectrum 1 n/a 1 1989 79
Y0000754 Methenamine 1 10 mg 1 1545 Yes +5C 3C 79
M0960000 Methionine 2 50 mg 1 0788,1027 Yes +5C 3C 79
M0950000 DL-Methionine 1 50 mg 1 0624 Yes +5C 3C 79
M1000000 Methotrexate 7 100 mg 1 See leaflet CHNO 0560 Yes +5C 3C 79
Y0000663 Methotrexate impurity C 2 10 mg 1 (2S)-2-[[4-[[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]methylamino] 0560 Yes +5C 3C 79
benzoyl]amino]pentanedioic acid (N-methylfolic acid, methopteridine)
M1000008 Methotrexate impurity D 4 10 mg 1 4-[[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]methylamino]benzoic 0560 Yes +5C 3C 79
acid (N10-methylpteroic acid) ; Batch 3 is valid until 31 October 2016
Y0000664 Methotrexate impurity E 1 10 mg 1 4-[[(2,4-diaminopteridin-6-yl)methyl]methylamino]benzoic acid (4-amino- 0560 Yes +5C 3C 79
N10-methylpteroic acid, APA)
Y0000602 Methotrexate for peak identification 1 20 mg 1 0560 Yes +5C 3C 79
Y0001668 Methotrexate for system suitability 1 100 mg 1 0560 Yes +5C 3C 79
M1470000 Methyl 2-(4-chlorophenoxy)-2-methylpropionate 1 0.5 ml 1 0318 Yes +5C 3C 79
M1556000 Methyl 12-hydroxystearate 2 100 mg 1 1497 Yes +5C 3C 79
Y0001488 Methyl methacrylate 1 50 mg 1 1975 Yes +5C 3C 79
Y0000398 Methyl nicotinate 1 25 mg 1 2129 Yes +5C 3C 79
M1650000 Methyl parahydroxybenzoate 4 150 mg 1 See leaflet 0409,1262,2 Yes +5C 3C 79
134,1999
M1770180 Methyl ricinoleate 3 125 mg 1 Batch 2 is valid until 30 September 2016 0051,2367 Yes +5C 3C 79
M1770200 Methyl stearate 3 100 mg 1 0051,1497, Yes +5C 3C 79
2367
M1300000 Methylatropine bromide 1 100 mg 1 0919 Yes +5C 3C 79

Council of Europe, all rights reserved 2017 53 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
M1500000 Methyldopa 2 50 mg 1 0045 Yes +5C 3C 79
New Y0001083 Methyldopa for system suitability 2 0.024 mg 1 Batch 1 is valid until 31 May 2017 0045 Yes +5C 3C 79
Y0001374 Racemic methyldopa 1 5 mg 1 0045 Yes +5C 3C 79
M1550000 Methylene chloride 3 2 mL 1 Batch 2 is valid until 31 May 2016 0932 Yes +5C 3C 79
Y0000776 Methylergometrine maleate 1 10 mg 1 1788 Yes +5C 3C 79
Y0000777 Methylergometrine for system suitability 1 0.53 mg 1 1788 Yes +5C 3C 79
M1625000 Methylnitrosoindoline 3 110 mg 1 1108 Yes +5C 3C 79
Y0001017 Methylphenidate hydrochloride - * narc 1 40 mg 1 2235 Yes +5C 3C 79
Y0001490 Methylphenidate impurity C 1 10 mg 1 (2RS)-2-phenyl-2-[(2RS)-piperidin-2-yl]acetamide 2235 Yes +5C 3C 79
Y0000910 Methylphenidate impurity mixture 1 0.04 mg 1 2235 Yes +5C 3C 79
M1700000 Methylphenobarbital - * psy 1 500 mg 1 0189 Yes +5C 3C 79
M1750000 Methylprednisolone 3 120 mg 1 See leaflet 0312,0561 Yes -20C 5C 79
Y0001799 Methylprednisolone for system suitability A 1 10 mg 1 0561 Yes -20C 5C 79
M1755000 Methylprednisolone acetate 2 110 mg 1 See leaflet CHO 0933 Yes +5C 3C 79
Y0001736 Methylprednisolone acetate for peak identification 1 0.01 mg 1 0933 Yes +5C 3C 79
Y0001760 Methylprednisolone acetate for system suitability 1 10 mg 1 0933 Yes +5C 3C 79
M1755200 Methylprednisolone hydrogen succinate 3 60 mg 1 See leaflet CHO 0768,1131 Yes +5C 3C 79
Y0001759 Methylprednisolone hydrogen succinate for peak 1 10 mg 1 1131 Yes +5C 3C 79
identification
M1755220 Methylprednisolone hydrogen succinate for 1 50 mg 1 1131 Yes +5C 3C 79
performance test
Y0001376 2-methylpyrazine 1 100 mg 1 2446,2447,2 Yes +5C 3C 79
708
Y0000190 N-Methylpyrrolidone - reference spectrum 1 n/a 1 1675 79
Y0000418 Methylrosanilinium chloride 1 40 mg 1 1990 Yes +5C 3C 79
Y0000407 Methylrosanilinium for system suitability 1 10 mg 1 1990 Yes +5C 3C 79
M1800000 Methyltestosterone 2 10 mg 1 Batch 1 is valid until 28 February 2017 0410 Yes +5C 3C 79
Y0000861 Methyltestosterone for system suitability 1 10 mg 1 0410 Yes +5C 3C 79
M1800900 Methylthioninium chloride 2 130 mg 1 See leaflet CHClNS,xHO 1132 Yes +5C 3C 79
Y0001744 Methylthioninium for system suitability 1 15 mg 1 1132 Yes +5C 3C 79
M1808000 Metixene hydrochloride 1 75 mg 1 1347 Yes +5C 3C 79
M1824990 Metoclopramide 1 100 mg 1 1348 Yes +5C 3C 79
M1825000 Metoclopramide hydrochloride 2 50 mg 1 0674,0856,1 Yes +5C 3C 79
303
M1824995 Metoclopramide impurity A 2 25 mg 1 4-(acetylamino)-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide 1348 Yes +5C 3C 79
M1825010 Metoclopramide impurity E 1 40 mg 1 N,N-diethylethane-1,2-diamine 1575 Yes +5C 3C 79
Y0000701 Metolazone 1 80 mg 1 See leaflet CHClNOS 1757 Yes +5C 3C 79

Council of Europe, all rights reserved 2017 54 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0000702 Metolazone for system suitability 1 10 mg 1 1757 Yes +5C 3C 79
Y0000171 Metoprolol succinate - reference spectrum 1 n/a 1 1448 79
M1830000 Metoprolol tartrate 2 60 mg 1 1028 Yes +5C 3C 79
Y0000145 Metoprolol impurity A 4 5 mg 1 (2RS)-1-(ethylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol ; Batch 3 is 1028,1448 Yes +5C 3C 79
valid until 31 July 2016
M1845000 Metrifonate 1 100 mg 1 1133 Yes +5C 3C 79
M1850000 Metronidazole 2 50 mg 1 0675,0934 Yes +5C 3C 79
Y0000087 Metronidazole impurity A 3 10 mg 1 2-methyl-4-nitroimidazole 0675, 0934 Yes +5C 3C 79
M1851000 Metronidazole benzoate 1 50 mg 1 1424 Yes +5C 3C 79
Y0000069 Metronidazole benzoate - reference spectrum 1 n/a 1 0934 79
M1860000 Mexiletine hydrochloride 1 100 mg 1 1029 Yes +5C 3C 79
Y0000202 Mexiletine impurity C 2 2 mg 1 see leaflet CHNO; 1,1'-[(3,3',5,5'-tetramethylbiphenyl-4,4'-diyl)bisoxy] 1029 Yes +5C 3C 79
dipropan-2-amine
Y0000203 Mexiletine impurity D 1 2 mg 1 (2RS)-2-(2,6-dimethylphenoxy)propan-1-amine 1029 Yes +5C 3C 79
M1875000 Mianserin hydrochloride 3 100 mg 1 0846 Yes +5C 3C 79
Y0001041 Mianserin impurity B 1 10 mg 1 (14bRS)-2-methyl-1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a] 0846 Yes +5C 3C 79
azepine-8-sulfonic acid
Y0000862 Mianserin for system suitability 1 1.01 mg 1 0846 Yes +5C 3C 79
M1880000 Miconazole 1 70 mg 1 0935 Yes +5C 3C 79
M1900000 Miconazole nitrate 2 100 mg 1 Batch 1 is valid until 31 May 2016 0513,1148 Yes +5C 3C 79
M2200000 Midazolam - * psy 3 50 mg 1 Batch 2 is valid until 28 February 2017 0936,1065 Yes +5C 3C 79
Y0000562 Midazolam impurity C 3 0.08 mg 1 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4] 0936 Yes +5C 3C 79
benzodiazepine-3-carboxylic acid
Y0000599 Midazolam for system suitability - * psy 3 1 mg 1 Batch 2 is valid until 31 March 2016 0936 Yes +5C 3C 79
Y0001687 Milk thistle dry extract HRS 2 120 mg 1 See leaflet ; Batch 1 is valid until 31 May 2016 1860,2071 Yes -20C 5C 79
M2280000 Minocycline hydrochloride 3 125 mg 1 See leaflet CHClNO 1030 Yes +5C 3C 79
M2300000 Minoxidil 1 50 mg 1 0937 Yes +5C 3C 79
Y0001432 Minoxidil for system suitability 1 10 mg 1 0937 Yes +5C 3C 79
Y0000705 Mirtazapine 1 10 mg 1 2338 Yes +5C 3C 79
Y0000721 Mirtazapine for system suitability 1 10 mg 1 2338 Yes +5C 3C 79
Y0000490 Misoprostol 3 60 mg 1 See leaflet CHO 1731 Yes -20C 5C 79
Y0001162 Misoprostol for system suitability 1 5 mg 1 1731 Yes -20C 5C 79
Y0000378 Mitomycin 2 120 mg 1 See leaflet CHNO 1655 Yes +5C 3C 79
M2305000 Mitoxantrone hydrochloride 4 60 mg 1 See leaflet 1243 Yes +5C 3C 79
New M2305005 Mitoxantrone impurity A 4 5 mg 1 1-amino-5,8-dihydroxy-4-[[2-[(2-hydroxyethyl)amino]ethyl] amino] 1243 Yes +5C 3C 79
anthracene-9,10-dione ; Batch 3 is valid until 30 June 2017
Y0000635 Modafinil 1 110 mg 1 See leaflet CHNOS 2307 Yes +5C 3C 79
Y0000636 Modafinil for system suitability 1 0.1 mg 1 2307 Yes +5C 3C 79
Council of Europe, all rights reserved 2017 55 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0000251 Molgramostim 1 0.3 ml 1 13.45 mg protein per ml CHNOS 1641 Yes -80C 10C 79
Y0000821 Molsidomine 1 5 mg 1 1701 Yes +5C 3C 79
Y0000822 Molsidomine impurity B 1 10 mg 1 4-nitrosomorpholine 1701 Yes +5C 3C 79
Y0000823 Molsidomine impurity D 1 10 mg 1 morpholine-4-carbaldehyde 1701 Yes +5C 3C 79
M2900000 Mometasone furoate 3 60 mg 1 Batch 2 is valid until 31 July 2016 1449 Yes +5C 3C 79
Y0001436 Montelukast dicyclohexylamine 2 150 mg 1 See leaflet 2583 Yes +5C 3C 79
Y0001433 Montelukast racemate 3 0.1 mg 1 Batch 2 is valid until 31 July 2016 2583 Yes +5C 3C 79
Y0001434 Montelukast sodium 2 20 mg 1 2583 Yes +5C 3C 79
Y0001435 Montelukast for peak identification 3 20 mg 1 Batch 2 is valid until 28 February 2016 2583 Yes +5C 3C 79
Y0000028 Morantel hydrogen tartrate 2 50 mg 1 1546 Yes +5C 3C 79
Y0000451 Morphine hydrochloride trihydrate - * narc 3 25 mg 1 See leaflet ; Batch 2 is valid until 30 November 2016 1839, 1840, Yes +5C 3C 79
0777, 1841,
0097
Y0000452 Morphine sulfate - * narc 1 40 mg 1 1244,1784 Yes +5C 3C 79
Y0000830 Morphine for system suitability - * narc 3 15 mg 1 1244, 0097 Yes +5C 3C 79
Y0000772 Moxidectin 3 70 mg 1 See leaflet 1656 Yes -20C 5C 79
Y0000747 Moxidectin for system suitability 2 10 mg 1 1656 Yes +5C 3C 79
Y0000703 Moxifloxacin hydrochloride 3 120 mg 1 See leaflet CHClFNO ; Batch 2 is valid until 30 June 2016 2254 Yes +5C 3C 79
Y0000717 Moxifloxacin for peak identification 2 10 mg 1 2254 Yes +5C 3C 79
New Y0000226 Moxonidine 2 50 mg 1 See leaflet CHClNO ; Batch 1 is valid until 30 June 2017 1758 Yes +5C 3C 79
Y0000222 Moxonidine impurity A 1 10 mg 1 4,6-dichloro-N-(imidazolidin-2-ylidene)-2-methylpyrimidin-5-amine (6- 1758 Yes +5C 3C 79
chloromoxonidine)
M3600000 Mumps vaccine (live) BRP 1 165 mg 1 See leaflet 0538,1057, Yes -80C 10C 90
2442
M3805000 Mupirocin - reference spectrum 1 n/a 1 1450 79
M3805500 Mupirocin calcium - reference spectrum 1 n/a 1 1451 79
M3806000 Mupirocin lithium 2 100 mg 1 See leaflet CHOLi 1450,1451 Yes +5C 3C 79
Y0000489 Mycophenolate mofetil 3 30 mg 1 1700 Yes +5C 3C 79
Y0000519 Mycophenolate mofetil for peak identification 6 10 mg 1 Batch 5 is valid until 31 July 2016 1700 Yes +5C 3C 79
Y0001810 Mycophenolate sodium 1 200 mg 1 See leaflet CHONa 2813 Yes +5C 3C 79
Y0000692 Mycoplasma fermentans BRP 1 1 ml 1 20607 Yes -80C 10C 120
Y0000690 Mycoplasma hyorhinis BRP 1 1 ml 1 20607 Yes -80C 10C 120
Y0000691 Mycoplasma orale BRP 1 1 ml 1 20607 Yes -80C 10C 120
Y0000689 Mycoplasma synoviae BRP 1 1 ml 1 20607 Yes -80C 10C 120
Y0000485 Myo-inositol 1 1020 mg 1 See leaflet 1805 Yes +5C 3C 79
N0020000 Nabumetone 1 60 mg 1 See leaflet CHO 1350 Yes +5C 3C 79
N0020020 Nabumetone impurity D 2 10 mg 1 (E)-4-(6-methoxynaphthalen-2-yl)but-3-en-2-one 1350 Yes +5C 3C 79

Council of Europe, all rights reserved 2017 56 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
N0020030 Nabumetone impurity F 5 10 mg 1 See leaflet; 6,6'-dimethoxy-2,2'-binaphthalenyl 1350 Yes +5C 3C 79
Y0000146 Nadolol 1 100 mg 1 1789 Yes +5C 3C 79
Y0001215 Nadolol impurity mixture 1 0.01 mg 1 1789 Yes +5C 3C 79
New N0025000 Nadroparin calcium 3 450 mg 1 Batch 2 is valid until 31 July 2017 0828,1134 Yes +5C 3C 79
Y0000077 Naftidrofuryl - reference spectrum 1 n/a 1 1594 79
Y0000120 Naftidrofuryl impurity A 1 10 mg 1 2-[(naphtalen-1-yl)methyl]-3-(tetrahydrofuran-2-yl)propanoic acid 1594 Yes +5C 3C 79
Y0000121 Naftidrofuryl impurity B 2 25 mg 1 ethyl 2-[(naphtalen-1-yl)methyl]- 3-(tetrahydrofuran-2-yl)propanoate 1594 Yes +5C 3C 79
Y0000331 Naftidrofuryl impurity F 1 10 mg 1 2-(diethylamino)ethyl 2-[(naphthalen-2-yl)methyl]-3- (tetrahydrofuran-2-yl) 1594 Yes +5C 3C 79
propanoate
N0050000 Nalidixic acid 1 100 mg 1 0701 Yes +5C 3C 79
Y0001792 Nalidixic acid impurity C 1 20 mg 1 diethyl (ethoxymethylidene)propanedioate 0701 Yes +5C 3C 79
N0075000 Naloxone hydrochloride dihydrate 3 100 mg 1 Batch 2 is valid until 28 February 2017 0729,2099 Yes +5C 3C 79
Y0001571 Naloxone impurity D 2 25 mg 1 7,8-didehydro-4,5-epoxy-3,14-dihydroxy-17-(prop-2-enyl)morphinan-6-one 0729 Yes +5C 3C 79
(7,8-didehydronaloxone)
New Y0000695 Naloxone for peak identification 3 5.1 mg 1 Batch 2 is valid until 31 May 2017 0729 Yes +5C 3C 79
Y0000400 Naltrexone hydrochloride 2 50 mg 1 Batch 1 is valid until 31 March 2016 1790 Yes +5C 3C 79
Y0000410 Naltrexone impurity C 1 15 mg 1 17-but-3-enyl-4,5-epoxy-3,14-dihydroxymorphinan-6-one 1790 Yes +5C 3C 79

Y0000542 Nandrolone decanoate 1 5 mg 1 1992 Yes -20C 5C 79


Y0000547 Nandrolone decanoate for peak identification 1 10 mg 1 1992 Yes -20C 5C 79
Y0000548 Nandrolone decanoate for system suitability 1 10 mg 1 1992 Yes -20C 5C 79
N0080000 Naphazoline hydrochloride 3 50 mg 1 0730,1162 Yes +5C 3C 79
N0100000 Naphazoline nitrate 2 10 mg 1 0147 Yes +5C 3C 79
N0200000 Naphazoline impurity A 5 15 mg 1 N-(2-aminoethyl)-2-(naphthalen-1-yl)acetamide 0147,0730 Yes +5C 3C 79
(naphthylacetylethylenediamine)
N0250000 Naproxen 3 50 mg 1 0731,1702 Yes +5C 3C 79
Y0000399 Naproxen (racemic) 1 10 mg 1 0731,1702 Yes +5C 3C 79
Y0000631 Naproxen impurity L 1 10 mg 1 1-(6-methoxynaphthalen-2-yl)ethanone 0731,1702 Yes +5C 3C 79
Y0001378 Naringin 1 20 mg 1 See leaflet CHO 2563 Yes +5C 3C 79
Y0001437 Nateglinide 1 200 mg 1 See leaflet CHNO 2575 Yes +5C 3C 79
Y0001440 Nateglinide impurity A 1 10 mg 1 trans-4-(1-methylethyl)cyclohexanecarboxylic acid 2575 Yes +5C 3C 79
Y0001441 Nateglinide impurity B 1 15 mg 1 N-[[trans-4-(1-methylethyl)cyclohexyl]carbonyl]-Lphenylalanine (L- 2575 Yes +5C 3C 79
phenylalanine isomer)
Y0001442 Nateglinide impurity C 1 10 mg 1 N-[[cis-4-(1-methylethyl)cyclohexyl]carbonyl]-D-phenylalanine (cis-isomer) 2575 Yes +5C 3C 79
N0300000 Neamine 5 0.5 mg 1 see leaflet 0180,0197 Yes +5C 3C 79
N0399000 Neohesperidin-dihydrochalcone 2 125 mg 1 See leaflet CHO ; Batch 1 is valid until 28 February 2016 1547 Yes -20C 5C 79

Council of Europe, all rights reserved 2017 57 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
N0399004 Neohesperidin-dihydrochalcone impurity B 2 10 mg 1 See leaflet CHO ; 7-[[2-O-(6-deoxy--L-mannopyranosyl) --D- 1547 Yes +5C 3C 79
glucopyranosyl]oxy]-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-
benzopyran-4-one (neodiosmin)
N0400000 Neomycin sulfate 3 50 mg 1 Not to be used for microbiological assay 0032,0033,0 Yes -20C 5C 79
053,
0180,0197,0
485, 0645
New N0401000 Neomycin sulfate for microbiological assay 5 25 mg 1 See leaflet ; Batch 4 is valid until 31 May 2017 20702 Yes -20C 5C 79
N0500000 Neostigmine bromide 1 50 mg 1 0046 Yes +5C 3C 79
N0550000 Neostigmine metilsulfate 1 50 mg 1 0626 Yes +5C 3C 79
Y0001639 Neostigmine impurity A 1 0.0025 mg 1 3-hydroxy-N,N,N-trimethylanilinium 0046,0626 Yes +5C 3C 79
N0559000 Netilmicin sulfate 1 25 mg 2 See leaflet; 1351,20702 Yes -20C 5C 79
Y0000520 Nevirapine (Anhydrous) 1 30 mg 1 See leaflet CHNO 2255, 2479 Yes +5C 3C 79
Y0001499 Nevirapine hemihydrate 1 15 mg 1 2479 Yes +5C 3C 79
Y0000521 Nevirapine for peak identification 1 0.058 mg 1 2255, 2479 Yes +5C 3C 79
Y0000388 Newcastle Disease Vaccine (inactivated) BRP 1 40 mg 1 The kit contains :1 vial BRP1 NDV reference antigen, 1 vial BRP1 NDV control 0870 Yes -20C 5C 180
antigen, 1 vial BRP1 NDV coating antibody, 1 vial BRP1 NDV conjugated,
detection antibody
Y0001373 Nicergoline 1 50 mg 1 1998 Yes +5C 3C 79
Y0001356 Nicergoline impurity D 1 20 mg 1 5-bromopyridine-3-carboxylic acid 1998 Yes +5C 3C 79
Y0001362 Nicergoline for peak identification 1 1 mg 1 1998 Yes +5C 3C 79
Y0001352 Nicergoline for system suitability 1 10 mg 1 1998 Yes +5C 3C 79
N0560000 Niclosamide (anhydrous) 3 50 mg 1 Batch 1 is valid until 31 March 2016 0679,0680 Yes +5C 3C 79
Y0001761 Nicorandil 1 5 mg 1 2332 Yes -20C 5C 79
Y0001762 Nicorandil impurity A 1 5 mg 1 2-[(pyridin-4-ylcarbonyl)amino]ethyl nitrate 2332 Yes -20C 5C 79
N0600000 Nicotinamide 1 50 mg 1 0047 Yes +5C 3C 79
N0590000 Nicotine - reference spectrum 1 n/a 1 1452,1792 79
N0590200 Nicotine ditartrate 5 120 mg 1 See leaflet CHN x 2 CHO ; Batch 4 is valid until 30 November 2016 1792 Yes +5C 3C 79
Y0001425 Nicotine ditartrate dihydrate 1 15 mg 1 2599 Yes +5C 3C 79
Y0001023 Nicotine for system suitability 4 1 mg 1 Batch 3 is valid until 31 October 2016 1452, 1792, Yes -20C 5C 79
2599
N0700000 Nicotinic acid 1 100 mg 1 0459 Yes +5C 3C 79
Y0001268 Nicotinic acid impurity mixture 1 0.12 mg 1 0459 Yes +5C 3C 79
N0750000 Nifedipine 1 50 mg 1 0627,1013 Yes +5C 3C 79
N0750010 Nifedipine impurity A 1 25 mg 1 Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)pyridine-3,5-dicarboxylate 0627 Yes +5C 3C 79
(nitrophenylpyridine analogue)
N0750015 Nifedipine impurity B 1 25 mg 1 Dimethyl 2,6-dimethyl-4-(2-nitrosophenyl)pyridine-3,5-dicarboxylate 0627 Yes +5C 3C 79
(nitrosophenylpyridine analogue)
Y0000824 Niflumic acid 1 10 mg 1 2115 Yes +5C 3C 79

Council of Europe, all rights reserved 2017 58 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0000825 Niflumic acid impurity A 1 10 mg 1 2-chloropyridine-3-carboxylic acid 2115 Yes +5C 3C 79
Y0000826 Niflumic acid impurity B 1 10 mg 1 2-hydroxy-N-(3-(trifluoromethyl)phenyl)pyridine-3-carboxamide 2115 Yes +5C 3C 79
Y0000827 Niflumic acid impurity E 1 15 mg 1 6-((3-(trifluoromethyl)phenyl)amino)pyridine-3-carboxylic acid 2115 Yes +5C 3C 79
Y0000836 Nifuroxazide 1 10 mg 1 1999 Yes +5C 3C 79
N0800000 Nikethamide 1 1 ml 1 0233 Yes +5C 3C 79
Y0000829 Nilutamide 1 110 mg 1 See leaflet CHFNO 2256 Yes +5C 3C 79
Y0000894 Nilutamide impurity B 1 5 mg 1 4-nitro-3-(trifluoromethyl)aniline (nifeline) 2256 Yes +5C 3C 79
N0845000 Nimesulide 2 100 mg 1 1548 Yes +5C 3C 79
N0845008 Nimesulide impurity D 5 0.004 mg 1 4-nitro-2-phenoxyaniline ; Batch 4 is valid until 31 October 2016 1548 Yes +5C 3C 79
Y0001237 Nimesulide for peak identification 1 10 mg 1 1548 Yes +5C 3C 79
N0850000 Nimodipine 2 50 mg 1 1245 Yes +5C 3C 79
Y0001784 Nimodipine for peak identification 1 15 mg 1 1245 Yes +5C 3C 79
N0850010 Nimodipine impurity A 4 1 mL 1 2-methoxyethyl 1-methylethyl 2,6-dimethyl-4-(3-nitrophenyl) pyridine-3,5- 1245 Yes +5C 3C 79
dicarboxylate
N0900000 Nitrazepam - * psy 2 100 mg 1 0415,0898 Yes +5C 3C 79
N0905000 Nitrendipine 2 60 mg 1 1246 Yes +5C 3C 79
N0905005 Nitrendipine impurity A 3 30 mg 1 ethyl methyl-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5- dicarboxylate 1246 Yes +5C 3C 79
Y0001456 Nitrendipine for peak identification 1 10 mg 1 1246 Yes +5C 3C 79
N0930000 Nitric oxide - reference spectrum 1 n/a 1 1550 79
N0950000 Nitrofural 2 150 mg 1 See leaflet CHNO 1135 Yes +5C 3C 79
Y0001570 Nitrofural impurity B 1 30 mg 1 See leaflet CHON; (5-nitrofuran-2-yl)methylene diacetate 1135 Yes +5C 3C 79
Y0001377 Nitrofural for peak identification 1 0.11 mg 1 1135 Yes +5C 3C 79
N1000000 Nitrosotriaminopyrimidine 1 50 mg 1 0058 Yes +5C 3C 79
N1090000 Nizatidine 1 250 mg 1 See leaflet CHNOS 1453 Yes +5C 3C 79
N1090060 Nizatidine impurity F 1 10 mg 1 (EZ)-N-methyl-N'-[2-[[[4-[[[2-[[(EZ)-1-(methylamino)-2-nitroethenyl]amino] 1453 Yes +5C 3C 79
ethyl]sulfanyl]methyl]thiazol-2-yl]methyl]sulfanyl]ethyl]-2-nitroethene-1,1-
diamine
Y0001278 Nizatidine for system suitability 1 10 mg 1 1453 Yes +5C 3C 79
N1080000 Nomegestrol acetate 2 100 mg 1 1551 Yes +5C 3C 79
N1080005 Nomegestrol acetate impurity A 2 50 mg 1 6-methyl-3,20-dioxo-19-norpregn-4-en-17-yl acetate 1551 Yes +5C 3C 79

Y0001314 1-nonadecanol 2 425 mg 1 0801,0802,0 Yes +5C 3C 79


847
Y0000670 Nonivamide 1 10 mg 2 See leaflet CHNO 1859,2336,2 Yes +5C 3C 79
337, 2529
Y0000755 Nonoxinol 9 1 10 mg 1 1454 Yes +5C 3C 79
N1100000 Noradrenaline tartrate 6 200 mg 1 0254,0285,0 Yes +5C 3C 79
732, 2303

Council of Europe, all rights reserved 2017 59 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0000681 Noradrenaline impurity D 2 15 mg 1 4[(1R)-2-amino-1-methoxyethyl]benzene-1,2-diol (noradrenaline methyl 0285,0732 Yes +5C 3C 79
ether) ; Batch 1 is valid until 31 August 2016
Y0000682 Noradrenaline impurity E 1 10 mg 1 2-chloro-1-(3,4-dihydroxyphenyl)ethanone 0285,0732 Yes +5C 3C 79
Y0000686 Noradrenaline impurity F 1 10 mg 1 N-benzyl-1-phenylmethanamine 0285,0732 Yes +5C 3C 79
N1130000 Norcyclobenzaprine 1 25 mg 1 0941 Yes +5C 3C 79
N1140000 Nordazepam -* psy 1 50 mg 1 Dipotassium clorazepate impurity B 0898 Yes +5C 3C 79
N1200000 Norethisterone 3 25 mg 1 0234,1212,0 Yes +5C 3C 79
926
Y0000522 Norethisterone for system suitability 1 10 mg 1 0234 Yes -20C 5C 79
N1225000 Norethisterone acetate 2 110 mg 1 See leaflet CHO ; Batch 1 is valid until 31 December 2016 0850 Yes +5C 3C 79
Y0001532 Norethisterone acetate for system suitability 1 2.585 mg 1 0850 Yes +5C 3C 79
N1230000 Norfloxacin 1 50 mg 1 1248 Yes +5C 3C 79
N1230010 Norfloxacin impurity A 1 20 mg 1 7-chloro-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid 1460 Yes +5C 3C 79
Y0001301 Norfloxacin for peak identification 1 10 mg 1 1248 Yes +5C 3C 79
Y0001015 Norfloxacin for system suitability 3 10 mg 1 Batch 2 is valid until 30 November 2016 1248 Yes +5C 3C 79
Y0001609 Norflurane - reference spectrum 1 1 mg 1 79
Y0000724 Norgestimate 1 10 mg 1 1732 Yes +5C 3C 79
Y0000725 Norgestimate for system suitability 1 5 mg 1 1732 Yes +5C 3C 79
N1250000 Norgestrel 1 30 mg 1 0940 Yes +5C 3C 79
N1279000 Norpseudoephedrine hydrochloride - * psy 2 50 mg 1 Cathine hydrochloride 0683 Yes +5C 3C 79
N1280000 Nortriptyline hydrochloride 2 10 mg 1 0941 Yes +5C 3C 79
Y0001296 Nortriptyline for system suitability 1 20 mg 1 0941 Yes +5C 3C 79
N1300000 Noscapine 2 100 mg 1 0102,0515,0 Yes +5C 3C 79
516
N1400000 Nystatin 7 100 mg 1 See leaflet 0517,1292,2 Yes -20C 5C 79
0702
O0100900 Octoxinol 10 2 300 mg 1 1553 Yes +5C 3C 79
Y0000368 Octyl gallate 1 30 mg 1 2057 Yes +5C 3C 79
O0101000 Octyldodecanol 5 500 mg 1 See leaflet CHO ; Batch 4 is valid until 30 June 2016 1136 Yes +5C 3C 79
O0120000 Ofloxacin 1 50 mg 1 1455 Yes +5C 3C 79
O0120010 Ofloxacin impurity A 3 20 mg 1 (3RS)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4- 1455 Yes +5C 3C 79
benzoxazine-6-carboxylic acid (FPA)
O0120050 Ofloxacin impurity E 4 20 mg 1 (3RS)-9-fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-2,3-dihydro-7H-pyrido 1455 Yes +5C 3C 79
[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid
Y0001370 Olanzapine 2 200 mg 1 See leaflet 2258 Yes +5C 3C 79
Y0001392 Olanzapine impurity A 2 5 mg 1 5-methyl-2-[(2-nitrophenyl)amino]thiophene-3-carbonitrile ; Batch 1 is valid 2258 Yes +5C 3C 79
until 31 October 2016
Y0001380 Olanzapine for system suitability 2 10 mg 1 Batch 1 is valid until 31 August 2016 2258 Yes +5C 3C 79

Council of Europe, all rights reserved 2017 60 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0001204 Oleanolic acid 1 20 mg 2 See leaflet 2463,2472 Yes +5C 3C 79
Y0001479 Oleic acid 1 2000 mg 1 See leaflet CHO 2579, 1848 Yes +5C 3C 79
Y0000805 Oleuropein 2 25 mg 1 See leaflet CHO 1878 Yes +5C 3C 79
New Y0001405 Olmesartan medoxomil 3 100 mg 1 see leaflet ; Batch 2 is valid until 30 June 2017 2600 Yes +5C 3C 79
Y0001424 Olmesartan medoxomil for system suitability 2 10 mg 1 2600 Yes +5C 3C 79
O0146000 Olsalazine sodium 2 70 mg 1 1457 Yes +5C 3C 79
O0146010 Olsalazine sodium for performance test 1 60 mg 1 1457 Yes +5C 3C 79
O0150000 Omeprazole 4 50 mg 1 See leaflet 0942,1032,2 Yes -20C 5C 79
372,
2374,2787
Y0001043 Omeprazole magnesium 1 10 mg 1 2374 Yes +5C 3C 79
O0151000 Omeprazole impurity D 2 10 mg 1 5-methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfonyl]-1H- 0942,1032, Yes -20C 5C 79
benzimidazole (omeprazole sulfone) 2372, 2374,
2787
Y0000218 Ondansetron hydrochloride dihydrate 4 200 mg 1 See leaflet CHClNO 2016 Yes +5C 3C 79
New Y0001042 Omeprazole for peak identification 2 10 mg 1 Batch 1 is valid until 31 July 2017 0942, 1032, Yes -20C 5C 79
2372, 2374,
2787
Y0001345 Ondansetron impurity A 2 10 mg 1 (3RS)-3-[(dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H- 2016 Yes +5C 3C 79
carbazol-4-one ; Batch 1 is valid until 31 January 2017
Y0000195 Ondansetron impurity D 3 15 mg 1 9-methyl-3-methylene-1,2,3,9-tetrahydro-4H-carbazol-4-one 2016 Yes +5C 3C 79
Y0001326 Ondansetron impurity E 1 10 mg 1 1H-imidazole 2016 Yes +5C 3C 79
Y0001320 Ondansetron impurity F 1 10 mg 1 2-methyl-1H-imidazole 2016 Yes +5C 3C 79
Y0001346 Ondansetron impurity G 2 10 mg 1 (3RS)-3-[(1H-imidazol-1-yl)methyl]-9-methyl-1,2,3,9-tetrahydro-4H- 2016 Yes +5C 3C 79
carbazol-4-one (C-desmethylondansetron) ; Batch 1 is valid until 30
November 2016
Y0000197 Ondansetron for LC system suitability 1 10 mg 1 2016 Yes +5C 3C 79
Y0000196 Ondansetron for TLC system suitability 2 30 mg 1 2016 Yes +5C 3C 79
Y0001125 Orbifloxacin 1 200 mg 1 2259 Yes +5C 3C 79
Y0001147 Orbifloxacin impurity mixture 1 0.0008 mg 1 2259 Yes +5C 3C 79
New O0180000 Orciprenaline sulfate 3 100 mg 1 Batch 2 is valid until 31 March 2017 1033,1332 Yes +5C 3C 79
Y0000895 Orciprenaline for system suitability 1 5 mg 1 1033 Yes +5C 3C 79
Y0001501 Orientvine stem HRS 1 600 mg 1 2450 Yes +5C 3C 79
Y0000101 Orphenadrine citrate 1 100 mg 1 1759 Yes +5C 3C 79
Y0000100 Orphenadrine hydrochloride 1 100 mg 1 1760 Yes +5C 3C 79
Y0000102 Orphenadrine impurity E 2 60 mg 1 (RS)-N,N-dimethyl-2-[(3-methylphenyl)phenylmethoxy] ethanamine (meta- 1759,1760 Yes +5C 3C 79
methylbenzyl isomer)
Y0001181 Orphenadrine for peak identification 2 0.44 mg 1 Batch 1 is valid until 30 June 2016 1759,1760 Yes +5C 3C 79
Y0001337 Oseltamivir phosphate (impurity B free) 1 300 mg 1 See leaflet CHNOP 2422 Yes +5C 3C 79

Council of Europe, all rights reserved 2017 61 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
New Y0001338 Oseltamivir impurity A 2 10 mg 1 (3R,4R,5S)-5-acetamido-4-amino-3-(1-ethylpropoxy)cyclohex-1-ene-1- 2422 Yes +5C 3C 79
carboxylic acid ; Batch 1 is valid until 30 June 2017
Y0001339 Oseltamivir impurity B 1 10 mg 1 ethyl (1R,2R,3S,4R,5S)-4-acetamido-5-amino-2-azido-3- 2422 Yes +5C 3C 79
(1-ethylpropoxy)cyclohexanecarboxylate
Y0001340 Oseltamivir impurity C 2 10 mg 1 See leaflet CHNO; (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy) 2422 Yes +5C 3C 79
cyclohex-1-ene-1-carboxylic acid ; Batch 1 is valid until 31 October 2016
Y0001341 Oseltamivir impurity H 1 30 mg 1 tributylphosphane oxide 2422 Yes +5C 3C 79
Y0001207 Osthole 1 20 mg 1 See leaflet CHO 2557 Yes +5C 3C 79
O0200000 Ouabain 2 150 mg 1 See leaflet CHO 0048 Yes +5C 3C 79
Y0000638 Oxacillin sodium monohydrate 1 110 mg 1 See leaflet CHNNaOS 2260 Yes +5C 3C 79
Y0000560 Oxacillin for peak identification 1 10 mg 1 2260 Yes -20C 5C 79
Y0000271 Oxaliplatin 4 250 mg 1 See leaflet CHNOPt 2017 Yes +5C 3C 79
Y0000272 Oxaliplatin impurity B 10 22 mg 1 See leaflet CHNOPtS; (SP-4-2)-diaqua[(1R,2R)-cyclohexane-1,2- 2017 Yes +5C 3C 79
diamineN,N]platinum (diaquodiaminocyclohexaneplatinum)
; Batch 9 is valid until 31 August 2016
Y0000273 Oxaliplatin impurity C 6 25 mg 1 (OC-6-33)-[(1R,2R)-cyclohexane-1,2-diamineN,N][ethanedioato(2-)- 2017 Yes +5C 3C 79
O1,O2]dihydroxyplatinum
Y0000274 Oxaliplatin impurity D 5 15 mg 1 (SP-4-2)-[(1S,2S)-cyclohexane-1,2-diamine-N,N'][ethanedioato(2-)- 2017 Yes +5C 3C 79
O1,O2]platinum (S,S-enantiomer of oxaliplatin)
; Batch 4 is valid until 31 July 2016
O0225000 Oxazepam - * psy 2 50 mg 1 0778 Yes +5C 3C 79
Y0000543 Oxazepam for peak identification 2 0.008 mg 1 0778 Yes +5C 3C 79
Y0001576 Oxcarbazepine 1 120 mg 1 See leaflet CHNO 2577 Yes +5C 3C 79
Y0001549 Oxcarbazepine impurity mixture 1 0.008 mg 1 2577 Yes +5C 3C 79
Y0000350 Oxeladin hydrogen citrate 1 50 mg 1 1761 Yes +5C 3C 79
Y0000404 Oxeladin impurity C 1 10 mg 1 2-(diethylamino)ethyl 2-ethyl-2-phenylbutanoate 1761 Yes +5C 3C 79
Y0000390 Oxeladin impurity D 1 20 mg 1 2-[2-(diethylamino)ethoxy]ethyl (2RS)-2-phenylbutanoate 1761 Yes +5C 3C 79
O0225800 Oxfendazole CRS 2 50 mg 1 1458 Yes +5C 3C 79
Y0000224 Oxfendazole impurity B 2 10 mg 1 See leaflet; methyl [5-(phenylsulfonyl)-1H-benzimidazole-2-yl]carbamate 1458 Yes +5C 3C 79
Y0000225 Oxfendazole with impurity D 1 10 mg 1 1458 Yes +5C 3C 79
O0260000 Oxibendazole 2 100 mg 1 1386 Yes +5C 3C 79
Y0001771 Oxidronate for radiochemical purity testing 1 34 mg 1 2376 Yes +5C 3C 79
Y0000709 Oxitropium bromide 1 50 mg 1 2170 Yes +5C 3C 79
Y0000715 Oxitropium bromide impurity B 1 15 mg 1 (1R,2R,4S,5S,7s)-7-[[(2S)-3-hydroxy-2-phenylpropanoyl]oxy]-9,9- 2170 Yes +5C 3C 79
dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane (methylhyoscine)
Y0000713 Oxitropium bromide impurity D 1 10 mg 1 (1R,2R,4S,5S,7s,9s)-9-ethyl-9-methyl-7-[(2-phenylacryloyl)oxy]-3-oxa-9- 2170 Yes +5C 3C 79
azoniatricyclo[3.3.1.02,4]nonane (apo-N-ethylhyoscine
O0240000 Oxolinic acid 1 50 mg 1 1353 Yes +5C 3C 79

Council of Europe, all rights reserved 2017 62 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
O0240005 Oxolinic acid impurity A 1 20 mg 1 8-hydroxy-1,3-dioxolo[4,5-g]quinoline-7-carboxylic acid 1353 Yes +5C 3C 79
O0240010 Oxolinic acid impurity B 1 20 mg 1 ethyl 5-ethyl-8-oxo-5,8-dihydro-1,3-dioxolo[4,5-g]quinoline-7- carboxylate 1353 Yes +5C 3C 79
O0250000 Oxprenolol hydrochloride 1 50 mg 1 0628,0876,1 Yes +5C 3C 79
072
O0270000 Oxybuprocaine hydrochloride 2 100 mg 1 1251 Yes +5C 3C 79
O0288000 Oxybutynin hydrochloride 2 50 mg 1 1354 Yes +5C 3C 79
O0288005 Oxybutynin impurity A 4 20 mg 1 See leaflet CHClNO; 4-(diethylamino)but-2-ynyl(RS)-2-(cyclohex-3- 1354 Yes +5C 3C 79
enyl)-2- cyclohexyl-2-hydroxyacetate
Y0000492 Oxycodone hydrochloride - * narc 1 100 mg 1 1784, 1793 Yes +5C 3C 79
Y0000453 Oxycodone impurity D 3 50 mg 1 7,8-didehydro-4,5-epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6- 1793 Yes +5C 3C 79
one (14-hydroxycodeinone)
O0290000 Oxymetazoline hydrochloride 2 80 mg 1 0943 Yes +5C 3C 79
Y0001044 Oxymetazoline impurity A 1 15 mg 1 N-(2-aminoethyl)-2-[4-(1,1-dimethylethyl)-3-hydroxy-2,6-dimethylphenyl] 0943 Yes +5C 3C 79
acetamide
Y0001896 Oxytetracycline 8 100 mg 1 see leaflet; This reference standard is suitable for use with monographs 0198, 0199 Yes +5C 3C 79
01/2017:0199 and 01/2017:0198.
Y0001850 Oxytetracycline for system suitability 1 15 mg 1 0198,0199 Yes +5C 3C 79
O0500000 Oxytetracycline hydrochloride 4 20 mg 1 0198,1030 Yes +5C 3C 79
O0700000 Oxytocin 5 41 mg 1 see leaflet 0779,0780 Yes -20C 5C 90
O0770000 Oxytocin/Desmopressin validation mixture 4 20 mg 1 0712,0779,0 Yes -20C 5C 79
780
Y0000698 Paclitaxel 3 40 mg 1 See leaflet CHNO ; Batch 2 is valid until 31 October 2016 1794 Yes +5C 3C 79
Y0000699 Paclitaxel impurity C 2 10 mg 1 N-debenzoyl-N-hexanoylpaclitaxel (paclitaxel C) 1794 Yes +5C 3C 79
; Batch 1 is valid until 31 March 2016
Y0000700 Paclitaxel natural for peak identification 1 10 mg 1 1794 Yes +5C 3C 79
Y0000719 Paclitaxel semi-synthetic for peak identification 2 10 mg 1 1794 Yes +5C 3C 79
Y0000739 Paclitaxel semi-synthetic for system suitability 2 1.013 mg 1 1794 Yes +5C 3C 79
Y0001856 Paeoniflorin 1 15 mg 1 see leaflet CHO 2424, 2425 Yes +5C 3C 79
P0090000 Palmitic acid 4 100 mg 1 0229,0882,1 Yes +5C 3C 79
474,1663,20
Y0000524 Pamidronate disodium pentahydrate 1 10 mg 1 58
1779 Yes +5C 3C 79
Y0001632 Pancreas powder (amylase) BRP 4 2000 mg 1 See leaflet 0350 Yes +5C 3C 79
Y0001631 Pancreas powder (lipase) BRP 4 2000 mg 1 See leaflet 0350 Yes +5C 3C 79
P0200000 Pancreas powder (protease) BRP 4 2000 mg 1 See leaflet 0350 Yes +5C 3C 79
P0250000 Pancuronium bromide 2 20 mg 1 Vecuronium impurity B 0681,1769 Yes +5C 3C 79
Y0000577 Pancuronium bromide for system suitability 1 20 mg 1 0681 Yes +5C 3C 79
Y0000835 Pantoprazole sodium sesquihydrate 1 20 mg 1 2296 Yes +5C 3C 79
Y0001001 Pantoprazole for system suitability 6 0.506 mg 1 2296 Yes +5C 3C 79

Council of Europe, all rights reserved 2017 63 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
P0270000 Papaverine hydrochloride 1 25 mg 1 0102,0573,0 Yes +5C 3C 79
515
P0300000 Paracetamol 4 50 mg 1 0049 Yes +5C 3C 79
Y0001781 Paracetamol for equipment qualification 1 250 mg 1 20248 Yes +5C 3C 79
Y0000780 Paraffin (hard) 1 10 mg 1 1034 Yes +5C 3C 79
Y0000058 Paraffin (liquid) - reference spectrum 1 n/a 1 0239,0240 79
Y0000913 Paraffin (White soft) 1 10 mg 1 1799 Yes +5C 3C 79
Y0000912 Paraffin (Yellow soft) 1 10 mg 1 1554 Yes +5C 3C 79
P0305000 Parnaparin sodium 2 200 mg 1 1252 Yes +5C 3C 79
Y0000578 Paroxetine hydrochloride (anhydrous) 1 100 mg 1 2283 Yes +5C 3C 79
Y0000579 Paroxetine hydrochloride (anhydrous) impurity C 1 10 mg 1 (3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-1-benzyl-4-(4-fluorophenyl) 2283 Yes +5C 3C 79
piperidine (N-benzylparoxetine)
Y0000581 Paroxetine hydrochloride (anhydrous) impurity H 1 10 mg 1 [(3S,4R)-1-benzyl-4-(4-fluorophenyl)piperidin-3-yl]methanol 2283 Yes +5C 3C 79
Y0000281 Paroxetine hydrochloride hemihydrate 3 200 mg 1 See leaflet CHClFNO ; Batch 2 is valid until 31 July 2016 2018,2283 Yes +5C 3C 79
Y0000233 Paroxetine impurity A 5 15 mg 1 (3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-phenylpiperidine 2018,2283 Yes +5C 3C 79
(desfluoroparoxetine)
Y0000256 Paroxetine impurity D 3 10 mg 1 See leaflet; (3R,4S)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl) 2018,2283 Yes +5C 3C 79
piperidine
((+)-trans-paroxetine)
Y0000580 Paroxetine impurity E 1 5 mg 1 (3RS,4RS)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine 2283 Yes +5C 3C 79
(cis-paroxetine)
Y0000630 Paroxetine for system suitability 1 5 mg 1 2018 Yes +5C 3C 79
P0309000 Pefloxacin mesilate dihydrate 1 200 mg 1 1460 Yes +5C 3C 79
P0309020 Pefloxacin impurity B 1 10 mg 1 6-chloro-1-ethyl-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3- 1460 Yes +5C 3C 79
carboxylic acid (chlorinated homologue of pefloxacin)
P0309030 Pefloxacin impurity C 2 0.01 mg 1 1-ethyl-6-fluoro-5-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3- 1460 Yes +5C 3C 79
carboxylic acid (isopefloxacin)
Y0001539 Pemetrexed disodium heptahydrate 2 200 mg 1 See leaflet ; Batch 1 is valid until 30 November 2016 2637 Yes +5C 3C 79
Y0001538 Pemetrexed for system suitability 1 20 mg 1 2637 Yes +5C 3C 79
Y0001535 Pemetrexed impurity mixture 2 0.002 mg 1 2637 Yes +5C 3C 79
P0307000 Penbutolol sulfate 1 100 mg 1 1461 Yes +5C 3C 79
P0307005 Penbutolol impurity A 2 20 mg 1 See leaflet CHNO; (2S)-1-[2-(cyclopent-1-enyl)phenoxy]-3-[(1,1- 1461 Yes +5C 3C 79
dimethylethyl) amino]propan-2-ol
P0310000 Penicillamine 1 100 mg 1 0566 Yes +5C 3C 79
P0320000 Penicillamine disulfide 3 100 mg 1 See leaflet CHNOS; 3,3-(disulphanediyl)bis[(2S)-2-amino-3- 0566 Yes +5C 3C 79
methylbutanoic] acid
P0400100 Pentaerythrityl tetranitrate diluted 2 600 mg 1 See leaflet CHNO 1355 Yes +5C 3C 79
P0405000 Pentamidine diisetionate 2 30 mg 1 1137,1436 Yes +5C 3C 79
P0405500 Pentazocine - reference spectrum 1 n/a 1 1462 79

Council of Europe, all rights reserved 2017 64 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
P0405510 Pentazocine hydrochloride - reference spectrum 1 n/a 1 1463 79
Y0000417 Pentazocine lactate - reference spectrum 1 n/a 1 2000 +5C 3C 79
Y0001051 Pentetate sodium calcium 1 100 mg 1 2353 Yes +5C 3C 79
P0500000 Pentobarbital - * psy 1 500 mg 1 0200,0419 Yes +5C 3C 79
P0510000 Pentoxifylline 2 100 mg 1 Batch 1 is valid until 31 January 2017 0851 Yes +5C 3C 79
Y0000076 Pentoxyverine hydrogen citrate - reference spectrum 1 n/a 1 1621 79
Y0000098 Pentoxyverine impurity A 1 10 mg 1 1-phenylcyclopentanecarboxylic acid 1621 Yes +5C 3C 79
Y0000099 Pentoxyverine impurity B 1 10 mg 1 2-(diethylamino)ethyl 1-phenylcyclopentanecarboxylate (caramiphen) 1621 Yes +5C 3C 79
P0525000 Pepsin powder BRP 2 2000 mg 1 See leaflet 0682 Yes +5C 3C 79
Y0000010 Pergolide mesilate 1 150 mg 1 See leaflet CHNOS 1555 Yes +5C 3C 79
Y0000238 Perindopril tert-butylamine 3 40 1 Batch 2 is valid until 31 March 2017 2019 Yes +5C 3C 79
Y0000237 Perindopril impurity A 2 10 mg 1 (2S,3aS,7aS)-octahydro-1H-indole-2-carboxylic acid 2019 Yes +5C 3C 79
Y0000771 Perindopril for peak identification 1 5 mg 1 2019 Yes +5C 3C 79
Y0000207 Perindopril for stereochemical purity 2 40 mg 1 2019 Yes +5C 3C 79
Y0001733 Permethrin (25:75) 1 350 mg 1 see leaflet 1762 Yes +5C 3C 79
Y0001741 Permethrin for system suitability 2 60 mg 1 Batch 1 is valid until 30 June 2016 1762 Yes +5C 3C 79
P0550000 Perphenazine 1 100 mg 1 0629,0904 Yes +5C 3C 79
Y0001045 Perphenazine for system suitability 1 5 mg 1 0629 Yes +5C 3C 79
Y0000021 Pertussis toxin BRP 1 0.05 mg 2 See leaflet See leaflet, Yes -20C 5C 90
1356, 1595,
1931, 1932,
1933, 1934,
2065, 2067,
2329,2764
P0600000 Pethidine hydrochloride - reference spectrum 1 n/a 1 0420 79
P0600002 Pethidine impurity A 2 20 mg 1 1-methyl-4-phenylpiperidine (MPP) ; Batch 1 is valid until 28 February 2017 0420 Yes +5C 3C 79
P0800000 Phenazone 2 20 mg 1 0421 Yes +5C 3C 79
Y0001138 Phenazone impurity A 1 20 mg 1 5-methyl-2-phenyl-2,4-dihydro-3-pyrazol-3-one 0421 Yes +5C 3C 79
New P0850000 Pheniramine maleate 3 250 mg 1 Batch 2 is valid until 30 June 2017 1357, 0977 Yes +5C 3C 79
Y0001428 Pheniramine impurity A 1 20 mg 1 2-benzylpyridine 1357 Yes +5C 3C 79
P0900000 Phenobarbital - * psy 5 200 mg 1 See leaflet CHNO ; Batch 4 is valid until 30 June 2016 0189,0201,0 Yes +5C 3C 79
630
Y0001350 Phenobarbital impurity A 1 15 mg 1 See leaflet CHNO; (5RS)-5-ethyl-2,6-diimino-5- 0201,0630 Yes +5C 3C 79
phenyltetrahydropyrimidin-4(1H)-one
Y0001351 Phenobarbital impurity B 1 15 mg 1 (5RS)-5-ethyl-6-imino-5-phenyldihydropyrimidine-2,4(1H,3H)-dione 0201,0630 Yes +5C 3C 79
P0950000 Phenoxyethanol 5 1 mL 1 Batch 4 is valid until 31 October 2016 0781 Yes +5C 3C 79
P1000000 Phenoxymethylpenicillin 2 250 mg 1 0148 Yes +5C 3C 79
Y0001868 Phenoxymethylpenicillin for system suitability 1 25 mg 1 0148,0149 Yes +5C 3C 79

Council of Europe, all rights reserved 2017 65 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
P1100000 Phenoxymethylpenicillin potassium 4 250 mg 1 See leaflet CHKNOS 0113,0114,0 Yes +5C 3C 79
148, 0149
Y0001127 Phentolamine mesilate 1 10 mg 1 1138 Yes +5C 3C 79
P1109000 Phentolamine mesilate - reference spectrum 1 n/a 1 1138 79
Y0001251 Phentolamine for system suitability 1 10 mg 1 1138 Yes +5C 3C 79
P1150000 Phenylalanine 4 60 mg 1 0782,2575 Yes +5C 3C 79
P1200000 Phenylbutazone 1 100 mg 1 0422,1574 Yes +5C 3C 79
Y0000147 Phenylbutazone impurity B 1 20 mg 1 4-butyl-4-hydroxy-1,2-diphenylpyrazolidine-3,5-dione 0422 Yes +5C 3C 79
P1240000 Phenylephrine 2 60 mg 1 1035 Yes +5C 3C 79
P1250000 Phenylephrine hydrochloride 3 50 mg 1 0632,1205 Yes +5C 3C 79
Y0000683 Phenylephrine hydrochloride for peak identification 4 2.004 mg 1 0632,1035 Yes +5C 3C 79
Y0000229 Phenylmercuric acetate - reference spectrum 1 n/a 1 2042 79
P1255100 Phenylmercuric borate - reference spectrum 1 n/a 1 0103 79
P1260000 Phenylpropanolamine hydrochloride - * Drug Precursor 1 50 mg 1 Norephedrin hydrochloride 0683 Yes +5C 3C 79
P1290000 Phenytoin 1 100 mg 1 1253,1988 Yes +5C 3C 79
P1300000 Phenytoin sodium 2 250 mg 1 0521 Yes +5C 3C 79
Y0001167 Phenytoin for system suitability 1 20 mg 1 0521,1253 Yes +5C 3C 79
Y0000493 Phloroglucinol (anhydrous) 2 220 mg 1 2301,2302 Yes +5C 3C 79
Y0000761 Pholcodine - * narc 1 10 mg 1 0522 Yes +5C 3C 79
Y0001865 Pholcodine for impurity G identification - * narc 1 15 mg 1 0522 Yes +5C 3C 79
Y0000798 Pholcodine for peak identification - * narc 1 10 mg 1 0522 Yes +5C 3C 79
Y0000766 Phthalic acid 1 20 mg 1 benzene-1,2-dicarboxylic acid 2348 Yes +5C 3C 79
P1500000 Phthalylsulfathiazole 1 100 mg 1 0352 Yes +5C 3C 79
P1600000 Physostigmine salicylate 2 100 mg 1 Batch 1 is valid until 30 April 2016 0286 Yes +5C 3C 79
P1609000 Phytomenadione 4 150 mg 1 see leaflet; Vitamin K1 1036 Yes +5C 3C 79
Y0001104 Picosulfate for system suitability 2 0.5 mg 1 Batch 1 is valid until 28 February 2017 1031 Yes +5C 3C 79
P1645000 Picotamide monohydrate 1 125 mg 1 1358 Yes +5C 3C 79
P1645005 Picotamide impurity A 1 25 mg 1 4-methoxybenzene-1,3-dicarboxylic acid 1358 Yes +5C 3C 79
Y0001508 Picrotin 1 40 mg 1 2486 Yes +5C 3C 79
Y0001528 Picrotoxinin 1 40 mg 1 See leaflet CHO 2486 Yes +5C 3C 79
Y0000124 Pidolate impurity B 3 110 mg 1 (2S)-2-[[[(2S)-5-oxopyrrolidin-2-yl]carbonyl]amino]pentanedioic acid 1619 Yes +5C 3C 79
Y0000123 Pidolic acid 2 125 mg 1 Batch 1 is valid until 30 April 2017 1619 Yes +5C 3C 79
P1650000 Pilocarpine hydrochloride 2 50 mg 1 0633 Yes +5C 3C 79
P1700000 Pilocarpine nitrate 1 50 mg 1 0104 Yes +5C 3C 79
Y0000106 Pilocarpine nitrate for system suitability 1 20 mg 1 0104,0633 Yes +5C 3C 79
Y0000525 Pimobendan 1 10 mg 1 2179 Yes +5C 3C 79

Council of Europe, all rights reserved 2017 66 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0000401 Pimobendan for system suitability 2 0.1 mg 1 Batch 1 is valid until 31 October 2016 2179 Yes +5C 3C 79
P1750000 Pimozide 1 150 mg 1 1254 Yes +5C 3C 79
P1800000 Pindolol 1 100 mg 1 0634,0871 Yes +5C 3C 79
Y0001520 Pioglitazone hydrochloride 1 120 mg 1 See leaflet CHClNOS 2601 Yes +5C 3C 79
Y0001519 Pioglitazone for system suitability 1 15 mg 1 2601 Yes +5C 3C 79
Y0001476 Pipemidic acid trihydrate 1 15 mg 1 1743 Yes +5C 3C 79
Y0000061 Pipemidic acid trihydrate - reference spectrum 1 n/a 1 1743 79
P1890000 Piperacillin 4 100 mg 1 See leaflet CHNOS 1168,1169 Yes +5C 3C 79
P1900000 Piperazine adipate 1 250 mg 1 0423 Yes +5C 3C 79
P2000000 Piperazine citrate 1 250 mg 1 0424 Yes +5C 3C 79
P2100000 Piperazine hydrate 1 250 mg 1 0425 Yes +5C 3C 79
Y0001217 Piperine 1 30 mg 1 See leaflet CHNO 2453,2477 Yes +5C 3C 79
Y0000288 Piracetam 3 150 mg 1 See leaflet CHNO 1733 Yes +5C 3C 79
Y0000038 Pirenzepine dihydrochloride monohydrate 1 250 mg 1 2001 Yes +5C 3C 79
P2120000 Piretanide 1 100 mg 1 1556 Yes +5C 3C 79
Y0001458 Piretanide for system suitability 1 10 mg 1 1556 Yes +5C 3C 79
Y0001769 Pirfenidone 1 120 mg 1 See Leaflet CHNO 2856 Yes +5C 3C 79
P2130000 Piroxicam 3 50 mg 1 0944 Yes +5C 3C 79
Y0001475 Piroxicam for system suitability 5 15 mg 1 Batch 4 is valid until 31 December 2016 0944 Yes +5C 3C 79
P2150000 Pivampicillin 1 125 mg 2 See leaflet 0808,0852 Yes +5C 3C 79
P2152000 Pivmecillinam hydrochloride 2 100 mg 1 See leaflet CHClNOS 1359 Yes -20C 5C 79
P2152015 Pivmecillinam impurity C 2 10 mg 1 methylene 2,2-dimethylpropanoate (2RS,4S)-2-[[[(hexahydo- 1H-azepin-1-yl) 1359 Yes +5C 3C 79
methylene]amino]methyl]-5,5-dimethylthiazolidin-4-carboxylate
P2155001 Plastic additive 01 1 2 ml 1 (2RS)-2-ethylhexyl) benzene-1,2-dicarboxylate 90001,9000 Yes +5C 3C 79
2, 30114
P2155003 Plastic additive 03 1 100 mg 1 N,N'-ethylenedialcanamide 90001,30114 Yes +5C 3C 79
E0800000 Plastic additive 04 1 500 mg 1 Epoxidised soya oil 90001,30114 Yes +5C 3C 79
P2155005 Plastic additive 05 1 500 mg 1 Epoxidised linseed oil 90001,30114 Yes +5C 3C 79
P2155008 Plastic additive 08 3 500 mg 1 ethylene bis[3,3-bis[3-(1,1-dimethylethyl)-4-hydroxyphenyl]butanoate] 30103,3010 Yes +5C 3C 79
4,
P2155009 Plastic additive 09 3 250 mg 1 See leaflet; pentaerythrityl tetrakis[3-(3,5-di-tert-butyl-4-hydroxyphenyl) 30105,3010
30103,3010 Yes +5C 3C 79
propionate] 5,
P2155010 Plastic additive 10 2 250 mg 1 4,4',4''-(2,4,6-trimethylbenzene-1,3,5-triyltrismethylene)trio[2,6-bis(1,1- 30106,3010
30103,3010 Yes +5C 3C 79
dimethylethyl)phenol] 5,
P2155011 Plastic additive 11 2 500 mg 1 Octadecyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)-propionate 30106,3010
30103,3010 Yes +5C 3C 79
5,
New P2155012 Plastic additive 12 4 250 mg 1 Tris (2,4-di-1,1-dimethylethylphenyl) phosphite R ; Batch 3 is valid until 30 30106,3010
30103,3010 Yes +5C 3C 79
June 2017 5,
30106,3010
Council of Europe, all rights reserved 2017 67 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
P2155013 Plastic additive 13 2 250 mg 1 1,3,5-tris(3,5-di-1,1-dimethylethyl-4-hydroxybenzyl)-1H,3H,5H-1,3,5- 30103,3010 Yes +5C 3C 79
triazine-2,4,6-trione 5, 30106
P2155014 Plastic additive 14 2 250 mg 1 2,2'-Di(octadecycloxy)-5,5'-spirobi(1,3,2-dioxaphosphorinane) R 30103,3010 Yes +5C 3C 79
5, 30106
P2155015 Plastic additive 15 2 500 mg 1 Dioctadecyl disulphide 30103,3010 Yes +5C 3C 79
4,
P2155016 Plastic additive 16 2 250 mg 1 Didodecyl 3,3'-thiodipropionate R 30105,3010
30103,3010 Yes +5C 3C 79
5, 30106
P2155017 Plastic additive 17 2 250 mg 1 Dioctadecyl 3,3'-thiodipropionate R 30103,3010 Yes +5C 3C 79
5, 30106
P2155018 Plastic additive 18 2 50 mg 1 30103 Yes +5C 3C 79
O0140000 Plastic additive 20 1 100 mg 1 Oleamide R 30103,3010 Yes +5C 3C 79
5,
E1260000 Plastic additive 21 1 100 mg 1 Erucamide R 30106,3010
30103, Yes +5C 3C 79
30105,
30106,
P2155022 Plastic additive 22 1 100 mg 1 Copolymer of dimethyl butanedioate and 1-(2-hydroxyethyl)-2,2,6,6- 30107
30103 Yes +5C 3C 79
tetramethylpiperidin-4-ol
Synonyms: copolymer of dimethyl succinate and (4-hydroxy-2,2,6,6-
tetramethylpiperidin-1-yl)ethanol
P2155023 Plastic additive 23 3 200 mg 1 di(isooctyl)2,2'-[(dioctylstannylene)bis(thio)]diacetate 30110,30111 Yes +5C 3C 79
containing about 27% of (tri(isooctyl)2,2',2''- [monooctyl- stannylidyne)tris
(thio)] triacetate.
; Batch 2 is valid until 28 February 2017
P2160000 Poliomyelitis vaccine (inactivated) BRP 3 0.6 mL 3 See leaflet ; Batch 2 is valid until 28 February 2017 0214,2066,2 Yes -80C 10C 90
065,
2328,2061,2
067,
1934,2329,2
0720
P2163920 Poloxamer 124 2 500 mg 1 Batch 1 is valid until 31 March 2017 1464 Yes +5C 3C 79
P2164009 Poloxamer 188 2 50 mg 1 Batch 1 is valid until 30 April 2016 1464 Yes +5C 3C 79
P2164020 Poloxamer 237 1 100 mg 1 1464 Yes +5C 3C 79
P2164021 Poloxamer 338 2 100 mg 1 Batch 1 is valid until 30 April 2016 1464 Yes +5C 3C 79
P2164030 Poloxamer 407 1 100 mg 1 1464 Yes +5C 3C 79
Y0001557 Poly (vinyl acetate) 1 100 mg 1 1962 Yes +5C 3C 79
Y0000792 Poly(vinyl acetate) dispersion 30 per cent 1 1500 mg 1 2152 Yes +5C 3C 79
Y0001550 Poly(vinyl alcohol) 1 100 mg 1 1961 Yes +5C 3C 79
P2600000 Poly(vinyl chloride) 1 100 mg 1 90001,9000 Yes +5C 3C 79
2, 30114
P2170000 Polyacrylate - reference spectrum 1 n/a 1 0733 79
Y0001855 Polydatin 1 15 mg 1 see leaflet CHO 2724 Yes +5C 3C 79

Council of Europe, all rights reserved 2017 68 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0001860 Polygonum orientale fruit for system suitability 1 510 mg 1 2726 Yes +5C 3C 79
P2400000 Polymyxin B sulfate 6 25 mg 1 see leaflet 0203 Yes +5C 3C 79
Y0000355 Polymyxin B sulfate for microbiological assay 2 25 mg 1 See leaflet 20702 Yes -20C 5C 79
Y0001712 Polyoxypropylene stearyl ether 1 250 mg 1 2602 Yes +5C 3C 79
Y0000289 Polysorbate 20 - reference spectrum 1 n/a 1 0426 79
Y0000290 Polysorbate 40 - reference spectrum 1 n/a 1 1914 79
Y0000291 Polysorbate 60 - reference spectrum 1 n/a 1 0427 79
Y0000007 Polysorbate 80 - reference spectrum 1 n/a 1 0428 79
P2649610 Potassium clavulanate - reference spectrum 1 n/a 1 1140 79
Y0001168 Potassium clavulanate impurity G 2 5 mg 1 4-[[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]amino]-4-oxobutanoic acid (N- 1653,1140 Yes -20C 5C 79
(hydrogensuccinyl)tyrosine)
Y0000315 Potassium hydrogen aspartate hemihydrate 1 50 mg 1 2076 Yes +5C 3C 79
P2650000 Potassium sorbate 2 100 mg 1 0618 Yes +5C 3C 79
Y0001275 Potassium sucrose octasulfate 1 100 mg 1 See leaflet CHKOS 1796 Yes +5C 3C 79
P2660000 Povidone 2 50 mg 1 0685 Yes +5C 3C 79
Y0000466 Povidone (iodinated) 1 10 mg 1 1142 Yes +5C 3C 79
Y0001266 Pramipexole dihydrochloride monohydrate 1 5 mg 1 2416 Yes +5C 3C 79
Y0001267 Pramipexole impurity D 2 5 mg 1 (6R)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine 2416 Yes +5C 3C 79
Y0001187 Pramipexole for system suitability 1 15 mg 1 2416 Yes +5C 3C 79
Y0000215 Pravastatin sodium - reference spectrum 1 n/a 1 2059 79
Y0000223 Pravastatin impurity A 5 0.1 mg 1 (3R,5R)-3,5-dihydroxy-7-[(1S,2S,6R,8S,8aR)-6-hydroxy-2-methyl-8- 2059 Yes -20C 5C 79
[[(2S)-2-methylbutanoyl]oxy]-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]
heptanoic acid (6'-epipravastatin)
Y0000204 Pravastatin 1,1,3,3-tetramethylbutylamine 2 30 mg 1 See leaflet CHO 2059 Yes -20C 5C 79
P2669000 Prazepam -* psy 1 50 mg 1 1466 Yes +5C 3C 79
P2670000 Praziquantel 3 200 mg 1 See leaflet 0855 Yes +5C 3C 79
Y0001533 Praziquantel for system suitability 1 10 mg 1 0855 Yes +5C 3C 79
P2680000 Prazosin hydrochloride 2 30 mg 1 0856 Yes +5C 3C 79
P2698000 Prednicarbate 2 100 mg 1 See leaflet CHO 1467 Yes +5C 3C 79
Y0001630 Prednicarbate for system suitability A 1 10 mg 1 1467 Yes +5C 3C 79
P2700000 Prednisolone 8 150 mg 1 See leaflet 0335,0353,0 Yes +5C 3C 79
354, 0735
Y0001359 Prednisolone for peak identification 1 10 mg 1 0353 Yes +5C 3C 79
Y0001355 Prednisolone for system suitability 2 10 mg 1 0353 Yes +5C 3C 79
P2800000 Prednisolone acetate 4 120 mg 1 0734,0736,0 Yes +5C 3C 79
933,
0975,1467,0
334

Council of Europe, all rights reserved 2017 69 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0000582 Prednisolone acetate for peak identification 1 10 mg 1 0734 Yes +5C 3C 79
P2804000 Prednisolone hexanoate 1 10 mg 1 1212 Yes +5C 3C 79
P2805000 Prednisolone pivalate 2 120 mg 1 0734,0736 Yes +5C 3C 79
P2810000 Prednisolone sodium phosphate 4 100 mg 1 0549,0735,0 Yes +5C 3C 79
810
P2900000 Prednisone 4 100 mg 1 0354 Yes +5C 3C 79
Y0001805 Pregabalin 2 260 mg 1 See leaflet CHNO ; Batch 1 is valid until 30 April 2017 2777 Yes +5C 3C 79
Y0001806 Pregabalin impurity A 1 0.25 mg 1 See leaflet CHNO; (4S)-4-(2-methylpropyl)pyrrolidin-2-one 2777 Yes +5C 3C 79
Y0001808 Pregabalin impurity D 1 10 mg 1 1-methylethyl (2RS)-2-hydroxy-2-phenylacetate 2777 Yes +5C 3C 79
P2920000 Pregnenolone isobutyrate 6 200 mg 1 0593,0993,2 Yes -20C 5C 79
397
Y0000263 Prekallikrein activator in albumin BRP 5 200 mg 3 See leaflet ; Batch 4 is valid until 31 August 2016 See leaflet, Yes -20C 5C 90
20615
P2939000 Prilocaine 1 150 mg 1 1362 Yes +5C 3C 79
P2939060 Prilocaine hydrochloride 1 100 mg 1 1363 Yes +5C 3C 79
Y0001408 Prilocaine impurity B 1 80 mg 1 2-methylbenzenamine (o-toluidine) 1362,1363 Yes +5C 3C 79
P2939025 Prilocaine impurity E 1 25 mg 1 (2RS)-N-(4-methylphenyl)-2-(propylamino)propanamide 1362,1363 Yes +5C 3C 79
Y0001681 Prilocaine for peak identification 1 20 mg 1 1363 Yes +5C 3C 79
P2940000 Primaquine diphosphate 3 500 mg 1 0635 Yes +5C 3C 79
P2950000 Primidone 2 150 mg 1 See leaflet 0584 Yes +5C 3C 79
Y0000369 Primidone for peak identification 1 10 mg 1 0584 Yes +5C 3C 79
P3000000 Probenecid 1 100 mg 1 0243 Yes +5C 3C 79
P3050000 Procainamide hydrochloride 1 100 mg 1 0567 Yes +5C 3C 79
P3090000 Procaine benzylpenicillin 4 250 mg 1 See leaflet ; Batch 3 is valid until 30 June 2016 0115 Yes +5C 3C 79
P3100000 Procaine hydrochloride 1 100 mg 1 0050 Yes +5C 3C 79
P3200000 Prochlorperazine maleate 1 100 mg 1 0244 Yes +5C 3C 79
P3300000 Progesterone 3 110 mg 1 See leaflet 0429 Yes +5C 3C 79
Y0001667 Progesterone for impurity H identification 2 20 mg 1 see leaflet ; Batch 1 is valid until 31 January 2017 0429 Yes +5C 3C 79
Y0001666 Progesterone for peak identification 1 5 mg 1 0429 Yes +5C 3C 79
Y0001665 Progesterone for system suitability 1 5 mg 1 0429 Yes +5C 3C 79
New Y0001885 Proguanil for system suitability 1 15 mg 1 2002 Yes +5C 3C 79
New Y0001901 Proguanil hydrochloride 1 10 mg 1 2002 Yes +5C 3C 79
Y0000179 Proguanil hydrochloride - reference spectrum 1 n/a 1 2002 79
New Y0001909 Proguanil impurity B 1 15 mg 1 4-chloroaniline 2002 Yes +5C 3C 79
Y0000181 Proguanil impurity C 2 10 mg 1 1,5-bis(4-chlorophenyl)biguanide 2002 Yes +5C 3C 79
Y0000182 Proguanil impurity D 2 10 mg 1 1,5-bis(1-methylethyl)biguanide 2002 Yes +5C 3C 79
P3350000 Proline 3 60 mg 1 0785 Yes +5C 3C 79

Council of Europe, all rights reserved 2017 70 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
P3390000 Promazine hydrochloride 2 40 mg 1 0475,1365 Yes +5C 3C 79
P3400000 Promethazine hydrochloride 2 50 mg 1 0524 Yes +5C 3C 79
Y0000769 Promethazine impurity D 2 15 mg 1 (2RS)-N,N-dimethyl-1-(10H-phenothiazin-10-yl)propan-2-amine S-oxide 0524 Yes +5C 3C 79
Y0000797 Promethazine for peak identification 2 5 mg 1 0524 Yes +5C 3C 79
P3490000 Propacetamol hydrochloride - reference spectrum 1 n/a 1 1366 79
Y0000455 Propafenone hydrochloride 1 10 mg 1 2103 Yes +5C 3C 79
Y0000456 Propafenone impurity B 1 10 mg 1 (2E)-1-[2-[(2RS)-2-hydroxy-3-(propylamino)propoxy]phenyl]-3- 2103 Yes +5C 3C 79
phenylprop-2-en-1-one
Y0000278 Propanol - reference spectrum 1 n/a 1 2036 79
Y0000016 Propofol 6 650 mg 1 See leaflet 1558 Yes +5C 3C 79
Y0000018 Propofol impurity J 4 20 mg 1 2,6-bis(1-methylethyl)benzene-1,4-dione 1558 Yes +5C 3C 79
Y0000017 Propofol for peak identification 3 0.1 ml 1 1558 Yes +5C 3C 79
P3500000 Propranolol hydrochloride 2 30 mg 1 0568,0923 Yes +5C 3C 79
P3600000 Propranolol hydrochloride for performance test 3 15 mg 1 0568 Yes +5C 3C 79
Y0001547 Propylene glycol 1 150 mg 1 1403,1804,2 Yes +5C 3C 79
645
Y0000318 Propylene glycol dilaurate 1 100 mg 1 2087 Yes +5C 3C 79
Y0000319 Propylene glycol monolaurate 1 100 mg 1 1915 Yes +5C 3C 79
P3640000 Propyl gallate 3 50 mg 1 1039 Yes +5C 3C 79
P3650000 Propyl parahydroxybenzoate 4 150 mg 1 See leaflet CHO ; Batch 3 is valid until 28 February 2016 0431,0852,1 Yes +5C 3C 79
263
P3700000 Propylthiouracil 2 30 mg 1 Batch 1 is valid until 31 May 2016 0525 Yes +5C 3C 79
P3750000 Propyphenazone 4 200 mg 1 0636 Yes +5C 3C 79
P3760000 Protirelin 3 5.03 mg 2 See leaflet CHNO 1144 Yes -20C 5C 79
P3760020 D-His-Protirelin 2 0.1 mg 1 approx. 0.1 mg per vial 1144 Yes -20C 5C 79
P3800000 Proxyphylline 1 100 mg 1 0526 Yes +5C 3C 79
P3850000 Pseudoephedrine hydrochloride - * Drug Precursor 3 50 mg 1 0487,1367 Yes +5C 3C 79
Y0000387 Pseudoisoeugenyl 2-methylbutyrate for peak 1 100 mg 1 Star anise oil 2108 Yes +5C 3C 79
identification
Y0001537 Purified quillaia saponins 1 30 mg 1 1843 Yes -20C 5C 79
P3900000 Purpureaglycoside A 1 25 mg 1 0117 Yes +5C 3C 79
P4000000 Purpureaglycoside B 1 25 mg 1 0117 Yes +5C 3C 79
Y0000402 Pyrantel embonate 1 10 mg 1 1680 Yes +5C 3C 79
Y0000403 Pyrantel impurity A 2 20 mg 1 1-methyl-2-[(Z)-2-(thiophen-2-yl)eth-1-en-1-yl]-1,4,5,6-tetrahydropyrimidine 1680 Yes +5C 3C 79
Y0001817 Pyrantel impurity D 1 20 mg 1 1,2-dimethyl-1,4,5,6,-tetrahydropyrimidine 1680 Yes +5C 3C 79
P4050000 Pyrazinamide 2 30 mg 1 0859 Yes +5C 3C 79
P4099900 Pyridostigmine bromide 4 30 mg 1 Batch 3 is valid until 31 October 2016 1255 Yes +5C 3C 79

Council of Europe, all rights reserved 2017 71 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
P4099910 Pyridostigmine impurity A 1 20 mg 1 pyridin-3-yl-dimethylcarbamate 1255 Yes +5C 3C 79
Y0001486 Pyridostigmine impurity B 1 10 mg 1 3-hydroxy-1-methylpyridinium 1255 Yes +5C 3C 79
P4100000 Pyridoxine hydrochloride 2 100 mg 1 0245 Yes +5C 3C 79
Y0001226 Pyridoxine impurity A 3 5 mg 1 6-methyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol 0245 Yes +5C 3C 79
P4200000 Pyrimethamine 1 250 mg 1 0288 Yes +5C 3C 79
Y0000659 Pyrrolidone 1 20 mg 1 2180 Yes +5C 3C 79
Y0001009 Quercetin dihydrate 3 25 mg 1 See leaflet CHO 1827 Yes +5C 3C 79
Y0001657 Quetiapine fumarate 1 50 mg 1 2541 Yes +5C 3C 79
Y0001419 Quetiapine for system suitability 3 2.005 mg 1 Batch 2 is valid until 31 July 2016 2541 Yes +5C 3C 79
Y0001564 Quillaia saponin for assay 1 30 mg 1 See leaflet CHNO; monoammonium glycyrrhizate 1843 Yes +5C 3C 79
Y0001491 Quinapril hydrochloride 1 30 mg 1 1763 Yes +5C 3C 79
Y0001502 Quinapril for peak identification 1 5.075 mg 1 1763 Yes +5C 3C 79
Y0001503 Quinapril for system suitability 1 5.125 mg 1 1763 Yes +5C 3C 79
Q0100000 Quinidine sulfate 1 300 mg 1 0017,0018,0 Yes +5C 3C 79
019
Q0200000 Quinine sulfate 2 300 mg 1 0017,0018,0 Yes +5C 3C 79
019
Y0001783 Rabeprazole sodium hydrate 1 100 mg 1 See leaflet CHNaNOS 2331,2868 +5C 3C 79
R0100000 Rabies vaccine (inactivated) for veterinary use BRP 5 86 mg 2 See leaflet ; Batch 4 is valid until 31 March 2016 0451 Yes -20C 5C 90
Y0000896 Racecadotril 2 120 mg 1 See leaflet CHNOS ; Batch 1 is valid until 31 January 2017 2171 Yes +5C 3C 79
Y0000897 Racecadotril impurity A 3 1.5 mL 1 ethanethioic acid (thioacetic acid) 2171 Yes +5C 3C 79
; Batch 2 is valid until 31 August 2016
Y0000898 Racecadotril impurity G 1 10 mg 1 benzyl [[(2RS)-2-benzyl-3-sulfanylpropanoyl]amino]acetate 2171 Yes +5C 3C 79
Y0000902 Racecadotril for peak identification 1 5 mg 1 2171 Yes +5C 3C 79
Y0001134 Raloxifene hydrochloride 1 110 mg 1 See leaflet CHClNOS 2375 Yes +5C 3C 79
Y0001135 Raloxifene for peak identification 1 10 mg 1 2375 Yes +5C 3C 79
R0145000 Ramipril 2 20 mg 1 1368 Yes +5C 3C 79
R0145005 Ramipril impurity A 4 10 mg 1 (2S,3aS,6aS)-1-[(2S)-2-[[(1S)-1-(methoxycarbonyl)-3-phenylpropyl]amino] 1368 Yes +5C 3C 79
propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid (ramipril methyl
ester)
; Batch 3 is valid until 30 October 2016
R0145010 Ramipril impurity B 3 10 mg 1 (2S,3aS,6aS)-1-[(2S)-2-[[(1S)-1-[(1-methylethoxy)carbonyl]-3-phenylpropyl] 1368 Yes +5C 3C 79
amino]propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid
(ramiprilisopropyl ester)
R0145015 Ramipril impurity C 3 10 mg 1 (2S,3aS,6aS)-1-[(2S)-2-[[(1S)-3-cyclohexyl-1-(ethoxycarbonyl)-propyl] 1368 Yes +5C 3C 79
amino]propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid
(hexahydroramipril)
R0145020 Ramipril impurity D 4 10 mg 1 ethyl (2S)-2-[(3S,5aS,8aS,9aS)-3-methyl-1,4-dioxodecahydro-2H-cyclopenta 1368 Yes +5C 3C 79
[4,5]pyrrolo[1,2-a]pyrazin-2-yl]-4-phenylbutanoate (ramipril diketopiperazine)

Council of Europe, all rights reserved 2017 72 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
R0150000 Ranitidine hydrochloride 3 100 mg 1 0946,1453 Yes +5C 3C 79
Y0000416 Ranitidine impurity J 7 0.00025 1 1,1'-N-[methylenebis(sulfanediylethylene)]bis(N'-methyl-2-nitroethene-1,1- 0946 Yes -20C 5C 79
mg diamine) ; Batch 6 is valid until 31 January 2017
Y0001787 Ranitidine for impurity A identification 1 15 mg 1 0946 Yes +5C 3C 79
Y0001565 Recombinant Major Allergen rBet v 1 1 0.01025 mg 1 See leaflet 1063 Yes -20C 5C 90
Y0001566 Recombinant Major Allergen rPhl p 5a 1 0.00856 mg 1 See leaflet 1063 Yes -20C 5C 90
New Y0001884 Remifentanil impurity mixture - *narc 1 15 mg 1 2644 Yes +5C 3C 79
Y0000457 Repaglinide 1 20 mg 1 2135 Yes +5C 3C 79
Y0000459 Repaglinide impurity E 3 10 mg 1 2-ethoxy-4-[2-[[(1R)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl]amino]-2- 2135 Yes +5C 3C 79
oxoethyl]benzoic acid ; Batch 2 is valid until 31 August 2016
Y0000458 Repaglinide for system suitability 3 6 mg 1 2135 Yes +5C 3C 79
R0200000 Reserpine 3 100 mg 1 See leaflet CHNO 0528 Yes +5C 3C 79
R0250000 Residual solvent solution class 1 6 1.4 mL 1 20424 Yes +5C 3C 79
Y0000767 Resorcinol 1 20 mg 1 benzene-1,3-diol 2348 Yes +5C 3C 79
Y0001194 Resveratrol 1 20 mg 1 See leaflet CHO 2433 Yes -20C 5C 79
R0300000 Retinol acetate 7 500 mg 1 See leaflet ; Batch 6 is valid until 31 December 2016 0218,0219,0 Yes -20C 5C 79
220,1192,11
93,2398
R0290000 Retinol esters 1 100 mg 1 0217,0218,0 Yes +5C 3C 79
219, 0220
Y0000377 Ribavirin 3 150 mg 2 See leaflet CHNO ; Batch 2 is valid until 30 November 2016 2109 Yes +5C 3C 79
R0600000 Riboflavin 4 130 mg 1 Vitamin B2 0292,0786 Yes +5C 3C 79
Y0000757 Riboflavin for peak identification 4 0.12 mg 1 Batch 3 is valid until 30 April 2017 0292 Yes +5C 3C 79
R0630000 Riboflavin sodium phosphate 2 250 mg 1 0786 Yes +5C 3C 79
Y0000662 Ribonucleic acid 1 100 mg 1 See leaflet 2090 Yes +5C 3C 79
Y0000149 Rifabutin 2 150 mg 1 See leaflet CHNO 1657 Yes +5C 3C 79
Y0000184 Rifabutin impurity A 1 20 mg 1 1-(2-methylpropyl)piperidin-4-one 1657 Yes +5C 3C 79
R0700000 Rifampicin 2 100 mg 1 0052 Yes +5C 3C 79
R0800000 Rifampicin quinone 4 100 mg 1 0052 Yes +5C 3C 79
R1000000 Rifamycin sodium 4 150 mg 1 see leaflet CHNNaO 0432,20702 Yes -20C 5C 79
R0900000 Rifamycin B 3 25 mg 1 See leaflet CHNO; Rifamycin impurity A 0432 Yes +5C 3C 79
R0950000 Rifamycin S 3 100 mg 1 0432 Yes +5C 3C 79
Y0001074 Rifaximin 2 160 mg 1 See leaflet 2362 Yes +5C 3C 79
Y0001075 Rifaximin for system suitability 1 10 mg 1 2362 Yes +5C 3C 79
Y0000250 Rilmenidine dihydrogenophosphate - reference spectrum 1 n/a 1 2020 79
Y0000187 Rilmenidine for system suitability 1 30 mg 1 2020 Yes +5C 3C 79
Y0001541 Risedronate sodium 2.5-hydrate 1 15 mg 1 2572 Yes +5C 3C 79

Council of Europe, all rights reserved 2017 73 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0001558 Risedronate impurity A 1 15 mg 1 See leaflet; [(3RS,6RS and 3R,6S-meso)-2,5-dihydroxy-2,5-dioxo-3,6-bis 2572 Yes +5C 3C 79
[(pyridin-3-yl)methyl]-1,4,25,55-dioxadiphosphinane-3,6-diyl]bis
(phosphonic acid)
Y0001540 Risedronate impurity E 1 15 mg 1 [2-(pyridin-3-yl)ethylidene]bis(phosphonic acid) 2572 Yes +5C 3C 79
R1000600 Risperidone 2 50 mg 1 1559 Yes +5C 3C 79
Y0001276 Risperidone impurity K 2 0.015 mg 1 3-[2-[4-(1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9- 1559 Yes +5C 3C 79
tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one (desfluoro risperidone)
Y0000370 Risperidone for system suitability 5 20 mg 1 1559 Yes +5C 3C 79
Y0000714 Ritonavir 1 80 mg 1 See leaflet CHNOS 2136 Yes +5C 3C 79
Y0000706 Ritonavir for peak identification 1 10 mg 1 2136 Yes +5C 3C 79
Y0001516 Rivastigmine hydrogen tartrate 2 350 mg 1 See leaflet CHNO 2629,2630 Yes +5C 3C 79
Y0001515 Rivastigmine impurity D 1 10 mg 1 3-[(1R)-1-(dimethylamino)ethyl]phenyl ethyl(methyl)carbamate ((R)- 2629,2630 Yes +5C 3C 79
enantiomer)
Y0001485 Rivastigmine for system suitability 1 1.0114 mg 1 2629,2630 Yes +5C 3C 79
Y0001302 Rizatriptan benzoate 1 200 mg 1 See leaflet CHNO 2585 Yes +5C 3C 79
Y0001303 Rizatriptan for system suitability 1 15 mg 1 2585 Yes +5C 3C 79
R1300000 RK 13 cells 1 1 ml 2 cell lines (kidney, rabbit) titration of live measles, mumps and rubella vaccines 0162,1057 Yes Liquid nitrogen 100
Y0001580 Rocuronium bromide 1 10 mg 1 1764 Yes -20C 5C 79
Y0000527 Rocuronium for peak identification 1 10 mg 1 1764 Yes -20C 5C 79
Y0001773 Ropinirole hydrochloride 1 125 mg 1 See leaflet CHClNO 2604 Yes +5C 3C 79
Y0001774 Ropinirole impurity A 1 25 mg 1 4-[2-(dipropylamino)ethyl]-1H-indole-2,3-dione 2604 Yes +5C 3C 79
Y0001775 Ropinirole for peak identification 1 1 15 mg 1 2604 Yes +5C 3C 79
Y0001776 Ropinirole for peak identification 2 1 15 mg 1 2604 Yes +5C 3C 79
Y0000742 Ropivacaine hydrochloride monohydrate 1 10 mg 1 2335 Yes +5C 3C 79
Y0000743 Ropivacaine impurity G 2 5 mg 1 (+)-(2R)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide ((R)- 2335 Yes +5C 3C 79
ropivacaine) ; Batch 1 is valid until 31 March 2017
Y0000786 Rosmarinic acid 3 50 mg 1 See leaflet CHO 1447,2382, Yes +5C 3C 79
2524,1229,
2723
Y0001719 Rosuvastatin Calcium 2 100 mg 1 See leaflet CHCaFNOS ; Batch 1 is valid until 30 June 2016 2631 Yes +5C 3C 79
New Y0001721 Rosuvastatin for system suitability 3 15 mg 1 Batch 1 is valid until 30 September 2016 2631 Yes +5C 3C 79
Batch 2 is valid until 31 May 2017
Y0001722 Rosuvastatin impurity G 2 0.004 mg 1 (3S,5R,6E)-7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl 2631 Yes +5C 3C 79
(methylsulfonyl)amino]pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid
R1500000 Roxithromycin 5 125 mg 1 See leaflet CHNO 1146 Yes +5C 3C 79
Y0000220 Roxithromycin for system suitability 2 10 mg 1 1146 Yes +5C 3C 79
R2000000 Rubella vaccine (live) BRP 1 90 mg 1 See leaflet; One sale unit is composed of a bag of 5 vials. The unit quantity of 1057,0162,2 Yes -80C 10C 90
each vial is 18 mg. 442
Y0000494 Ruscogenins 1 10 mg 1 See leaflet 1847 Yes +5C 3C 79
Council of Europe, all rights reserved 2017 74 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0000105 Rutoside trihydrate 3 100 mg 1 See leaflet CHO 1795,1874,2 Yes +5C 3C 79
184,
2427,2639
S0040000 Saccharin 1 30 mg 1 0947 Yes +5C 3C 79
S0050000 Saccharin sodium 1 50 mg 1 0787 Yes +5C 3C 79
S0100000 Salbutamol 2 50 mg 1 0529,1033 Yes +5C 3C 79
Y0000030 Salbutamol impurity B 5 10 mg 1 (1RS)-2-[(1,1-dimethylethyl)amino]-1-(4-hydroxyphenyl)ethanol 0529 Yes +5C 3C 79
Y0000071 Salbutamol impurity D 6 10 mg 1 5-[(1RS)-2-[(1,1-dimethylethyl)amino]-1-hydroxyethyl]-2- 0529,0687 Yes +5C 3C 79
hydroxybenzaldehyde ; Batch 5 is valid until 30 November 2016
New Y0000031 Salbutamol impurity F 6 10 mg 1 See leaflet; 1,1'-[oxybis[methylene(4-hydroxy-1,3-phenylene)]]bis[2-[(1,1- 0529,0687 Yes +5C 3C 79
dimethylethyl)amino]ethanol] ; Batch 5 is valid until 31 May 2017
Y0000034 Salbutamol impurity G 4 10 mg 1 See leaflet CHNO; 2-[benzyl(1,1-dimethylethyl)amino]-1-[4-hydroxy-3- 0529 Yes +5C 3C 79
(hydroxymethyl)phenyl]ethanone ; Batch 3 is valid until 31 March 2017
Y0000032 Salbutamol impurity I 4 0.006 mg 1 (1RS)-2-[(1,1-dimethylethyl)amino]-1-[4-(benzyloxy)-3-(hydroxymethyl) 0529 Yes +5C 3C 79
phenyl]ethanol
New Y0001186 Salbutamol impurity J 3 0.00045 1 2-[(1,1-dimethylethyl)amino]-1-[4-hydroxy-3-(hydroxymethyl)phenyl] 0687 Yes +5C 3C 79
mg ethanone (salbutamone)
; Batch 2 is valid until 31 July 2017
S0150000 Salbutamol sulfate 3 50 mg 1 0687 Yes +5C 3C 79
Y0001288 Salbutamol sulfate for system suitability 2 10 mg 1 0687 Yes +5C 3C 79
Y0000669 Salicin 1 50 mg 1 See leaflet CHO 2312,1583 Yes +5C 3C 79
S0200000 Salicylic acid 2 100 mg 1 0366,1185 Yes +5C 3C 79
Y0000405 Salicylic acid impurity B 2 10 mg 1 4-hydroxyisophthalic acid 0366 Yes +5C 3C 79
Y0000422 Salmeterol xinafoate 2 70 mg 1 see leaflet 1765 Yes +5C 3C 79
Y0001625 Salmeterol xinafoate for peak identification 1 15 mg 1 1765 Yes +5C 3C 79
Y0000423 Salmeterol xinafoate for system suitability 2 25 mg 1 1765 Yes +5C 3C 79
Y0001559 Salvianolic acid B 2 15 mg 1 See leaflet CHO ; Batch 1 is valid until 15 December 2016 2663 Yes -20C 5C 79
Y0001052 Santonin 1 20 mg 1 See leaflet 1391,1809 Yes +5C 3C 79
Y0001049 Saquinavir mesilate 1 70 mg 1 See leaflet CHNOS 2267 Yes +5C 3C 79
Y0001056 Saquinavir for system suitability 1 0.3033 mg 1 2267 Yes +5C 3C 79
Y0001483 Saw palmetto extract HRS 1 8000 mg 1 1848, 2579 Yes -20C 5C 79
Y0001818 Schisandrin 1 15 mg 1 See leaflet CHO 2428 Yes +5C 3C 79
Y0000814 Selamectin 2 120 mg 1 see leaflet 2268 Yes +5C 3C 79
Y0001734 Selamectin for peak identification 1 5 mg 1 2268 Yes +5C 3C 79

Council of Europe, all rights reserved 2017 75 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0001661 Selamectin impurity B 1 0.005 mg 1 (2aE,2'S,4E,5'S,6S,6'R,7S,8E,11R,15S,17aR,20Z,20aR,20bS)-6'- 2268 Yes +5C 3C 79
cyclohexyl-7-[(2,6-dideoxy-3-O-methyl--L-arabino-hexopyranosyl)oxy]-20b-
hydroxy-20-(hydroxyimino)-5',6,8,19-tetramethyl-5',6,6',7,10,11,14,15,17a,
20,20a,20b-dodecahydrospiro[2H,17H-11,15-methanofuro[4,3,2-pq][2,6]
benzodioxacyclooctadecine-13,2'-pyran]-17-one ((5Z,25R)-25-cyclohexyl-4'-
O-de(2,6-dideoxy-3-O-methyl--L-arabino-hexopyranosyl)-5-demethoxy-25-
de(1-methylpropyl)-5-(hydroxyimino)avermectinA1a)
S0360000 Selegiline hydrochloride 1 50 mg 2 1260 Yes +5C 3C 79
S0360090 (RS)-Selegiline hydrochloride 2 25 mg 1 1260 Yes +5C 3C 79
S0400000 Senna extract 1 50 mg 1 0206,0207,0 Yes -20C 5C 79
208, 1261
S0450000 Serine 1 50 mg 1 0788 Yes +5C 3C 79
S0460000 Sertaconazole nitrate 2 125 mg 1 1148 Yes +5C 3C 79
Y0000828 Sertraline hydrochloride 3 200 mg 1 See leaflet 1705 Yes +5C 3C 79
Y0001285 Sertraline impurity E 1 15 mg 1 (2R)-hydroxyphenylacetic acid ((R)-mandelic acid) 1705 Yes +5C 3C 79
Y0000866 Sertraline for peak identification 5 5.4 mg 1 Batch 4 is valid until 31 March 2017 1705 Yes +5C 3C 79
Y0000867 Sertraline for system suitability 3 6.2 mg 1 Batch 2 is valid until 30 April 2016 1705 Yes +5C 3C 79
Y0000371 Sestamibi labelling kit 3 22 mg 1 1926 Yes +5C 3C 79
Y0001046 Sevoflurane 2 1 mL 1 2269 Yes +5C 3C 79
Y0001578 Sildenafil citrate 1 100 mg 1 See leaflet 2270 Yes +5C 3C 79
New Y0001891 Sildenafil for peak identification 1 15 mg 1 2270 Yes +5C 3C 79
Y0001579 Sildenafil impurity A 1 10 mg 1 5-[2-ethoxy-5-[(4-methylpiperazin-1-yl)sulfonyl]phenyl]-1-methyl-3-(2- 2270 Yes +5C 3C 79
methylpropyl)-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one
S0500000 Silicone elastomer 3 2000 mg 1 30109 Yes +5C 3C 79
S0600000 Silicone oil 2 1 mL 1 30108 Yes +5C 3C 79
S0650000 Simvastatin 5 200 mg 1 See leaflet 1563 Yes -20C 5C 79
Y0001066 Simvastatin for peak identification 1 10 mg 1 1563 Yes -20C 5C 79
Y0001208 Sinomenine 1 20 mg 1 See leaflet CHNO 2450 Yes +5C 3C 79
S0660000 Sisomicin sulfate 3 60 mg 1 See leaflet CHNOS 0331,1351 Yes -20C 5C 79
Y0001615 Beta-sitosterol 1 25 mg 1 See leaflet CHO 2579 Yes -20C 5C 79
Y0001812 Sitagliptin phosphate monohydrate 1 160 mg 1 See leaflet CHFNO, HO 2778,2927 Yes +5C 3C 79
Y0001811 Sitagliptin containing impurity A 1 15 mg 1 2778 Yes +5C 3C 79
Y0001727 Sodium alendronate trihydrate 2 150 mg 1 see leaflet CHNNaOP,3HO ; Batch 1 is valid until 31 December 2016 1564 Yes +5C 3C 79
Y0001678 Sodium alendronate for system suitability 1 5 mg 1 1564 Yes +5C 3C 79
S0695000 Sodium amidotrizoate 1 125 mg 1 1150 Yes +5C 3C 79
Y0001669 Sodium aminosalicylate dihydrate 1 10 mg 1 1993 Yes +5C 3C 79
Y0000300 Sodium aminosalicylate dihydrate - reference spectrum 1 n/a 1 79

Council of Europe, all rights reserved 2017 76 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0000039 Sodium ascorbate 1 50 mg 1 1791 Yes +5C 3C 79
S0700000 Sodium calcium edetate 1 100 mg 1 0231 Yes +5C 3C 79
S0710000 Sodium cetostearyl sulfate 1 100 mg 1 0847 Yes +5C 3C 79
S0750000 Sodium cromoglicate 2 10 mg 1 0562 Yes +5C 3C 79
Y0001300 Sodium cromoglicate for system suitability 1 20 mg 1 0562 Yes +5C 3C 79
S0760000 Sodium cyclamate 2 100 mg 1 0774 Yes +5C 3C 79
Y0001410 Sodium fusidate 1 10 mg 1 0848 Yes +5C 3C 79
S0780000 Sodium hyaluronate BRP 2 300 mg 1 0912 Yes +5C 3C 79
S0781000 Sodium hyaluronate - reference spectrum 1 n/a 1 1472 79
Y0001468 Sodium iodohippurate 1 15 mg 1 2352 Yes +5C 3C 79
Y0000620 Sodium laurilsulfate 1 40 mg 1 0802 Yes +5C 3C 79
Y0001772 Sodium lauroylsarcosinate 1 550 mg 1 2542 Yes +5C 3C 79
Y0000808 Sodium phenylbutyrate 1 5 mg 1 2183 Yes +5C 3C 79
Y0000809 Sodium phenylbutyrate impurity C 1 10 mg 1 4-cyclohexylbutanoic acid 2183 Yes +5C 3C 79
S0785000 Sodium picosulfate 2 50 mg 1 1031 Yes +5C 3C 79
Y0000210 Sodium polystyrene sulfonate - reference spectrum 1 n/a 1 1909 79
Y0000268 Sodium propionate - reference spectrum 1 n/a 1 2041 79
S0800000 Sodium salicylate 1 100 mg 1 0413 Yes +5C 3C 79
S0808000 Sodium stearyl fumarate 1 50 mg 1 1567 Yes +5C 3C 79
S0808060 Sodium stearyl maleate 2 10 mg 1 1567 Yes +5C 3C 79
S0900000 Sodium taurocholate BRP 2 10000 mg 1 0350 Yes +5C 3C 79
S0930000 Sodium valproate 5 50 mg 1 0678 Yes +5C 3C 79
Y0001743 Solifenacin for system suitability 1 2.52 mg 1 2779 Yes +5C 3C 79
Y0001763 Solifenacin succinate 1 5 mg 1 2779 Yes +5C 3C 79
S0945000 Somatostatin 6 2.09 mg 1 See leaflet 0949 Yes -20C 5C 90
S0947000 Somatropin 3 55 mg 1 See leaflet 0950, Yes -20C 5C 150
0951,0952,
2370
Y0000711 Somatropin/desamidosomatropin resolution mixture 1 33 mg 1 See leaflet 0950,0951,0 Yes -20C 5C 150
952
S0950000 Sorbic acid 2 10 mg 1 0592 Yes +5C 3C 79
Y0000385 1,4-Sorbitan 2 50 mg 1 See leaflet CHO 2048 Yes +5C 3C 79
S1000000 Sorbitol 4 1250 mg 1 See leaflet 0435,0436,0 Yes +5C 3C 79
437,
1235,1236,1
337,
1381,1531,2
048

Council of Europe, all rights reserved 2017 77 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0000114 Sotalol hydrochloride 1 25 mg 1 2004 Yes +5C 3C 79
Y0000115 Sotalol impurity B 2 20 mg 1 N-[4-[[(1-methylethyl)amino]acetyl]phenyl]methanesulfonamide 2004 Yes +5C 3C 79
Y0001011 Spanish sage oil for peak identification 2 250 mg 1 Batch 1 is valid until 30 April 2016 1849 Yes +5C 3C 79
Y0000549 Spectinomycin for system suitability 1 20 mg 1 1152, 1658 Yes -20C 5C 79
Y0000597 Spectinomycin hydrochloride 2 100 mg 1 See leaflet 1152, 1658 Yes -20C 5C 79
Y0000655 Spectinomycin sulfate tetrahydrate 1 10 mg 1 1658 Yes -20C 5C 79
Y0001126 Spike lavender oil 1 400 l 1 2419 Yes +5C 3C 79
S1100000 Spiramycin 5 200 mg 1 See leaflet ; Batch 5 is valid until 21 October 2016 0179,0293,1 Yes -20C 5C 79
982,20702
Y0000381 Spirapril hydrochloride monohydrate 1 60 mg 1 See leaflet CHClNOS 1766 Yes +5C 3C 79
Y0000332 Spirapril for system suitability 1 15 mg 1 1766 Yes +5C 3C 79
S1200000 Spironolactone 4 160 mg 1 See leaflet; Spironolactone CRS 2 is suitable for monograph 01/2008:0688 0688 Yes +5C 3C 79
only.
Y0001295 Spironolactone for system suitability 2 2.057 mg 1 0688 Yes +5C 3C 79
Y0000185 Squalane 1 250 l 1 See leaflet CH 1630 Yes +5C 3C 79
Y0001050 St. John's wort dry extract 2 500 mg 1 See leaflet ; Batch 1 is valid until 31 March 2016 1874 Yes -20C 5C 79
S1250000 Stanozolol 2 50 mg 1 1568 Yes +5C 3C 79
S1250010 Stanozolol impurity A 1 10 mg 1 17-hydroxy-17-methyl-5-androstan-3-one (mestanolone) 1568 Yes +5C 3C 79

Y0001420 Stanozolol impurity B 1 10 mg 1 17-hydroxy-2-(hydroxymethylene)-17-methyl-5-androstan-3-one 1568 Yes +5C 3C 79


(oxymetholone)
S1300000 Starch BRP 4 50000 mg 1 0350 Yes +5C 3C 79
Y0000408 Stavudine 1 100 mg 1 see leaflet 2130 Yes +5C 3C 79
Y0001683 Stavudine impurity I 1 5 mg 1 1-(5-O-benzoyl-2,3-dideoxy--d-glycero-pent-2-enofuranosyl)-5- 2130 Yes +5C 3C 79
methylpyrimidine-2,4(1H,3H)-dione
Y0000421 Stavudine for system suitability 1 10 mg 1 2130 Yes +5C 3C 79
S1340000 Stearic acid 3 100 mg 1 Plastic additive 19 0229,0882,1 Yes +5C 3C 79
474, 1663,
2058,
30103,
30105,
S1350000 Stearyl alcohol 2 250 mg 1 See leaflet CHO 30106,3010
0702,0753,0 Yes +5C 3C 79
7
801,
0802,0847,0
969,
1123,1340,1
411
Y0000868 Streptokinase for system suitability 1 30 l 1 0356 Yes -20C 5C 79
S1400000 Streptomycin sulfate 4 100 mg 1 See leaflet 0032,0033,0 Yes -20C 5C 79
053,
0485,20702
Council of Europe, all rights reserved 2017 78 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0001195 Strychnine 1 40 mg 1 see leaflet 2513,2514 Yes +5C 3C 79
Y0001324 Sucralfate 1 10 mg 1 1796 Yes +5C 3C 79
Y0001344 Sucralose 1 550 mg 1 See leaflet CHClO 2368 Yes +5C 3C 79
Y0001342 Sucralose impurity B 3 0.5 mg 1 1,6-dichloro-1,6-dideoxy--D-fructofuranosyl 2368 Yes +5C 3C 79
6-chloro-6-deoxy--D-glucopyranoside (1',6,6'-trichloro-
1',6,6'-trideoxysucrose)
; Batch 2 is valid until 30 April 2017
S1600000 Sucrose 1 100 mg 1 0204,1570,2 Yes +5C 3C 79
318, 2319
S1608100 Sufentanil - reference spectrum 1 n/a 1 1569 79
S1609000 Sufentanil citrate - reference spectrum 1 n/a 1 1269 79
Y0000528 Sulbactam 2 150 mg 1 See leaflet 2209, 2211, Yes -20C 5C 79
2212
Y0000529 Sulbactam sodium 1 10 mg 1 See leaflet 2209 Yes +5C 3C 79
Y0000550 Sulbactam for peak identification 1 20 mg 1 2209 Yes +5C 3C 79
S1700000 Sulfacetamide sodium 1 50 mg 1 0107,0295 Yes +5C 3C 79
S1800000 Sulfadiazine 1 100 mg 1 0294 Yes +5C 3C 79
Y0001480 Sulfadiazine for identification of impurity F 1 15 mg 1 0294 Yes +5C 3C 79
Y0001469 Sulfadiazine impurity A 1 20 mg 1 pyrimidin-2-amine 0294 Yes +5C 3C 79
Y0001677 Sulfadimethoxine 1 60 mg 1 see leaflet 2741, 2745 Yes +5C 3C 79
Y0001679 Sulfadimethoxine for peak identification 1 10 mg 1 2741, 2745 Yes +5C 3C 79
S1900000 Sulfadimidine 1 100 mg 1 0295 Yes +5C 3C 79
Y0001495 Sulfadimidine for peak identification 1 50 mg 1 0295 Yes +5C 3C 79
S1950000 Sulfadoxine 2 50 mg 1 0740 Yes +5C 3C 79
S1975000 Sulfafurazole 1 100 mg 1 0741 Yes +5C 3C 79
S1975600 Sulfaguanidine 2 60 mg 1 0295,1476 Yes +5C 3C 79
S2000000 Sulfamerazine 1 100 mg 1 0358,1571 Yes +5C 3C 79
S2050000 Sulfamethizole 1 100 mg 1 0637 Yes +5C 3C 79
S2100000 Sulfamethoxazole 1 50 mg 1 0108 Yes +5C 3C 79
Y0000412 Sulfamethoxazole impurity A 1 5 mg 1 N-[4-[(5-methylisoxazol-3-yl)sulfamoyl]phenyl]acetamide 0108 Yes +5C 3C 79
Y0000413 Sulfamethoxazole impurity F 3 5 mg 1 4-amino-N-(3-methylisoxazol-5-yl)benzenesulfonamide 0108 Yes +5C 3C 79
; Batch 2 is valid until 28 February 2016
S2150000 Sulfamethoxypyridazine 1 50 mg 1 0638 Yes +5C 3C 79
S2151000 Sulfanilamide 2 100 mg 1 1571 Yes +5C 3C 79
S2159100 Sulfapyridine 1 20 mg 1 0863 Yes +5C 3C 79
S2155000 Sulfasalazine 4 250 mg 2 See leaflet CHNOS 0863,1457 Yes +5C 3C 79
S2155010 Sulfasalazine derivative for resolution 1 20 mg 1 2-hydroxy-5-[[4-[[(6-methylpyridin-2-yl)amino]-sulfonyl]phenyl]azo]benzoic 0863 Yes +5C 3C 79
acid
Council of Europe, all rights reserved 2017 79 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
S2158000 Sulfathiazole 2 100 mg 1 Batch 1 is valid until 31 July 2016 0742 Yes +5C 3C 79
S2159000 Sulfinpyrazone 1 30 mg 1 0790 Yes +5C 3C 79
S2159010 Sulfinpyrazone impurity A 3 20 mg 1 1,2-diphenyl-4-[2-(phenylsulfonyl)ethyl]pyrazolidine-3,5-dione 0790 Yes +5C 3C 79
S2159015 Sulfinpyrazone impurity B 3 20 mg 1 1,2-diphenyl-4-[2-(phenylsulfanyl)ethyl]pyrazolidine-3,5-dione 0790 Yes +5C 3C 79
Y0001238 Sulfinpyrazone for system suitability 1 0.5 mg 1 0790 Yes +5C 3C 79
S2180000 Sulindac 3 50 mg 1 See leaflet CHFOS; Contains 0.3% m/m of E-isomer 0864 Yes +5C 3C 79
S2190000 Sulpiride 4 100 mg 1 1045,1348 Yes +5C 3C 79
S2191000 Sulpiride impurity A 4 20 mg 1 [(2RS)-1-ethylpyrrolidin-2-yl]methanamine ; Batch 3 is valid until 31 March 1045,1490 Yes +5C 3C 79
2016
S2192000 Sulpiride impurity B 3 10 mg 1 methyl 2-methoxy-5-sulfamoylbenzoate 1045 Yes +5C 3C 79
Y0000530 Sultamicillin 1 10 mg 1 2211 Yes +5C 3C 79
Y0000532 Sultamicillin for peak identification 1 10 mg 1 2211 Yes +5C 3C 79
Y0000531 Sultamicillin tosilate 3 200 mg 1 See leaflet 2211,2212 Yes +5C 3C 79
Y0000022 Sumatriptan succinate 1 50 mg 1 See leaflet CHNOS 1573 Yes -20C 5C 79
Y0000026 Sumatriptan impurity mixture 8 3 mg 1 1573 Yes -20C 5C 79
New Y0000027 Sumatriptan for system suitability 6 10 mg 1 Batch 5 is valid until 30 June 2017 1573 Yes -20C 5C 79
S2200000 Suxamethonium chloride 1 1000 mg 1 0248 Yes +5C 3C 79
Y0001778 Rabeprazole for system suitability 1 15 mg 1 2331,2868 Yes +5C 3C 79
S2400000 Suxibuzone 1 50 mg 1 1574 Yes +5C 3C 79
S2400004 Suxibuzone impurity B 1 10 mg 1 (4-butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-yl)methyl ethyl butanedioate 1574 Yes +5C 3C 79
S2400006 Suxibuzone impurity C 1 10 mg 1 4-butyl-4-(hydroxymethyl)-1,2-diphenyl-1,2-dihydro-4H-pyrazole-3,5-dione 1574 Yes +5C 3C 79
S5000001 Swine erysipelas bacteria, serotyp 1 (for vaccines - vet. 1 1 mg 1 See leaflet See leaflet, Yes +5C 3C 90
use) BRP 0064
S5000002 Swine erysipelas bacteria, serotyp 2 (for vaccines - vet. 1 1 mg 1 See leaflet See leaflet, Yes +5C 3C 90
use) BRP 0064
Y0001854 Tacalcitol monohydrate 1 15 mg 1 see leaflet CHO,HO 2272 Yes -20C 5C 79
Y0001610 Tacalcitol for system suitability 1 0.025 mg 1 2272 Yes -20C 5C 79
Y0001824 Tacalcitol impurity A 1 0.001 mg 1 (5E,7E)-(24R)-9,10-secocholesta-5,7,10(19)-triene-1,3,24-triol (trans- 2272 Yes -20C 5C 79
tacalcitol)
Y0001910 Tacalcitol monohydrate - reference spectrum 1 1 1 2272 79
Y0001417 Tadalafil 2 200 mg 1 see leaflet 2606 Yes +5C 3C 79
T0010000 Talampicillin hydrochloride 1 50 mg 1 0808,0852 Yes +5C 3C 79
T0014000 Tamoxifen citrate 2 80 mg 1 1046 Yes +5C 3C 79
T0015000 Tamoxifen citrate for performance test 3 10 mg 1 1046 Yes +5C 3C 79
Y0000650 Tamsulosin hydrochloride 1 10 mg 1 2131 Yes +5C 3C 79
Y0000651 Tamsulosin impurity D 2 10 mg 1 2-methoxy-5-[(2R)-2-[[2-(2-methoxyphenoxy)ethyl]amino]propyl] 2131 Yes +5C 3C 79
benzenesulfonamide

Council of Europe, all rights reserved 2017 80 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0000652 Tamsulosin impurity H 2 10 mg 1 (2R)-N-[2-(2-ethoxyphenoxy)ethyl]-1-(4-methoxyphenyl)propan-2-amine 2131 Yes +5C 3C 79
Y0000653 Tamsulosin racemate 2 15 mg 1 2131 Yes +5C 3C 79
Y0001560 Tanshinone IIa 1 15 mg 1 See leaflet CHO 2663 Yes +5C 3C 79
Y0001840 Taxifolin 1 15 mg 1 See leaflet CHO 2726 Yes -20C 5C 79
Y0001102 Teicoplanin 2 50 mg 1 see leaflet 2358 Yes -20C 5C 79
Y0001047 Teicoplanin for identification 1 40 mg 1 2358 Yes -20C 5C 79
Y0000648 Telmisartan 1 30 mg 1 2154 Yes +5C 3C 79
Y0000649 Telmisartan for peak identification 3 10 mg 1 Batch 2 is valid until 31 August 2016 2154 Yes +5C 3C 79
Y0001003 Telmisartan for system suitability 4 0.26 mg 1 Batch 3 is valid until 28 February 2016 2154 Yes +5C 3C 79
T0040000 Temazepam - * psy 1 50 mg 1 0954 Yes +5C 3C 79
Y0000344 Temazepam impurity C 1 5 mg 1 (3RS)-7-chloro-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4- 0954 Yes +5C 3C 79
benzodiazepin-3-yl acetate
Y0000345 Temazepam impurity D 1 5 mg 1 (3RS)-7-chloro-3-methoxy-1-methyl-5-phenyl-1,3-dihydro-2H-1,4- 0954 Yes +5C 3C 79
benzodiazepin-2-one
Y0000346 Temazepam impurity F 2 10 mg 1 (5RS)-7-chloro-1-methyl-5-phenyl-4,5-dihydro-1H-1,4-benzodiazepine-2,3- 0954 Yes +5C 3C 79
dione
Y0000347 Temazepam impurity G 1 5 mg 1 (5RS)-7-chloro-1,4-dimethyl-5-phenyl-4,5-dihydro-1H-1,4- 0954 Yes +5C 3C 79
benzodiazepine-2,3-dione
Y0001827 Temozolomide 1 70 mg 1 See leaflet CHNO 2780 Yes +5C 3C 79
T0040800 Tenoxicam 2 100 mg 1 1156 Yes +5C 3C 79
Y0001114 Tenoxicam impurity mixture 1 0.0042 mg 1 1156 Yes +5C 3C 79
Y0000621 Terazosin hydrochloride dihydrate 1 40 mg 1 2021 Yes +5C 3C 79
Y0000622 Terazosin impurity A 1 10 mg 1 2-chloro-6,7-dimethoxyquinazolin-4-amine 2021 Yes +5C 3C 79
Y0000665 Terazosin impurity E 1 10 mg 1 2,2'-(piperazine-1,4-diyl)bis(6,7-dimethoxyquinazolin-4-amine) 2021 Yes +5C 3C 79
Y0000623 Terazosin impurity L 1 10 mg 1 1-(furan-2-ylcarbonyl)piperazine 2021 Yes +5C 3C 79
Y0000624 Terazosin impurity N 1 10 mg 1 See leaflet CHNO; 1-[[(2RS)-tetrahydrofuran-2-yl]carbonyl]piperazine 2021 Yes +5C 3C 79
Y0000666 Terazosin for system suitability 1 0.5 mg 1 2021 Yes +5C 3C 79
Y0000535 Terbinafine hydrochloride 1 10 mg 1 1734 Yes +5C 3C 79
Y0001143 Terbinafine for system suitability 2 10 mg 1 1734 Yes +5C 3C 79
T0050000 Terbutaline sulfate 2 100 mg 1 0690, 2451 Yes +5C 3C 79
T0050015 Terbutaline impurity C 4 15 mg 1 1-(3,5-dihydroxyphenyl)-2-[(1,1-dimethylethyl)amino]ethanone ; Batch 3 is 0690 Yes +5C 3C 79
valid until 30 November 2016
T0060000 Terconazole 2 250 mg 1 1270 Yes +5C 3C 79
T0071000 Terfenadine 1 100 mg 1 0955 Yes +5C 3C 79
T0080000 Terfenadine impurity A 2 20 mg 1 1-[4-(1,1-dimethylethyl)phenyl]-4-[4-(hydroxydiphenylmethyl) piperidin-1-yl] 0955 Yes +5C 3C 79
butan-1-one
Y0001895 Teriparatide for system suitability 1 1.3 mg 1 2829 Yes -20C 5C 79
T0100000 Testosterone 3 30 mg 1 1373, 1048 Yes +5C 3C 79

Council of Europe, all rights reserved 2017 81 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0000342 Testosterone for impurity D identification 2 20 mg 1 1373 Yes +5C 3C 79
Y0000343 Testosterone for system suitability 3 20 mg 1 Batch 2 is valid until 28 February 2016 1373 Yes +5C 3C 79
T0210000 Testosterone caproate 1 50 mg 1 1048 Yes +5C 3C 79
T0240000 Testosterone decanoate 2 50 mg 1 See leaflet CHO 1048, 1736 Yes -20C 5C 79
Y0000696 Testosterone decanoate for system suitability 1 0.4 mg 1 1736 Yes -20C 5C 79
T0250000 Testosterone enantate 2 40 mg 1 Batch 1 is valid until 31 October 2016 1048 Yes -20C 5C 79
Y0001313 Testosterone enantate impurity H 1 10 mg 1 androst-5-ene-3,17-diyl diheptanoate 1048 Yes -20C 5C 79

Y0001312 Testosterone enantate for peak identification 1 10 mg 1 1048 Yes -20C 5C 79


Y0001317 Testosterone enantate for system suitability 1 2 mg 1 1048 Yes -20C 5C 79
T0260000 Testosterone isocaproate 2 50 mg 1 See leaflet CHO 1048,1737 Yes +5C 3C 79
Y0000716 Testosterone isocaproate for system suitability 1 5 mg 1 1737 Yes +5C 3C 79
T0300000 Testosterone propionate 2 60 mg 1 See leaflet CHO 0297 Yes +5C 3C 79
Y0001409 Testosterone propionate for system suitability 1 5 mg 1 0297 Yes +5C 3C 79
T0400000 Tetanus vaccine (adsorbed) 3 30 mg 1 See leaflet See leaflet, Yes -20C 5C 90
20708
T0500000 Tetracaine hydrochloride 1 100 mg 1 0057 Yes +5C 3C 79
Y0001002 Tetracaine for system suitability 1 2 mg 1 0057 Yes +5C 3C 79
T0550000 Tetracosactide 3 20.4 mg 2 See leaflet CHNOS 0644 Yes -20C 5C 79
T0600000 Tetracycline hydrochloride 3 100 mg 1 See leaflet CHClNO 0173, Yes +5C 3C 79
0210,0211,1
654
Y0001165 Tetrandrine 1 20 mg 1 See leaflet CHNO 2478 Yes +5C 3C 79
Y0001087 Tetra-O-acetyl-mannose triflate 1 60 mg 1 See leaflet CHFOS 2294 Yes -20C 5C 79
Y0000015 Tetrazepam - reference spectrum 1 n/a 1 1738 79
Y0000008 Tetrazepam impurity C 1 20 mg 1 7-chloro-5-cyclohexyl-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one 1738 Yes +5C 3C 79
Y0000460 Tetryzoline hydrochloride 1 10 mg 1 2101 Yes +5C 3C 79
Y0000723 Thebaine - * narc 1 15 mg 1 see leaflet 0777,1839,1 Yes +5C 3C 79
840,1841
T0700000 Theobromine 2 25 mg 1 0298 Yes +5C 3C 79
T0800000 Theophylline 1 100 mg 1 0300,0301 Yes +5C 3C 79
Y0000294 Theophylline - reference spectrum 1 n/a 1 0299,0302 79
Y0000336 Thiamazole 1 125 mg 1 0884,1706 Yes +5C 3C 79
Y0000372 Thiamazole impurity A 1 15 mg 1 2,2-dimethoxy-N-methylethanamine 1706 Yes +5C 3C 79
New Y0000373 Thiamazole impurity C 4 20 mg 1 1-methyl-2-(methylsulfanyl)-1H-imidazole 1706 Yes +5C 3C 79
; Batch 2 is valid until 30 November 2016
Batch 3 is valid until 31 March 2017
Y0000467 Thiamine hydrochloride 2 10 mg 1 0303 Yes +5C 3C 79
Y0001749 Thiamine for system suitability 1 0.5 mg 1 0303,0531 Yes +5C 3C 79
Council of Europe, all rights reserved 2017 82 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0001758 Thiamine nitrate 1 15 mg 1 0531 Yes +5C 3C 79
T1100000 Thiamphenicol 1 125 mg 1 0109 Yes +5C 3C 79
Y0001789 Thiocolchicoside hydrate 1 60 mg 1 See leaflet CHNOS 2814,2896 Yes +5C 3C 79
Y0001790 Thiocolchicoside crystallised from ethanol 1 10 mg 1 2896 Yes +5C 3C 79
Y0001791 Thiocolchicoside for system suitability 1 10 mg 1 2814,2896 Yes +5C 3C 79
Y0000546 Thioctic acid 2 110 mg 1 See leaflet 1648 Yes +5C 3C 79
Y0000545 Thioctic acid containing impurity B 2 25 mg 1 1648 Yes +5C 3C 79
Y0000592 Thioctic acid for system suitability 2 15 mg 1 Batch 1 is valid until 30 June 2016 1648 Yes +5C 3C 79
Y0000109 Thiomersal 1 30 mg 1 1625 Yes +5C 3C 79
T1200000 Thiopental 1 500 mg 1 0212 Yes +5C 3C 79
Y0001478 Thiopental for system suitability 1 10 mg 1 0212 Yes +5C 3C 79
Y0000704 Thioridazine 1 10 mg 1 2005 Yes +5C 3C 79
T1300000 Thioridazine hydrochloride 1 100 mg 1 0586 Yes +5C 3C 79
Y0000541 Thioridazine for system suitability 1 0.21 mg 1 0586, 2005 Yes +5C 3C 79
T1305100 Thioxanthene 3 20 mg 1 1347 Yes +5C 3C 79
T1305000 Thioxanthone 2 10 mg 1 1347 Yes +5C 3C 79
T1340000 Threonine 1 50 mg 1 1049 Yes +5C 3C 79
T1350000 Thymol 2 50 mg 1 0791 Yes +5C 3C 79
T1410000 Tiabendazole 1 50 mg 1 0866 Yes +5C 3C 79
Y0000379 Tiamulin - reference spectrum 1 n/a 1 1660 79
Y0000333 Tiamulin hydrogen fumarate 2 500 mg 1 See leaflet CHNOS 1659,1660 Yes +5C 3C 79
Y0000414 Tiamulin for peak identification 2 10 mg 1 1659 Yes +5C 3C 79
Y0000151 Tianeptine sodium - reference spectrum 1 n/a 1 2022 79
Y0000153 Tianeptine impurity A 1 30 mg 1 ethyl 7-bromoheptanoate 2022 Yes +5C 3C 79
Y0000152 Tianeptine for system suitability 1 30 mg 1 2022 Yes +5C 3C 79
T1405000 Tiapride hydrochloride 1 60 mg 1 1575 Yes +5C 3C 79
T1405050 Tiapride N-oxide 1 20 mg 1 1575 Yes +5C 3C 79
T1410900 Tiaprofenic acid 1 50 mg 1 1157 Yes +5C 3C 79
T1410910 Tiaprofenic acid impurity C 1 20 mg 1 (2RS)-2-(5-benzoylthiophen-3-yl)propanoic acid 1157 Yes +5C 3C 79
Y0000748 Tibolone - reference spectrum 1 n/a 1 1739 79
Y0000668 Tibolone for system suitability 1 10 mg 1 1739 Yes +5C 3C 79
New Y0000465 Ticarcillin monosodium 3 250 mg 1 see leaflet ; Batch 2 is valid until 8 February 2017 0956 Yes -20C 5C 79
T1420010 Ticarcillin impurity A 2 50 mg 1 See leaflet; (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[[(thiophen-3-yl)acetyl]- 0956 Yes +5C 3C 79
amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(decarboxyticarcillin)
T1423000 Ticlopidine hydrochloride 3 50 mg 1 1050 Yes +5C 3C 79

Council of Europe, all rights reserved 2017 83 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
T1423025 Ticlopidine impurity F 3 15 mg 1 6-(2-chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine ; Batch 2 is valid 1050 Yes +5C 3C 79
until 31 August 2016
Y0000325 Tilidine hydrochloride hemihydrate - reference spectrum 1 n/a 1 1767 79
Y0000644 (R)-timolol 2 20 mg 1 0572 Yes +5C 3C 79
T1450000 Timolol maleate 3 100 mg 1 0572 Yes +5C 3C 79
Y0001690 Timolol impurity F 1 10 mg 1 4-(4-chloro-1,2,5-thiadiazol-3-yl)morpholine 0572 Yes +5C 3C 79
Y0001270 Timolol for system suitability 2 5.045 mg 1 0572 Yes +5C 3C 79
T1470000 Tinidazole 1 100 mg 1 1051 +5C 3C 79
Y0000899 Tinidazole impurity A 1 15 mg 1 2-methyl-5-nitro-1H-imidazole 1051 Yes +5C 3C 79
T1471000 Tinidazole impurity B 4 20 mg 1 1-[2-(ethylsulphonyl)ethyl]-2-methyl-4-nitro-1H-imidazole 1051 Yes +5C 3C 79
T1490000 Tinzaparin sodium 1 250 mg 1 1271 Yes +5C 3C 79
Y0000292 Tioconazole - reference spectrum 1 n/a 1 2074 79
Y0000282 Tioconazole for system suitability 1 50 mg 1 2074 Yes +5C 3C 79
Y0001188 Tiotropium bromide monohydrate 1 10 mg 1 2420 Yes +5C 3C 79
Y0001216 Tiotropium impurity F 2 15 mg 1 dithiophen-2-ylmethanone 2420 Yes +5C 3C 79
Y0001189 Tiotropium for system suitability 2 10 mg 1 2420 Yes +5C 3C 79
Y0001179 Tiotropium impurity mixture 2 0.08 mg 1 2420 Yes +5C 3C 79
Y0001700 Tizanidine hydrochloride 1 100 mg 1 See leaflet CHClNS 2578 Yes +5C 3C 79
Y0001698 Tizanidine impurity B 1 10 mg 1 N-(5-chloro-2,1,3-benzothiadiazol-4-yl)thiourea 2578 Yes +5C 3C 79
T1500000 Tobramycin 4 49 mg 1 See leaflet CHNO; Suitable for LC assay only 0645 Yes +5C 3C 79
Y0001210 Tobramycin for identification 1 250 mg 1 Suitable for identification tests only 0645 Yes +5C 3C 79
T1550000 alpha-Tocopherol 7 500 mg 1 See leaflet CHO ; Vitamin E ; Batch 7 is valid until 8 October 2016 0692,1256 Yes +5C 3C 79
T1600000 alpha-Tocopheryl acetate 9 500 mg 1 See leaflet CHO 0439,0691,1 Yes +5C 3C 79
257
Y0000383 All-rac-alpha-tocopherol for peak identification 3 50 mg 1 0692 Yes +5C 3C 79
Y0000384 All-rac-alpha-tocopheryl acetate for peak identification 2 30 mg 1 0439 Yes +5C 3C 79
T1610000 RRR-alpha-Tocopheryl hydrogen succinate 1 150 mg 1 See leaflet CHO 1258,1259 Yes +5C 3C 79
T1700000 Tolbutamide 1 100 mg 1 0304 Yes +5C 3C 79
Y0000154 Tolfenamic acid 1 100 mg 1 2039 Yes +5C 3C 79
T1707000 Tolnaftate 1 60 mg 1 1158 Yes +5C 3C 79
Y0001123 Tolnaftate for system suitability 1 10 mg 1 1158 Yes +5C 3C 79
Y0001696 Tolterodine tartrate 1 5 mg 1 2781 Yes +5C 3C 79
Y0001699 Tolterodine impurity E 1 5 mg 1 4-methyl-2-[(1RS)-3-[(1-methylethyl)amino]-1-phenylpropyl]phenol 2781 Yes +5C 3C 79
Y0001697 Tolterodine for system suitability 1 5 mg 1 2781 Yes +5C 3C 79
Y0000461 Torasemide anhydrous 1 10 mg 1 2132 Yes +5C 3C 79
Y0001366 Torasemide impurity E 1 0.0006 mg 1 ethyl [[4-[(3-methylphenyl)amino]pyridin-3-yl]sulfonyl]carbamate 2132 Yes +5C 3C 79
Y0000462 Torasemide for system suitability 2 5 mg 1 2132 Yes +5C 3C 79
Council of Europe, all rights reserved 2017 84 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0000155 Tramadol hydrochloride 3 75 mg 1 1681 Yes +5C 3C 79
Y0000156 Tramadol impurity A 4 25 mg 1 (1RS,2SR)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)-cyclohexanol 1681 Yes +5C 3C 79
Y0000157 Tramadol impurity E 4 15 mg 1 (2RS)-2-[(dimethylamino)methyl]cyclohexanone ; Batch 3 is valid until 31 1681 Yes +5C 3C 79
January 2017
Y0000072 Tramazoline hydrochloride monohydrate 1 20 mg 1 1597 Yes +5C 3C 79
Y0000065 Tramazoline impurity A 2 15 mg 1 N-(naphthalen-1-yl)-4,5-dihydro-1H-imidazol-2-amine 1597 Yes +5C 3C 79
Y0000066 Tramazoline impurity B 2 15 mg 1 See leaflet; Mixture of 1-acetyl-N-(5,6,7,8-tetrahydronaphthalen-1-yl)-4,5- 1597 Yes +5C 3C 79
dihydro-1H-imidazol-2-amine and 1-[(EZ)-1-[(5,6,7,8-
tetrahydronaphthalen-1-yl)imino]ethyl]imidazolidin-2-one ; Batch 1 is valid
until 31 December 2016
Y0000501 Trandolapril 1 10 mg 1 2245 Yes +5C 3C 79
Y0000495 Trandolapril impurity C 1 10 mg 1 (2S,3aR,7aS)-1-[(2S)-2-[[(1S)-3-cyclohexyl-1-(ethoxycarbonyl)propyl]amino] 2245 Yes +5C 3C 79
propanoyl]octahydro-1H-indole-2-carboxylic acid (hexahydrotrandolapril)
Y0000496 Trandolapril impurity D 1 10 mg 1 ethyl (2S)-2-[(3S,5aS,9aR,10aS)-3-methyl-1,4-dioxodecahydropyrazino[1,2- 2245 Yes +5C 3C 79
a]indol-2(1H)-yl]-4-phenylbutanoate (trandolapril diketopiperazine)
T1810000 Tranexamic acid 5 50 mg 1 Batch 4 is valid until 30 April 2016 0875 Yes +5C 3C 79
T1820000 Trapidil 1 50 mg 1 1576 Yes +5C 3C 79
T1820002 Trapidil impurity A 1 20 mg 1 5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-ol 1576 Yes +5C 3C 79
T1820004 Trapidil impurity B 1 20 mg 1 1,2,4-triazol-3-amine 1576 Yes +5C 3C 79
Y0001172 Trehalose dihydrate 1 250 mg 1 See leaflet CHO,2HO 2297 Yes +5C 3C 79
T1850000 Tretinoin 2 50 mg 1 0693,1019,1 Yes +5C 3C 79
385
G0400010 Triacetin - reference spectrum 1 n/a 1 1106 79
T1899990 Triamcinolone 2 150 mg 1 1376 Yes +5C 3C 79
Y0000050 Triamcinolone impurity C 1 10 mg 1 9-fluoro-11,16,17,21-tetrahydroxypregn-4-ene-3,20-dione 1376 Yes +5C 3C 79
(pretriamcinolone)
T1900000 Triamcinolone acetonide 6 150 mg 1 See leaflet CHFO ; Batch 5 is valid until 31 March 2016 0533,0867,1 Yes +5C 3C 79
075
Y0001459 Triamcinolone acetonide for system suitability 1 10 mg 1 0533 Yes +5C 3C 79
T1950000 Triamcinolone hexacetonide 3 100 mg 1 See leaflet CHFO ; Batch 2 is valid until 31 December 2016 0533,0867 Yes +5C 3C 79
Y0000837 Triamterene 1 10 mg 1 0058 Yes +5C 3C 79
Y0000870 Triamterene impurity B 1 0.5 mg 1 2,7-diamino-6-phenylpteridin-4-ol 0058 Yes +5C 3C 79
T1975000 Triazolam - * psy 1 10 mg 1 1065 Yes +5C 3C 79
Y0000165 Tribenoside 3 150 mg 1 See leaflet 1740 Yes -20C 5C 79
Y0000166 Tribenoside impurity A 4 70 mg 1 See leaflet CHO; 3,5,6-tri-O-benzyl-1,2-O-(1-methylethylidene)--d- 1740 Yes -20C 5C 79
glucofuranose
Y0001628 Tribenoside impurity D 1 35 mg 1 Benzyl ether 1740 +5C 3C 79
Y0001055 Tributyl acetylcitrate 2 1 mL 1 1770 Yes +5C 3C 79
Y0000799 Tributyl acetylcitrate for peak identification 1 25 mg 1 1770 Yes +5C 3C 79

Council of Europe, all rights reserved 2017 85 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
New T1977990 Tricaprin 2 150 mg 1 Batch 1 is valid until 31 May 2017 1410 Yes -20C 5C 79
T1977995 Tricaproin 1 40 mg 1 1410 Yes -20C 5C 79
T1978000 Tricaprylin 1 225 mg 1 1410 Yes -20C 5C 79
Y0000111 Trichloroacetic acid - reference spectrum 1 n/a 1 1967 79
T1985000 Trichlorotrifluoroethane 1 2.5 ml 1 0393 Yes +5C 3C 79
Y0001737 Triclabendazole 1 10 mg 1 2609 Yes +5C 3C 79
Y0001723 Triclabendazole for system suitability 1 0.012 mg 1 2609 Yes +5C 3C 79
T1986000 Triethyl citrate - reference spectrum 1 n/a 1 1479 79
T2000000 Trifluoperazine hydrochloride 1 100 mg 1 0059 Yes +5C 3C 79
T2005000 Triflusal 1 50 mg 1 1377 Yes +5C 3C 79
T2005010 Triflusal impurity B 1 15 mg 1 2-hydroxy-4-(trifluoromethyl)benzoic acid (4-(trifluoromethyl)salicylic acid) 1377 Yes +5C 3C 79
Y0000720 Triglycerol diisostearate 1 200 mg 1 2032 Yes +5C 3C 79
Y0000108 Trihexyphenidyl hydrochloride 1 100 mg 1 1626 Yes +5C 3C 79
Y0000068 Trihexyphenidyl impurity A 1 20 mg 1 1-phenyl-3-(piperidin-1-yl)propan-1-one 1626 Yes +5C 3C 79
T2009000 Trilaurin 3 1250 mg 1 Batch 2 is valid until 31 May 2016 1410 Yes -20C 5C 79
Y0001319 Trimebutine maleate 1 10 mg 1 2182 Yes +5C 3C 79
Y0001260 Trimebutine for system suitability 2 1.02 mg 1 Batch 1 is valid until 31 May 2016 2182 Yes +5C 3C 79
Y0000092 Trimetazidine dihydrochloride - reference spectrum 1 n/a 1 1741 79
Y0000093 Trimetazidine for system suitability 3 50 mg 1 1741 Yes +5C 3C 79
T2100000 Trimethadione 1 250 mg 1 See leaflet CHNO 0440 Yes +5C 3C 79
T2200000 Trimethoprim 1 50 mg 1 0060 Yes +5C 3C 79
T2200010 Trimethoprim impurity B 5 15 mg 1 (2,4-diaminopyrimidin-5-yl)(3,4,5-trimethoxyphenyl)methanone ; Batch 4 is 0060 Yes +5C 3C 79
valid until 30 April 2016
Y0000684 Trimethoprim for system suitability 4 0.00075 mg 1 Batch 3 is valid until 30 November 2016 0060 Yes +5C 3C 79
Y0001497 3-trimethylsilyl-1-propanesulfonic acid sodium salt 2 120 mg 1 See leaflet CHOSSi,Na ; Batch 1 is valid until 31 May 2016 2645, 2165 Yes +5C 3C 79
T2450000 Trimethyltetradecylammonium bromide 2 200 mg 1 0378 Yes +5C 3C 79
T2500000 Trimipramine maleate 1 100 mg 1 0534 Yes +5C 3C 79
Y0000759 Trimipramine for peak identification 1 0.51 mg 1 0534 Yes +5C 3C 79
T2500100 Trimyristin 2 500 mg 1 1410 Yes -20C 5C 79
Y0000279 Tri-n-butyl phosphate 1 300 l 1 1682 Yes +5C 3C 79
Y0001113 Triolein 1 30 mg 1 See leaflet CHO 2454 Yes -20C 5C 79
T2501200 Tristearin 1 100 mg 1 1410 Yes -20C 5C 79
T2545000 Trolamine 3 2250 mg 1 1577 Yes +5C 3C 79
Y0001184 Trolamine impurity A 2 250 mg 1 2-aminoethanol (ethanolamine) 1577 Yes +5C 3C 79
; Batch 1 is valid until 30 June 2016
Y0001183 Trolamine impurity B 3 1.5 mL 1 2,2-iminodiethanol (diethanolamine) 1577 Yes +5C 3C 79
; Batch 1 is valid until 31 August 2016
Council of Europe, all rights reserved 2017 86 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
T2550000 Trometamol 4 100 mg 1 Batch 3 is valid until 31 January 2017 1053 Yes +5C 3C 79
T2580000 Tropicamide 2 50 mg 1 1159,1197 Yes +5C 3C 79
Y0001247 Tropicamide impurity C 1 10 mg 1 (2RS)-3-hydroxy-2-phenylpropanoic acid (tropic acid) 1159 Yes +5C 3C 79
Y0001248 Tropicamide impurity D (Phenylacetic acid - * Drug 1 10 mg 1 Phenylacetic acid 1159 Yes +5C 3C 79
Precursor)
Y0001316 Tropicamide for peak identification 1 10 mg 1 1159 Yes +5C 3C 79
T2580300 Tropine 1 50 mg 1 1308, 2102 Yes +5C 3C 79
Y0000616 Tropisetron hydrochloride 1 40 mg 1 2102 Yes +5C 3C 79
Y0000618 Tropisetron impurity B 1 10 mg 1 1H-indole-3-carboxylic acid 2102 Yes +5C 3C 79
Y0000429 Trospium chloride 1 10 mg 1 1798 Yes +5C 3C 79
Y0000432 Trospium impurity A 1 20 mg 1 hydroxydiphenylacetic acid (benzilic acid) 1798 Yes +5C 3C 79
Y0000431 Trospium impurity B 2 20 mg 1 (1R,3r,5S)-8-azabicyclo[3.2.1]oct-3-yl hydroxydiphenylacetate 1798 Yes +5C 3C 79
Y0000430 Trospium impurity C 3 5 mg 1 (1R,3R,5S)-3-hydroxyspiro[8-azoniabicyclo[3.2.1]octane-8,1'-pyrrolidinium] 1798 Yes +5C 3C 79
Y0000497 Troxerutin 1 30 mg 1 2133 Yes +5C 3C 79
T2600000 Trypsin BRP 2 100 mg 1 See leaflet 0476,0579,0 Yes +5C 3C 79
580, 0694
T2610000 Tryptophan 2 100 mg 1 See leaflet ; Batch 1 is valid until 31 May 2016 1272, 2290 Yes +5C 3C 79
T2880000 Tylosin 2 150 mg 1 see leaflet 1273,1274,1 Yes +5C 3C 79
661, 20702
T2880100 Tylosin D 2 5 mg 1 1273,1274,1 Yes +5C 3C 79
661
T2880200 Tylosin tartrate - reference spectrum 1 n/a 1 1274 79
Y0000498 Tylosin phosphate for peak identification 1 10 mg 1 1273,1274,1 Yes +5C 3C 79
661
T2900000 Tyrosine 2 50 mg 1 1161, 1384 Yes +5C 3C 79
T3000000 Tyrothricin 2 20 mg 1 0907,1662 Yes +5C 3C 79
U0020000 Ubidecarenone 3 70 mg 1 See leaflet CHO ; Batch 2 is valid until 30 June 2016 1578 Yes +5C 3C 79
U0020008 Ubidecarenone impurity D 2 5 mg 1 5,6-dimethoxy-3-methyl-2-[(all-E)-3,7,11,15,19,23,27,31,35- 1578 Yes +5C 3C 79
nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaenyl]benzene-1,4-
dione (ubiquinone-9)
Y0001861 Uncaria stem with hooks dry extract for system suitability 1 10 mg 1 2729 Yes -20C 5C 79
U0020001 Ubidecarenone for system suitability 3 1 mg 1 1578 Yes +5C 3C 79
U0100000 Uracil arabinoside 2 60 mg 1 0760 Yes +5C 3C 79
U0600000 Urea 2 100 mg 1 0743 Yes +5C 3C 79
New U0800000 Ursodeoxycholic acid 3 100 mg 1 Batch 2 is valid until 30 June 2017 1189,1275 Yes +5C 3C 79
Y0001163 Ursodeoxycholic acid for system suitability 3 1.26 mg 1 Batch 2 is valid until 31 October 2016 1275 Yes +5C 3C 79
Y0001523 Ursolic acid 1 25 mg 1 See leaflet CHO 2439 Yes +5C 3C 79
Y0000834 Valaciclovir hydrochloride (anhydrous) 1 100 mg 1 See leaflet CHNOCl 1768,2751 Yes +5C 3C 79

Council of Europe, all rights reserved 2017 87 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0001096 Valaciclovir impurity D 1 10 mg 1 2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-ethyl-l-valinate 1768 Yes +5C 3C 79
Y0001097 Valaciclovir impurity E 1 10 mg 1 2-[(2-amino-6-oxo-1,6 dihydro-9H-purin-9-yl)methoxy]ethyl N-[(benzyloxy) 1768 Yes +5C 3C 79
carbonyl]-L-valinate
Y0001098 Valaciclovir impurity F para-toluenesulfonate 1 12 mg 1 2-hydroxyethyl L-valinate 1768 Yes +5C 3C 79
Y0001099 Valaciclovir impurity G 1 10 mg 1 N,N-dimethylpyridin-4-amine 1768,2751 Yes +5C 3C 79
Y0001662 Valaciclovir impurity P 1 5 mg 1 2,2-[methylenebis[imino(6-oxo-1,6-dihydro-9H-purine-9,2-diyl) 2751 Yes -20C 5C 79
methyleneoxy]]diethyl di(l-valinate)
Y0001655 Valaciclovir impurity S 1 15 mg 1 2751 Yes +5C 3C 79
Y0001225 Valaciclovir for system suitability 1 10 mg 1 1768,2751 Yes +5C 3C 79
Y0000583 Valerian dry extract 3 400 mg 1 See leaflet 0453,1898,1 Yes -20C 5C 79
899,2400,25
V0030000 Valine 1 50 mg 1 26
0796 Yes +5C 3C 79
Y0000584 Valnemulin hydrochloride 1 10 mg 1 2137 Yes +5C 3C 79
Y0000586 Valnemulin impurity E 1 10 mg 1 (3aS,4R,5S,6S,8R,9R,9aR,10R)-6-ethenyl-5-hydroxy-4,6,9,10-tetramethyl-1- 2137 Yes +5C 3C 79
oxodecahydro-3a,9-propano-3aH-cyclopenta[8]annulen-8-yl 2-hydroxyacetate
(pleuromulin)
Y0000585 Valnemulin for peak identification 1 10.25 mg 1 2137 Yes +5C 3C 79
Y0000533 Valnemulin hydrogen tartrate 1 120 mg 1 See leaflet CHNOS 2137 Yes +5C 3C 79
V0033000 Valproic acid 3 100 mg 1 1378 Yes +5C 3C 79
Y0001422 Valproic acid for system suitability 3 10 mg 1 Batch 2 is valid until 30 November 2016 0678,1378 Yes +5C 3C 79
Y0001132 Valsartan 1 15 mg 1 2423 Yes +5C 3C 79
Y0001131 Valsartan for peak identification 2 10 mg 1 2423 Yes +5C 3C 79
Y0001145 Valsartan for system suitability 2 0.202 mg 1 2423 Yes +5C 3C 79
V0045000 Vancomycin hydrochloride 3 100 mg 1 See leaflet 1058,20702 Yes -20C 5C 79
V0050000 Vanillin 2 100 mg 1 Batch 1 is valid until 30 November 2016 0747 Yes +5C 3C 79
Y0001648 Vardenafil for system suitability 1 10 mg 1 2782 Yes +5C 3C 79
Y0001647 Vardenafil hydrochloride 1 120 mg 1 See leaflet 2782 Yes +5C 3C 79
Y0001198 Varicella vaccine ( live) 1 420 mg 1 See leaflet 0648, 2442 Yes -20C 5C 90
Y0000561 Vecuronium bromide 1 10 mg 1 1769 Yes +5C 3C 79
Y0000625 Vecuronium for peak identification 1 10 mg 1 The reference standard Y0000625 will be deleted from the monograph 1769 Yes +5C 3C 79
07/2013:1769 on 2017/04/01. ; Batch 1 is valid until 31 March 2017
Y0001093 Vedaprofen 1 5 mg 1 2248 Yes +5C 3C 79
Y0001118 Vedaprofen impurity mixture 1 0.006 mg 1 2248 Yes +5C 3C 79
Y0000587 Venlafaxine hydrochloride 2 50 mg 1 2119 Yes +5C 3C 79
Y0000588 Venlafaxine for system suitability 3 1.002 mg 1 2119 Yes +5C 3C 79
V0100000 Verapamil hydrochloride 1 100 mg 1 0573 Yes +5C 3C 79
V0100018 Verapamil impurity I 3 5 mg 1 (2RS)-2-(3,4-dimethoxyphenyl)-2-[2-[[2-(3,4-dimethoxy-phenyl)ethyl] 0573 Yes +5C 3C 79
(methyl)amino]ethyl]-3-methylbutanenitrile
Council of Europe, all rights reserved 2017 88 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
V0100026 Verapamil impurity M 2 10 mg 1 5,5'-[[2-(3,4-dimethoxyphenyl)ethyl]imino]bis[2-(3,4-dimethoxyphenyl)-2-(1- 0573 Yes +5C 3C 79
methylethyl)pentanenitrile]
Y0000661 Verbenalin 1 11 mg 1 See leaflet CHO 1854 Yes +5C 3C 79
V0180000 VERO cells 1 1 ml 2 Cell lines (kidney, african green monkey, Cercopithecus aethiops) titration of 0213,0538,1 Yes Liquid nitrogen 100
live measles, mumps and rubella vaccines 057
Y0001400 Vigabatrin 1 10 mg 1 2305 Yes +5C 3C 79
Y0001401 Vigabatrin impurity A 1 25 mg 1 See leaflet CHNO; (5RS)-5-ethenylpyrrolidin-2-one 2305 Yes -20C 5C 79
Y0001402 Vigabatrin impurity B 1 20 mg 1 (2E)-2-(2-aminoethyl)but-2-enoic acid 2305 Yes +5C 3C 79
Y0001404 Vigabatrin impurity D 1 50 mg 1 4-aminobutanoic acid 2305 Yes +5C 3C 79
Y0001403 Vigabatrin impurity E 1 10 mg 1 2-[(2RS)-2-aminobut-3-enyl]propanedioic acid 2305 Yes +5C 3C 79
V0300000 Vinblastine sulfate 4 5.01 mg 1 See leaflet CHNOS 0748,0749 Yes -80C 10C 79
V0305000 Vinblastine sulfate - reference spectrum 1 n/a 1 0748 79
V0400000 Vincristine sulfate 5 4.96 mg 1 see leaflet 0748,0749 Yes -80C 10C 79
V0405000 Vincristine sulfate - reference spectrum 1 n/a 1 0749 79
V0500000 Vindesine sulfate 3 5 mg 1 See leaflet CHNOS 1276 Yes -80C 10C 79
V0500010 Vindesine sulfate - reference spectrum 1 n/a 1 1276 79
Y0000463 Vinorelbine tartrate 3 50 mg 1 2107 Yes -80C 10C 79
Y0000464 Vinorelbine impurity B 4 7 mg 1 methyl (3aR,4R,5S,5aR,10bR,13aR)-3a-ethyl-9-[(6R,8S)-4-ethyl-8- 2107 Yes -80C 10C 79
(methoxycarbonyl)1,3,6,7,8,9-hexahydro-2,6-methano-2H-azacyclodecino
[4,3-b]indol-8-yl]-4,5-dihydroxy-8-methoxy-6-methyl-3a,4,5,5a,6,11,12,13a-
octahydro-1Hindolizino[8,1-cd]carbazole-5-carboxylate
Y0000589 Vinpocetine 1 10 mg 1 2139 Yes +5C 3C 79
Y0000590 Vinpocetine impurity A 2 15 mg 1 ethyl (12S,13aS,13bS)-13a-ethyl-12-hydroxy-2,3,5,6,12,13,13a,13b- 2139 Yes +5C 3C 79
octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-
carboxylate (ethyl vincaminate)
; Batch 1 is valid until 31 January 2017
Y0000591 Vinpocetine impurity B 2 10 mg 1 methyl (13aS,13bS)-13a-ethyl-2,3,5,6,13a,13b-hexahydro-1H-indolo[3,2,1- 2139 Yes +5C 3C 79
de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate (apovincamine)
; Batch 1 is valid until 31 January 2017
Y0000790 Vinpocetine impurity C 2 15 mg 1 ethyl (13aS,13bS)-13a-ethyl-10-methoxy-2,3,5,6,13a,13b-hexahydro-1H- 2139 Yes +5C 3C 79
indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
(methoxyvinpocetine)
Y0000760 Vinpocetine impurity D 2 10 mg 1 ethyl (12RS,13aRS,13bRS)-13a-ethyl-2,3,5,6,12,13,13a,13b-octahydro-1H- 2139 Yes +5C 3C 79
indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
(dihydrovinpocetine)
; Batch 1 is valid until 28 February 2017
Y0000793 Vinyl acetate 1 200 mg 1 2152,2523 Yes +5C 3C 79
Y0001395 Voriconazole 2 120 mg 1 See leaflet CHFNO 2576 Yes +5C 3C 79
Y0001396 Voriconazole impurity B 2 10 mg 1 (2RS,3SR)-2-(2,4-difluorophenyl)-3-pyrimidin-4-yl-1-(1H-1,2,4-triazol-1-yl) 2576 Yes +5C 3C 79
butan-2-ol ; Batch 1 is valid until 31 December 2016

Council of Europe, all rights reserved 2017 89 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0001398 Voriconazole impurity D 2 10 mg 1 (2S,3R)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4- 2576 Yes +5C 3C 79
triazol-1-yl)butan-2-ol (voriconazole enantiomer)
; Batch 1 is valid until 31 March 2016
Y0001397 Voriconazole impurity E 1 50 mg 1 [(1R,4S)-7,7-dimethyl-2-oxobicyclo[2.2.1]hept-1-yl]methanesulfonic acid 2576 Yes +5C 3C 79
((+-)-camphorsulfonic acid)
W0100000 Warfarin sodium 2 10 mg 1 0698 Yes +5C 3C 79
Y0000778 Warfarin sodium clathrate 1 10 mg 1 0699 Yes +5C 3C 79
Y0001599 Wedelolactone 1 15 mg 1 See leaflet 2564 Yes -20C 5C 79
X0075000 Xylazine hydrochloride 1 125 mg 1 1481 Yes +5C 3C 79
Y0000158 Xylazine impurity C 3 50 mg 1 2,6-dimethylphenyl isothiocyanate ; Batch 2 is valid until 28 February 2017 1481 Yes +5C 3C 79
Y0001224 Xylazine impurity mixture 1 0.02 mg 1 1481 Yes +5C 3C 79
X0080000 Xylitol 2 500 mg 1 See leaflet 1381 Yes +5C 3C 79
X0100000 Xylometazoline hydrochloride 3 100 mg 1 0972,1162 Yes +5C 3C 79
New X0101000 Xylometazoline impurity A 3 15 mg 1 N-(2-aminoethyl)-2-[4-(1,1-dimethylethyl)-2,6-dimethylphenyl]acetamide 1162 Yes +5C 3C 79
; Batch 2 is valid until 30 June 2017
X0200000 Xylose 1 100 mg 1 1278 Yes +5C 3C 79
Y0000656 Yohimbine hydrochloride 1 20 mg 1 See leaflet CHClNO 2172 Yes +5C 3C 79
Y0001715 Zanamivir hydrate 1 5 mg 1 2611 Yes +5C 3C 79
Y0001703 Zanamivir impurity F 1 10 mg 1 see leaflet CHClN; 1H-pyrazole-1-carboximidamide 2611 Yes +5C 3C 79
Y0001702 Zanamivir for assay 1 50 mg 1 see leaflet CHNO 2611 Yes +5C 3C 79
Y0001708 Zanamivir for system suitability 1 10 mg 1 2611 Yes +5C 3C 79
Z1900000 Zidovudine 3 60 mg 1 see leaflet 1059 Yes +5C 3C 79
Z1904000 Zidovudine impurity B 3 5 mg 1 1-(3-chloro-2,3-dideoxy--d-erythro-pentofuranosyl)-5-methylpyrimidine-2,4 1059 Yes +5C 3C 79
(1H,3H)-dione
Y0001654 Zidovudine impurity D 1 15 mg 1 Triphenylmethanol 1059 Yes +5C 3C 79
Y0001641 Zidovudine for system suitability 1 10 mg 1 1059 Yes +5C 3C 79
Y0001807 Pregabalin impurity B 1 5 mg 1 (3R)-3-(aminomethyl)-5-methylhexanoic acid (pregabalin enantiomer) 2777 Yes +5C 3C 79
Z2000000 Zinc acexamate 1 50 mg 1 1279 Yes +5C 3C 79
Z2000010 Zinc acexamate impurity A 1 50 mg 1 6-[[6-(acetylamino)hexanoyl]amino]hexanoic acid 1279 Yes +5C 3C 79
Y0001286 Ziprasidone hydrochloride monohydrate 1 100 mg 1 see leaflet CHClNOS 2421,2649 Yes +5C 3C 79
Y0001626 Ziprasidone mesilate trihydrate 1 30 mg 1 2649 Yes +5C 3C 79
Y0001272 Ziprasidone for system suitability 1 1 10 mg 1 2421, 2649 Yes +5C 3C 79
Y0001241 Ziprasidone for system suitability 2 1 0.465 mg 1 2421, 2649 Yes +5C 3C 79
Z2500000 Zolpidem tartrate - * psy 3 200 mg 1 1280 Yes +5C 3C 79
Z2500010 Zolpidem impurity A 4 10 mg 1 N,N-dimethyl-2-[7-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl] 1280 Yes +5C 3C 79
acetamide
Z3000000 Zopiclone -* psy 2 40 mg 1 1060 Yes +5C 3C 79

Council of Europe, all rights reserved 2017 90 For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards Effective from 2017/2/5
Order Reference Standard Batch n Quantity Sale Information Monograph Leaflet Storage Price
Code per vial Unit
Y0001822 Zopiclone Impurity B 1 10 mg 1 (7RS)-6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b] 1060 Yes +5C 3C 79
pyrazin-5-one
Z3001000 Zopiclone oxide 3 20 mg 1 1060 Yes +5C 3C 79
Y0000062 Zuclopenthixol decanoate - reference spectrum 1 n/a 1 1707 79
Y0000083 Zuclopenthixol impurity B 1 10 mg 1 2-chloro-9H-thioxanthen-9-one 1707 Yes +5C 3C 79
Y0000534 Zuclopenthixol for system suitability 1 0.26 mg 1 1707 Yes +5C 3C 79
Y0001843 Triamcinolone Hexacetonide for system suitability 1 10 mg 1 0867 Yes +5C 3C 79

Council of Europe, all rights reserved 2017 91 For extra charges, please see supply terms and conditions.